BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389:1238-1252. [PMID: 27887750 DOI: 10.1016/s0140-6736(16)32064-5] [Cited by in Crossref: 928] [Cited by in F6Publishing: 1179] [Article Influence: 154.7] [Reference Citation Analysis]
Number Citing Articles
1 Umeres-francia GE, Rojas-fernández MV, Herrera-añazco P, Benites-zapata VA. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as risk factors for mortality in Peruvian adults with chronic kidney disease. Ren Replace Ther 2022;8. [DOI: 10.1186/s41100-022-00420-9] [Reference Citation Analysis]
2 Hua R, Liu X, Yuan E. Red blood cell distribution width at admission predicts outcome in critically ill patients with kidney failure: a retrospective cohort study based on the MIMIC-IV database. Ren Fail 2022;44:1182-91. [PMID: 35834358 DOI: 10.1080/0886022X.2022.2098766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Groth T, Stegmayr BG, Ash SR, Kuchinka J, Wieringa FP, Fissell WH, Roy S. Wearable and implantable artificial kidney devices for end-stage kidney disease treatment-Current status and review. Artif Organs 2022. [PMID: 36129158 DOI: 10.1111/aor.14396] [Reference Citation Analysis]
4 Tian Y, Chen XM, Liang XM, Wu XB, Yao CM. SGLT2 inhibitors attenuate nephrin loss and enhance TGF-β1 secretion in type 2 diabetes patients with albuminuria: a randomized clinical trial. Sci Rep 2022;12:15695. [PMID: 36127497 DOI: 10.1038/s41598-022-19988-7] [Reference Citation Analysis]
5 Zhang F, Bai Y, Zhao X, Huang L, Wang W, Zhou W, Zhang H. Therapeutic effects of exercise interventions for patients with chronic kidney disease: an umbrella review of systematic reviews and meta-analyses. BMJ Open 2022;12:e054887. [PMID: 36123085 DOI: 10.1136/bmjopen-2021-054887] [Reference Citation Analysis]
6 Chang Y, Ben Y, Li H, Xiong Y, Chen G, Hao J, Ma X, Gao X, Qiang P, Shimosawa T, Wang X, Yang F, Xu Q, Olatunji LA. Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-10. [DOI: 10.1155/2022/1283729] [Reference Citation Analysis]
7 Liu H, Shao X, Jiang X, Liu X, Bai P, Lin Y, Chen J, Hou F, Cui Z, Zhang Y, Lu C, Liu H, Zhou S, Yu P. Joint exposure to outdoor ambient air pollutants and incident chronic kidney disease: A prospective cohort study with 90,032 older adults. Front Public Health 2022;10:992353. [DOI: 10.3389/fpubh.2022.992353] [Reference Citation Analysis]
8 Dritsas E, Trigka M. Machine Learning Techniques for Chronic Kidney Disease Risk Prediction. BDCC 2022;6:98. [DOI: 10.3390/bdcc6030098] [Reference Citation Analysis]
9 Bejaoui W, Mahmoudi M, Charradi K, Abbes-belhadj M, Boukhalfa H, Ben-attia M, Limam F, Aouani E. Preventive and healing effect of high dosing grape seed flour on CKD patients of various stages and etiologies. Biomarkers. [DOI: 10.1080/1354750x.2022.2125580] [Reference Citation Analysis]
10 Liang H, Liu B, Gao Y, Nie J, Feng S, Yu W, Wen S, Su X. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis. Front Immunol 2022;13:978262. [DOI: 10.3389/fimmu.2022.978262] [Reference Citation Analysis]
11 Qiang P, Hao J, Yang F, Han Y, Chang Y, Xian Y, Xiong Y, Gao X, Liang L, Shimosawa T, Xu Q. Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone. Front Immunol 2022;13:948658. [DOI: 10.3389/fimmu.2022.948658] [Reference Citation Analysis]
12 Martins GKM, Pereira NC, Cunha NVD, Agostinetto L. Exposure of patients with chronic kidney disease on dialysis to pesticides. J Bras Nefrol 2022:S0101-28002022005045401. [PMID: 36074120 DOI: 10.1590/2175-8239-JBN-2022-0030en] [Reference Citation Analysis]
13 Xie SS, Dong ZH, He Y, Chen ZW, Yang Q, Ma WX, Li C, Chen Y, Wang JN, Yu JT, Xu CH, Ni WJ, Hou R, Suo XG, Wen JG, Jin J, Li J, Liu MM, Meng XM. Cpd-0225 attenuates renal fibrosis via inhibiting ALK5. Biochem Pharmacol 2022;204:115240. [PMID: 36070847 DOI: 10.1016/j.bcp.2022.115240] [Reference Citation Analysis]
14 Wen J, Jiao B, Tran M, Wang Y. Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis. Cells 2022;11:2762. [PMID: 36078170 DOI: 10.3390/cells11172762] [Reference Citation Analysis]
15 Martins GKDM, Pereira NC, Cunha NVD, Agostinetto L. Exposição de pacientes com doença renal crônica em tratamento dialítico aos agrotóxicos. Braz J Nephrol . [DOI: 10.1590/2175-8239-jbn-2022-0030pt] [Reference Citation Analysis]
16 Shi Q, Gao Z, Guo H, Zeng X, Sandanayake S, Vithanage M. Hydrogeochemical factors controlling the occurrence of chronic kidney disease of unknown etiology (CKDu). Environ Geochem Health 2022. [PMID: 36063240 DOI: 10.1007/s10653-022-01379-6] [Reference Citation Analysis]
17 Safi W, Marco A, Moya D, Prado P, Garreta E, Montserrat N. Assessing kidney development and disease using kidney organoids and CRISPR engineering. Front Cell Dev Biol 2022;10:948395. [DOI: 10.3389/fcell.2022.948395] [Reference Citation Analysis]
18 Sun H, Li X, Chen X, Xiong Y, Cao Y, Wang Z. Drp1 activates ROS/HIF-1α/EZH2 and triggers mitochondrial fragmentation to deteriorate hypercalcemia-associated neuronal injury in mouse model of chronic kidney disease. J Neuroinflammation 2022;19:213. [PMID: 36050772 DOI: 10.1186/s12974-022-02542-7] [Reference Citation Analysis]
19 Kolak E, Radić J, Vučković M, Bučan Nenadić D, Begović M, Radić M. Nutritional and Hydration Status and Adherence to Dietary Recommendations in Dalmatian Dialysis Patients. Nutrients 2022;14:3553. [DOI: 10.3390/nu14173553] [Reference Citation Analysis]
20 Wang Y, Yu F, Li A, He Z, Qu C, He C, Ma X, Zhan H. The progress and prospect of natural components in rhubarb (Rheum ribes L.) in the treatment of renal fibrosis. Front Pharmacol 2022;13:919967. [DOI: 10.3389/fphar.2022.919967] [Reference Citation Analysis]
21 Yao L, Zhao R, He S, Feng Q, Qiao Y, Wang P, Li J. Effects of salvianolic acid A and salvianolic acid B in renal interstitial fibrosis via PDGF-C/PDGFR-α signaling pathway. Phytomedicine 2022;106:154414. [PMID: 36057144 DOI: 10.1016/j.phymed.2022.154414] [Reference Citation Analysis]
22 Murtas S, Aquilani R, Fiori G, Maestri R, Iadarola P, Graccione C, Contu R, Deiana ML, Macis F, Secci R, Serra A, Cadeddu M, D’amato M, Putzu P, Marongiu M, Bolasco P. Effects of a Novel Amino Acid Formula on Nutritional and Metabolic Status, Anemia and Myocardial Function in Thrice-Weekly Hemodialysis Patients: Results of a Six-Month Randomized Double-Blind Placebo-Controlled Pilot Study. Nutrients 2022;14:3492. [DOI: 10.3390/nu14173492] [Reference Citation Analysis]
23 Wang Y, Wen Q, Jin L, Chen W. Artificial Intelligence-Assisted Renal Pathology: Advances and Prospects. J Clin Med 2022;11:4918. [PMID: 36013157 DOI: 10.3390/jcm11164918] [Reference Citation Analysis]
24 Zhang X, Fang Y, Zou Z, Hong P, Zhuo Y, Xu Y, Wan J, Sasso FC. Risk Factors for Progression of CKD with and without Diabetes. Journal of Diabetes Research 2022;2022:1-12. [DOI: 10.1155/2022/9613062] [Reference Citation Analysis]
25 Amraotkar AR, Bushau-Sprinkle AM, Keith RJ, Hamorsky KT, Palmer KE, Gao H, Rai SN, Bhatnagar A. Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination. Vaccines (Basel) 2022;10:1363. [PMID: 36016250 DOI: 10.3390/vaccines10081363] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Cao C, Zhang D, Liu W. Abnormal topological parameters in the default mode network in patients with impaired cognition undergoing maintenance hemodialysis. Front Neurol 2022;13:951302. [DOI: 10.3389/fneur.2022.951302] [Reference Citation Analysis]
27 Tanaka S, Zheng S, Kharel Y, Fritzemeier RG, Huang T, Foster D, Poudel N, Goggins E, Yamaoka Y, Rudnicka KP, Lipsey JE, Radel HV, Ryuh SM, Inoue T, Yao J, Rosin DL, Schwab SR, Santos WL, Lynch KR, Okusa MD. Sphingosine 1-phosphate signaling in perivascular cells enhances inflammation and fibrosis in the kidney. Sci Transl Med 2022;14:eabj2681. [PMID: 35976996 DOI: 10.1126/scitranslmed.abj2681] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Afolabi OB, Oloyede OI, Aluko BT, Johnson JA. Cytoprotective Effect of Biogenic Magnesium Hydroxide Nanoparticles Using Monodora myristica Aqueous Extract Against Oxidative Damage in Streptozotocin-Induced Diabetic Rats. BioNanoSci . [DOI: 10.1007/s12668-022-01025-6] [Reference Citation Analysis]
29 Sertsu A, Worku T, Fekadu G, Tura AK. Prevalence of chronic kidney disease and associated factors among patients visiting renal unit of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia: A cross-sectional study design. SAGE Open Med 2022;10:20503121221116942. [PMID: 35966210 DOI: 10.1177/20503121221116942] [Reference Citation Analysis]
30 Ram CVS. Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review. Cardiol Ther 2022. [PMID: 35969319 DOI: 10.1007/s40119-022-00276-4] [Reference Citation Analysis]
31 Zixin Y, Lulu C, Xiangchang Z, Qing F, Binjie Z, Chunyang L, Tai R, Dongsheng O. TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review. Front Pharmacol 2022;13:929262. [DOI: 10.3389/fphar.2022.929262] [Reference Citation Analysis]
32 Ahmed MM, Shafat Z, Tazyeen S, Ali R, Almashjary MN, Al-raddadi R, Harakeh S, Alam A, Haque S, Ishrat R. Identification of pathogenic genes associated with CKD: An integrated bioinformatics approach. Front Genet 2022;13:891055. [DOI: 10.3389/fgene.2022.891055] [Reference Citation Analysis]
33 Zhao J, Dai K, Xie J, Fang C, Chen N, Dai J, Xu D. Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report. Front Pharmacol 2022;13:927299. [DOI: 10.3389/fphar.2022.927299] [Reference Citation Analysis]
34 Dorotea D, Jiang S, Pak ES, Son JB, Choi HG, Ahn SM, Ha H. Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress. Exp Mol Med 2022. [PMID: 35918533 DOI: 10.1038/s12276-022-00810-3] [Reference Citation Analysis]
35 Rubio-Aliaga I, Krapf R. Phosphate intake, hyperphosphatemia, and kidney function. Pflugers Arch 2022;474:935-47. [PMID: 35511366 DOI: 10.1007/s00424-022-02691-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Khan MS, Shahid I, Butler J. Reporting and Definition of Kidney Death in Heart Failure Clinical Trials. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101382] [Reference Citation Analysis]
37 Nakano Y, Mandai S, Genma T, Akagi Y, Fujiki T, Ando F, Susa K, Mori T, Iimori S, Naito S, Sohara E, Uchida S, Fushimi K, Rai T. Nationwide mortality associated with perioperative acute dialysis requirement in major surgeries. International Journal of Surgery 2022. [DOI: 10.1016/j.ijsu.2022.106816] [Reference Citation Analysis]
38 Wang M, Peter SS, Chu CD, Tuot DS, Chen JH. Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression. JAMA Netw Open 2022;5:e2225797. [PMID: 35984661 DOI: 10.1001/jamanetworkopen.2022.25797] [Reference Citation Analysis]
39 Chen Y, Tu S, Chen Z, Xia J, Chen B, Chen J, Liang J, Liu X, Tang L, Kern AJM. Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome. Journal of Interventional Cardiology 2022;2022:1-9. [DOI: 10.1155/2022/6476777] [Reference Citation Analysis]
40 Hof A, Geißen S, Singgih K, Mollenhauer M, Winkels H, Benzing T, Baldus S, Hoyer FF. Myeloid leukocytes' diverse effects on cardiovascular and systemic inflammation in chronic kidney disease. Basic Res Cardiol 2022;117:38. [PMID: 35896846 DOI: 10.1007/s00395-022-00945-4] [Reference Citation Analysis]
41 Sakamoto Y, Shimada S, Kamiyama T, Sugiyama K, Asahi Y, Nagatsu A, Orimo T, Kakisaka T, Kamachi H, Ito YM, Taketomi A. Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection. World J Gastrointest Surg 2022; 14(7): 670-684 [DOI: 10.4240/wjgs.v14.i7.670] [Reference Citation Analysis]
42 Wei X, Hou Y, Long M, Jiang L, Du Y. Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis. Front Endocrinol 2022;13:927329. [DOI: 10.3389/fendo.2022.927329] [Reference Citation Analysis]
43 Zhu Y, Tang Y, He H, Hu P, Sun W, Jin M, Wang L, Xu X. Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia. Front Cell Infect Microbiol 2022;12:919352. [DOI: 10.3389/fcimb.2022.919352] [Reference Citation Analysis]
44 Paramasivam G, Rao IR, Samanth J, Nayak K, Nayak R, Martis SA, Jerome R, Nagaraju SP, Prabhu RA, Devasia T. A comparative analysis of conventional and speckle-tracking strain echocardiographic findings in diabetic and non-diabetic kidney disease patients with normal ejection fraction. Int J Cardiovasc Imaging. [DOI: 10.1007/s10554-022-02687-9] [Reference Citation Analysis]
45 Bian J, Liebert A, Bicknell B, Chen X, Huang C, Pollock CA. Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease. IJMS 2022;23:8043. [DOI: 10.3390/ijms23148043] [Reference Citation Analysis]
46 Araújo O, Hernández-rodríguez J, Pelegrín L, Feliu M, Boland M, Hernández-negrín H, Adán A, Espinosa G, Cervera R. Why lupus patients discontinue antimalarials in real life: A 50 years-experience from a reference centre. Lupus. [DOI: 10.1177/09612033221115618] [Reference Citation Analysis]
47 Chen C, Xie C, Xiong Y, Wu H, Wu L, Zhu J, Xing C, Mao H. Damage of uremic myocardium by p-cresyl sulfate and the ameliorative effect of Klotho by regulating SIRT6 ubiquitination. Toxicol Lett 2022;367:19-31. [PMID: 35839976 DOI: 10.1016/j.toxlet.2022.06.006] [Reference Citation Analysis]
48 Chtourou Y, Morjen M, Ammar R, Mhiri R, Jemaà M, Elbini-dhouib I, Fetoui H, Srairi-abid N, Marrakchi N, Jebali J. Investigation of the Renal Protective Effect of Combined Dietary Polyphenols in Streptozotocin-Induced Diabetic Aged Rats. Nutrients 2022;14:2867. [DOI: 10.3390/nu14142867] [Reference Citation Analysis]
49 Hamdy MM, Abdel-Rahman MS, Badary DM, Sabra MS. Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats. Eur J Med Res 2022;27:117. [PMID: 35820963 DOI: 10.1186/s40001-022-00747-3] [Reference Citation Analysis]
50 Han T, Cong H, Yu B, Shen Y. Application of peptide biomarkers in life analysis based on liquid chromatography-mass spectrometry technology. Biofactors 2022. [PMID: 35816279 DOI: 10.1002/biof.1875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Banimfreg BH, Alshraideh H, Shamayleh A, Guella A, Semreen MH, Al Bataineh MT, Soares NC. Untargeted Metabolomic Plasma Profiling of Emirati Dialysis Patients with Diabetes versus Non-Diabetic: A Pilot Study. Biomolecules 2022;12:962. [DOI: 10.3390/biom12070962] [Reference Citation Analysis]
52 Li S, Meng Q, Laba C, Guan H, Wang Z, Pan Y, Wei J, Xu H, Zeng C, Wang X, Jiang M, Lu R, Guo B, Zhao X. Associations between long-term exposure to ambient air pollution and renal function in Southwest China: The China Multi-Ethnic Cohort (CMEC) study. Ecotoxicol Environ Saf 2022;242:113851. [PMID: 35816844 DOI: 10.1016/j.ecoenv.2022.113851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther 2022;7:216. [PMID: 35794109 DOI: 10.1038/s41392-022-01073-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol 2022. [PMID: 35788561 DOI: 10.1038/s41581-022-00590-z] [Reference Citation Analysis]
55 Silva EO, Conde C, Machado DI, Ventura S, Couto SMF, Vattimo MFF. Effect of curcumin on acute chronic kidney disease due to ischemia-reperfusion syndrome. Rev Esc Enferm USP 2022;56:e20210440. [PMID: 35770890 DOI: 10.1590/1980-220X-REEUSP-2021-0440en] [Reference Citation Analysis]
56 Rodrigues AS, de Abreu LC, Morais MJD, Leitao FNC, do Amaral GLG, de Sousa Santos EF, do Souto RP. Temporal trend of mortality and hospitalization for chronic kidney disease in adults from Northern Brazil. Medicine (Baltimore) 2022;101:e29702. [PMID: 35777060 DOI: 10.1097/MD.0000000000029702] [Reference Citation Analysis]
57 Jam SA, Moloudpour B, Najafi F, Darbandi M, Pasdar Y. Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study. BMC Nephrol 2022;23:233. [PMID: 35778682 DOI: 10.1186/s12882-022-02858-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
58 Valdez Ortiz R, Escorza-valdivia S, Benitez-renteria S, Lopez-alvarenga JC, Pérez Navarro LM. Factors of Poor Prognosis Associated with Chronic Kidney Disease by Stage in Ambulatory Patients: A Cross-sectional Study. Archives of Medical Research 2022. [DOI: 10.1016/j.arcmed.2022.06.005] [Reference Citation Analysis]
59 Yang C, Wang W, Wang Y, Liang Z, Zhang F, Chen R, Liang C, Wang F, Li P, Ma L, Li S, Deng F, Zhang L. Ambient ozone pollution and prevalence of chronic kidney disease: A nationwide study based on the China National survey of chronic kidney disease. Chemosphere 2022. [DOI: 10.1016/j.chemosphere.2022.135603] [Reference Citation Analysis]
60 Masoudi-sobhanzadeh Y, Gholaminejad A, Gheisari Y, Roointan A. Discovering driver nodes in chronic kidney disease-related networks using Trader as a newly developed algorithm. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.105892] [Reference Citation Analysis]
61 Figueroa-garcía J, Granados-garcía V, Hernández-rivera JCH, Lagunes-cisneros M, Alvarado-gutiérrez T, Paniagua-sierra JR. Evolution of the stage of chronic kidney disease from the diagnosis of hypertension in primary care. Atención Primaria 2022;54:102364. [DOI: 10.1016/j.aprim.2022.102364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Jansson KP, Yu ASL, Stubbs JR. Contribution of phosphate and FGF23 to CKD progression. Curr Opin Nephrol Hypertens 2022;31:306-11. [PMID: 35283435 DOI: 10.1097/MNH.0000000000000793] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Pothuru S, Chan WC, Ranka S, Acharya P, Mehta H, Cannon C, Yarlagadda SG, Shah Z, Gupta K. Epidemiology and outcomes of hypertensive crisis in patients with chronic kidney disease: a nationwide analysis. J Hypertens 2022;40:1288-93. [PMID: 35703297 DOI: 10.1097/HJH.0000000000003136] [Reference Citation Analysis]
64 Suo XG, Wang F, Xu CH, He XY, Wang JN, Zhang Y, Ni WJ, Lu H, Ji ML, He Y, Xie SS, Yang YR, Wen JG, Jin J, Gong Q, Li J, Liu MM, Meng XM. Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosis. Eur J Pharmacol 2022;:175116. [PMID: 35780825 DOI: 10.1016/j.ejphar.2022.175116] [Reference Citation Analysis]
65 Zeng YQ, Yang YX, Guan CJ, Guo ZW, Li B, Yu HY, Chen RX, Tang YQ, Yan R. Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021. BMC Endocr Disord 2022;22:168. [PMID: 35773653 DOI: 10.1186/s12902-022-01082-8] [Reference Citation Analysis]
66 Liu F, Chen J, Luo C, Meng X. Pathogenic Role of MicroRNA Dysregulation in Podocytopathies. Front Physiol 2022;13:948094. [DOI: 10.3389/fphys.2022.948094] [Reference Citation Analysis]
67 Ren Y, Wang J, Guo W, Chen J, Wu X, Gu S, Xu L, Wu Z, Wang Y. Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway. Front Pharmacol 2022;13:830312. [PMID: 35754468 DOI: 10.3389/fphar.2022.830312] [Reference Citation Analysis]
68 Mulyanti B, Nugroho HS, Wulandari C, Rahmawati Y, Hasanah L, Hamidah I, Pawinanto RE, Majlis BY. SPR-Based Sensor for the Early Detection or Monitoring of Kidney Problems. Int J Biomater 2022;2022:9135172. [PMID: 35755268 DOI: 10.1155/2022/9135172] [Reference Citation Analysis]
69 Rzayeva L, Matyukhin I, Ritter O, Patschan S, Patschan D, Effa E. Health Care Quality in CKD Subjects: A Cross-Sectional In-Hospital Evaluation. International Journal of Nephrology 2022;2022:1-9. [DOI: 10.1155/2022/9432509] [Reference Citation Analysis]
70 Zhang F, Liao J, Zhang W, Huang L. Association Between Exercise Self-Efficacy and Health-Related Quality of Life Among Dialysis Patients: A Cross-Sectional Study. Front Psychol 2022;13:875803. [DOI: 10.3389/fpsyg.2022.875803] [Reference Citation Analysis]
71 Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA. Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients 2022;14:2528. [PMID: 35745257 DOI: 10.3390/nu14122528] [Reference Citation Analysis]
72 Chen CC, Wu CH, Lin CH, Chiu CC, Yang TY, Lei MH, Yeh HT, Jian W, Fang YA, Hao WR, Liu JC. Influenza Vaccination and Risk of Lung Cancer in Patients with Chronic Kidney Disease: A Nationwide, Population-Based Cohort Study. Cancers (Basel) 2022;14:2926. [PMID: 35740592 DOI: 10.3390/cancers14122926] [Reference Citation Analysis]
73 Masereeuw R. The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia. Toxins (Basel) 2022;14:402. [PMID: 35737063 DOI: 10.3390/toxins14060402] [Reference Citation Analysis]
74 Shen H, van der Kleij R, van der Boog PJM, Wang W, Song X, Li Z, Brakema E, Lou X, Chavannes N. Digital tools/eHealth to support CKD self-management: A qualitative study of perceptions, attitudes and needs of patients and health care professionals in China. Int J Med Inform 2022;165:104811. [PMID: 35753175 DOI: 10.1016/j.ijmedinf.2022.104811] [Reference Citation Analysis]
75 Dehghani A, Alishavandi S, Nourimajalan N, Fallahzadeh H, Rahmanian V. Prevalence of chronic kidney diseases and its determinants among Iranian adults: results of the first phase of Shahedieh cohort study. BMC Nephrol 2022;23:203. [PMID: 35681145 DOI: 10.1186/s12882-022-02832-5] [Reference Citation Analysis]
76 Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 2022;7:182. [PMID: 35680856 DOI: 10.1038/s41392-022-01036-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Nashwan AJ, Yassin MA, Abd‐alrazaq A, Shuweihdi F, Abdul Rahim HF, Shraim M. The prevalence of cardiac and hepatic iron overload in patients with kidney failure: A protocol for systematic review and meta‐analysis. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.692] [Reference Citation Analysis]
78 Migdalis IN, Ioannidis IM, Papanas N, Raptis AE, Sotiropoulos AE, Dimitriadis GD; on behalf of the Hellenic Diabetic Nephropathy Study (HDNS). Hypertriglyceridemia and Other Risk Factors of Chronic Kidney Disease in Type 2 Diabetes: A Hospital-Based Clinic Population in Greece. JCM 2022;11:3224. [DOI: 10.3390/jcm11113224] [Reference Citation Analysis]
79 Widowati W, Prahastuti S, Tjokropranoto R, Onggowidjaja P, Kusuma HSW, Afifah E, Arumwardana S, Maulana MA, Rizal R. Quercetin prevents chronic kidney disease on mesangial cells model by regulating inflammation, oxidative stress, and TGF-β1/SMADs pathway. PeerJ 2022;10:e13257. [DOI: 10.7717/peerj.13257] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Bandarian F, Esmaeili S, Nasli-Esfahani E, Arjmand B, Larijani B. Mapping research in diabetes complications; A scoping review. J Diabetes Metab Disord 2022;21:1171-6. [PMID: 35673473 DOI: 10.1007/s40200-022-01042-y] [Reference Citation Analysis]
81 Ghassabi A, Motavalli R, Iranzad R, Pourakbari R, Etemadi J, Dolati S, Yousefi M. Potential contribution of the immune system to the emergence of renal diseases. Immunology Letters 2022. [DOI: 10.1016/j.imlet.2022.06.003] [Reference Citation Analysis]
82 Zahan MS, Hasan A, Rahman MH, Meem KN, Moni A, Hannan MA, Uddin MJ. Protective effects of fucoidan against kidney diseases: Pharmacological insights and future perspectives. Int J Biol Macromol 2022;209:2119-29. [PMID: 35500767 DOI: 10.1016/j.ijbiomac.2022.04.192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Rydén A, Nolan S, Maher J, Meyers O, Kündig A, Bjursell M. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief. BMC Nephrol 2022;23:201. [PMID: 35641914 DOI: 10.1186/s12882-022-02826-3] [Reference Citation Analysis]
84 Waijer SW, Provenzano M, Mulder S, Rossing P, Persson F, Perkovic V, Heerspink HJL. Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology. Diabetes Obes Metab 2022;24:983-90. [PMID: 35112455 DOI: 10.1111/dom.14660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Raja A, Zelikoff JT, Jaimes EA. A contemporary review of nephrotoxicity and e-cigarette use. Current Opinion in Toxicology 2022. [DOI: 10.1016/j.cotox.2022.100361] [Reference Citation Analysis]
86 Mantri Y, Dorobek TR, Tsujimoto J, Penny WF, Garimella PS, Jokerst JV. Monitoring peripheral hemodynamic response to changes in blood pressure via photoacoustic imaging. Photoacoustics 2022;26:100345. [DOI: 10.1016/j.pacs.2022.100345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
87 Lázaro-martínez JL, García-madrid M, López-moral M, Tardáguila-garcía A, Álvaro-afonso FJ, García-álvarez Y. Clinical and Histological Outcomes of Negatively Charged Polystyrene Microspheres Applied Daily Versus Three Times per Week in Hard-to-Heal Diabetic Foot Ulcers: A Randomized Blinded Controlled Trial. The International Journal of Lower Extremity Wounds. [DOI: 10.1177/15347346221104946] [Reference Citation Analysis]
88 Li A, Zhao J, Mei Y, Zhou Q, Zhao M, Xu J, Ge X, Xu Q. Variability, Clearance, and Concentration of Multiple Metals and Risk of Kidney Function Abnormality: A New Integrative Metal Exposure Assessment Approach. Expo Health. [DOI: 10.1007/s12403-022-00484-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Wang R, Yuan W, Li L, Lu F, Zhang L, Gong H, Huang X. Resveratrol ameliorates muscle atrophy in chronic kidney disease via the axis of SIRT1/FoxO1. Phytother Res 2022. [PMID: 35606908 DOI: 10.1002/ptr.7499] [Reference Citation Analysis]
90 Li X, Yan R, Yue Z, Zhang M, Ren J, Wu B. Abnormal Dynamic Functional Connectivity in Patients With End-Stage Renal Disease. Front Neurosci 2022;16:852822. [DOI: 10.3389/fnins.2022.852822] [Reference Citation Analysis]
91 Cao H, Meng X. HDL and Kidney Diseases. Adv Exp Med Biol 2022;1377:163-70. [PMID: 35575929 DOI: 10.1007/978-981-19-1592-5_13] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Mendieta-condado E, Villaseñor-tapia EC, Gálvez-gastelum FJ, Yáñez-sánchez I, Pizano-martínez O, Canales-aguirre A, Márquez-aguirre AL, Petrica L. Effects of Etanercept on TNF-α Inhibition in Rats with Adenine-Induced Chronic Kidney Disease. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/4970753] [Reference Citation Analysis]
93 Velat I, Bušić Ž, Čulić V. Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease. Wien Klin Wochenschr 2022. [PMID: 35581380 DOI: 10.1007/s00508-022-02040-z] [Reference Citation Analysis]
94 Lightfoot CJ, Wilkinson TJ, Hadjiconstantinou M, Graham-brown M, Barratt J, Brough C, Burton JO, Hainsworth J, Johnson V, Martinez M, Nixon AC, Pursey V, Schreder S, Vadaszy N, Wilde L, Willingham F, Young HML, Yates T, Davies MJ, Smith AC. The co-development of ‘My Kidneys & Me’: a digital self-management programme for people with chronic kidney disease (Preprint). Journal of Medical Internet Research. [DOI: 10.2196/39657] [Reference Citation Analysis]
95 Wanner C, Schuchhardt J, Bauer C, Lindemann S, Brinker M, Kong SX, Kleinjung F, Horvat-Broecker A, Vaitsiakhovich T. Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database. J Nephrol 2022. [PMID: 35567698 DOI: 10.1007/s40620-022-01340-x] [Reference Citation Analysis]
96 Wang S, Zhao L, Liu H, Han R, Liu Y, Gao J, Bu R, Li B, Sun L, Hao J, Zhao J, Li G. Lanthanum hydroxide inhibits vascular calcification by regulating the HIF-1 pathway. Cell Biol Int 2022. [PMID: 35544947 DOI: 10.1002/cbin.11811] [Reference Citation Analysis]
97 Yan T, Yang S, Zhou X, Zhang C, Zhu X, Ma W, Tang S, Li J. Chronic kidney disease among greenhouse workers and field workers in China. Chemosphere 2022;302:134905. [PMID: 35561762 DOI: 10.1016/j.chemosphere.2022.134905] [Reference Citation Analysis]
98 Zhuang Y, Hu L, Wu Y, Yang C, Li S, Jing K, Liu H. Regulation of Mitochondrial Homeostasis and Nrf2 in Kidney Disease: Timing Is Critical. Oxid Med Cell Longev 2022;2022:9275056. [PMID: 35528519 DOI: 10.1155/2022/9275056] [Reference Citation Analysis]
99 Peng X, Wang X, Shao X, Wang Y, Feng S, Wang C, Ye C, Chen J, Jiang H. Serum Metabolomics Benefits Discrimination Kidney Disease Development in Type 2 Diabetes Patients. Front Med 2022;9:819311. [DOI: 10.3389/fmed.2022.819311] [Reference Citation Analysis]
100 Varga S, Gray DM. Naturalism, Disease, and Levels of Functional Description. The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine 2022. [DOI: 10.1093/jmp/jhac005] [Reference Citation Analysis]
101 Jin L, Yu B, Liu G, Nie W, Wang J, Chen J, Xiao L, Xia H, Han F, Yang Y. Mitophagy induced by UMI-77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis. FASEB J 2022;36:e22342. [PMID: 35524750 DOI: 10.1096/fj.202200199RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Ning Z, Chen S, Chen Z, Han H, Qiao H, Zhang N, Wang R, Shen R, Zhao X. Saturated multi-delay renal arterial spin labeling technique for simultaneous perfusion and T1 quantification in kidneys. Magn Reson Med 2022. [PMID: 35506512 DOI: 10.1002/mrm.29268] [Reference Citation Analysis]
103 Ilzkovitz M, Kayembe EE, Geers C, Pozdzik A. Kidney Stones, Proteinuria and Renal Tubular Metabolic Acidosis: What Is the Link? Healthcare 2022;10:836. [DOI: 10.3390/healthcare10050836] [Reference Citation Analysis]
104 Kanlaya R, Kapincharanon C, Fong-ngern K, Thongboonkerd V. Induction of mesenchymal-epithelial transition (MET) by epigallocatechin-3-gallate to reverse epithelial-mesenchymal transition (EMT) in SNAI1-overexpressed renal cells: A potential anti-fibrotic strategy. The Journal of Nutritional Biochemistry 2022. [DOI: 10.1016/j.jnutbio.2022.109066] [Reference Citation Analysis]
105 Fan LL, Du R, Liu JS, Jin JY, Wang CY, Dong Y, He WX, Yan RQ, Xiang R. Loss of RTN3 phenocopies chronic kidney disease and results in activation of the IGF2-JAK2 pathway in proximal tubular epithelial cells. Exp Mol Med 2022;54:653-61. [PMID: 35596061 DOI: 10.1038/s12276-022-00763-7] [Reference Citation Analysis]
106 Baralić M, Spasojević I, Miljuš G, Šunderić M, Robajac D, Dobrijević Z, Gligorijević N, Nedić O, Penezić A. Albumin at the intersection between antioxidant and pro-oxidant in patients on peritoneal dialysis. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.05.019] [Reference Citation Analysis]
107 Jiang S, Fuentes-lemus E, Davies MJ. Oxidant-mediated modification and cross-linking of beta-2-microglobulin. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.05.012] [Reference Citation Analysis]
108 Chaudhury D, Sen U, Sahoo BK, Bhat NN, Kumara K S, Karunakara N, Biswas S, Shenoy P S, Bose B. Thorium promotes lung, liver and kidney damage in BALB/c mouse via alterations in antioxidant systems. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109977] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Wang W, Chou M, Lee Y, Hsu W, Wang G. A simple electrochemical immunosensor based on a gold nanoparticle monolayer electrode for neutrophil gelatinase-associated lipocalin detection. Talanta 2022. [DOI: 10.1016/j.talanta.2022.123530] [Reference Citation Analysis]
110 García-maset R, Bover J, Segura de la Morena J, Goicoechea Diezhandino M, Cebollada del Hoyo J, Escalada San Martín J, Fácila Rubio L, Gamarra Ortiz J, García-donaire JA, García-matarín L, Gràcia Garcia S, Gutiérrez Pérez MI, Hernández Moreno J, Mazón Ramos P, Montañés Bermudez R, Muñoz Torres M, Pablos-velasco PD, Pérez-maraver M, Suárez Fernández C, Tranche Iparraguirre S, Górriz JL, García-maset R, Bover J, Segura J, Goicoechea M, Cebollada del Hoyo J, Escalada San Martín J, Fácila Rubio L, Gamarra Ortiz J, García-donaire JA, García-matarín L, Gràcia Garcia S, Isabel Gutiérrez Pérez M, Hernández Moreno J, Mazón Ramos P, Montañés Bermudez R, Muñoz Torres M, Pedro de Pablos-velasco, Pérez-maraver M, Suárez Fernández C, Tranche Iparraguirre S, Luis Górriz J. Documento de información y consenso para la detección y manejo de la enfermedad renal crónica. Nefrología 2022;42:233-64. [DOI: 10.1016/j.nefro.2021.07.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
111 Li M, Li L, Qin Y, Luo E, Wang D, Qiao Y, Tang C, Yan G. Elevated TyG Index Predicts Incidence of Contrast-Induced Nephropathy: A Retrospective Cohort Study in NSTE-ACS Patients Implanted With DESs. Front Endocrinol (Lausanne) 2022;13:817176. [PMID: 35273567 DOI: 10.3389/fendo.2022.817176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
112 Gu M, Ying P, Miao Z, Yu X, Bao R, Xiao J, Gao L, Chen J. Treatment of Modified Dahuang Fuzi Decoction on Cognitive Impairment Induced by Chronic Kidney Disease through Regulating AhR/NF-κB/JNK Signal Pathway. Evid Based Complement Alternat Med 2022;2022:8489699. [PMID: 35463092 DOI: 10.1155/2022/8489699] [Reference Citation Analysis]
113 Cheng HT, Huang HC, Lee TY, Liao YH, Sheng YH, Jin PR, Huang KW, Chen LH, Chen YT, Liu ZY, Lin TC, Wang HC, Chao CH, Juang IP, Su CT, Huang KH, Lin SL, Wang J, Sung YC, Chen Y. Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis. J Control Release 2022;346:169-79. [PMID: 35429575 DOI: 10.1016/j.jconrel.2022.04.004] [Reference Citation Analysis]
114 Kim J, Dorgan JF, Kim H, Kwon O, Kim Y, Kim Y, Ko KS, Park YJ, Park H, Jung S. Association between Use of Nutrition Labels and Risk of Chronic Kidney Disease: The Korean National Health and Nutrition Examination Survey (KNHANES) 2008-2019. Nutrients 2022;14:1731. [PMID: 35565698 DOI: 10.3390/nu14091731] [Reference Citation Analysis]
115 Thomas JM, Huuskes BM, Sobey CG, Drummond GR, Vinh A. The IL-18/IL-18R1 signalling axis: Diagnostic and therapeutic potential in hypertension and chronic kidney disease. Pharmacol Ther 2022;239:108191. [PMID: 35461924 DOI: 10.1016/j.pharmthera.2022.108191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
116 Wu M, Yang F, Huang D, Ye C. Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A. BMC Complement Med Ther 2022;22:110. [PMID: 35439976 DOI: 10.1186/s12906-022-03592-3] [Reference Citation Analysis]
117 Murzakhmetova A, Kemaykin V, Kuttymuratov A, Ainabay A, Meiramova A, Tursynbet Y, Ainabekova B. Evaluation of Kidneys’ Functional State in Acute Lymphoblastic Leukemia Patients Following Hematopoietic Stem Cell Transplantation. Open Access Maced J Med Sci 2022;10:937-43. [DOI: 10.3889/oamjms.2022.8847] [Reference Citation Analysis]
118 Wiznia DH, Nelson CL, Harrington M. Movement is Life - Optimizing Patient Access to Total Joint Arthroplasty: Chronic Kidney Disease Disparities. J Am Acad Orthop Surg 2022. [PMID: 35427242 DOI: 10.5435/JAAOS-D-21-00919] [Reference Citation Analysis]
119 Xiong Y, Zhang Y, Zhang F, Wu C, Luo P, Qin F, Yuan J. Genetic Evidence Supporting the Causal Role of Homocysteine in Chronic Kidney Disease: A Mendelian Randomization Study. Front Nutr 2022;9:843534. [DOI: 10.3389/fnut.2022.843534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Badawi A, Jefferson OC, Huuskes BM, Ricardo SD, Kerr PG, Samuel CS, Murthi P. A Novel Approach to Enhance the Regenerative Potential of Circulating Endothelial Progenitor Cells in Patients with End-Stage Kidney Disease. Biomedicines 2022;10:883. [DOI: 10.3390/biomedicines10040883] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Kwon J, Kim K, Jo Y, Jung M, Cho Y, Shin J, Lee Y, Ban J, Lee SY, Park J, Oh B. Artificial intelligence assessment for early detection and prediction of renal impairment using electrocardiography. Int Urol Nephrol. [DOI: 10.1007/s11255-022-03165-w] [Reference Citation Analysis]
122 Cao Q, Huang C, Chen XM, Pollock CA. Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease. Front Med (Lausanne) 2022;9:816656. [PMID: 35386912 DOI: 10.3389/fmed.2022.816656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Zhang F, Ye J, Bai Y, Wang H, Wang W. Exercise-Based Renal Rehabilitation: A Bibliometric Analysis From 1969 to 2021. Front Med (Lausanne) 2022;9:842919. [PMID: 35386913 DOI: 10.3389/fmed.2022.842919] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
124 Gryzinski GM, Bernie HL. Testosterone deficiency and the aging male. Int J Impot Res 2022. [PMID: 35393533 DOI: 10.1038/s41443-022-00555-7] [Reference Citation Analysis]
125 Cao YL, Lin JH, Hammes HP, Zhang C. Flavonoids in Treatment of Chronic Kidney Disease. Molecules 2022;27:2365. [PMID: 35408760 DOI: 10.3390/molecules27072365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Silveira ACMD, Sobrinho Á, Silva LDD, Costa EDB, Pinheiro ME, Perkusich A. Exploring Early Prediction of Chronic Kidney Disease Using Machine Learning Algorithms for Small and Imbalanced Datasets. Applied Sciences 2022;12:3673. [DOI: 10.3390/app12073673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Guerreiro Í, Ferreira-pêgo C, Carregosa D, Santos CN, Menezes R, Fernandes AS, Costa JG. Polyphenols and Their Metabolites in Renal Diseases: An Overview. Foods 2022;11:1060. [DOI: 10.3390/foods11071060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
128 Gordin D, Bjornstad P, van Raalte DH. Lipids in CKD: What do we actually know? Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.04.012] [Reference Citation Analysis]
129 Cao X, Lin Y, Yang B, Li Y, Zhou J. Comparison Between Statistical Model and Machine Learning Methods for Predicting the Risk of Renal Function Decline Using Routine Clinical Data in Health Screening. RMHP 2022;Volume 15:817-26. [DOI: 10.2147/rmhp.s346856] [Reference Citation Analysis]
130 Baptista BG, Ribeiro M, Cardozo LF, Leal VDO, Regis B, Mafra D. Nutritional benefits of ginger for patients with non-communicable diseases. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.04.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Fanton D'Andon C, Correia P, Rigaill J, Kably B, Perinel-Ragey S, Launay M. Ceftazidime dosing in obese patients: is it time for more? Expert Opin Drug Metab Toxicol 2022;18:277-84. [PMID: 35583387 DOI: 10.1080/17425255.2022.2080052] [Reference Citation Analysis]
132 Zhu P, Ma H, Cui S, Zhou X, Xu W, Yu J, Li J. ZLN005 Alleviates In Vivo and In Vitro Renal Fibrosis via PGC-1α-Mediated Mitochondrial Homeostasis. Pharmaceuticals 2022;15:434. [DOI: 10.3390/ph15040434] [Reference Citation Analysis]
133 Fan Z, Chen J, Yang Q, He J. Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Chongcaoyishen Decoction Against Chronic Kidney Disease. Front Mol Biosci 2022;9:847812. [DOI: 10.3389/fmolb.2022.847812] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Mizdrak M, Kumrić M, Kurir TT, Božić J. Emerging Biomarkers for Early Detection of Chronic Kidney Disease. JPM 2022;12:548. [DOI: 10.3390/jpm12040548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
135 Han X, Wang F, Wang J, He M. Cardiometabolic traits mediate the association of past shift work and chronic kidney disease: the Dongfeng-Tongji cohort study. Int Arch Occup Environ Health 2022. [PMID: 35357576 DOI: 10.1007/s00420-022-01854-8] [Reference Citation Analysis]
136 Rojas-franco P, Garcia-pliego E, Vite-aquino AG, Franco-colin M, Serrano-contreras JI, Paniagua-castro N, Gallardo-casas CA, Blas-valdivia V, Cano-europa E. The Nutraceutical Antihypertensive Action of C-Phycocyanin in Chronic Kidney Disease Is Related to the Prevention of Endothelial Dysfunction. Nutrients 2022;14:1464. [DOI: 10.3390/nu14071464] [Reference Citation Analysis]
137 Liu B, Denga J, Jie X, Lu F, Liu X, Zhang D. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition. J Ethnopharmacol 2022;:115242. [PMID: 35367329 DOI: 10.1016/j.jep.2022.115242] [Reference Citation Analysis]
138 Ko HL, Min HK, Lee SW. Risk of chronic kidney disease associated with orthostatic hypotensive stress: A community-based Korean study. Am J Hypertens 2022:hpac041. [PMID: 35353880 DOI: 10.1093/ajh/hpac041] [Reference Citation Analysis]
139 Rodríguez-zamora MC, Moreno-serrano AP, Cabrera-delgado AM, Regalado-ruiz LA, Amato-martínez JD. Vivencias del paciente ante el diagnóstico de enfermedad renal crónica y su ingreso a diálisis peritoneal. Enferm Nefrol 2022;25:59-65. [DOI: 10.37551/s2254-28842022007] [Reference Citation Analysis]
140 Zhang Y, Xiong Y, Shen S, Yang J, Wang W, Wu T, Chen L, Yu Q, Zuo H, Wang X, Lei X. Causal Association Between Tea Consumption and Kidney Function: A Mendelian Randomization Study. Front Nutr 2022;9:801591. [DOI: 10.3389/fnut.2022.801591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Zhou W, Chen MM, Liu HL, Si ZL, Wu WH, Jiang H, Wang LX, Vaziri ND, An XF, Su K, Chen C, Tan NH, Zhang ZH. Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho. Acta Pharmacol Sin 2022. [PMID: 35347248 DOI: 10.1038/s41401-022-00898-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Gollie JM, Patel SS, Harris-Love MO, Cohen SD, Blackman MR. Fatigability and the Role of Neuromuscular Impairments in Chronic Kidney Disease. Am J Nephrol 2022;53:253-63. [PMID: 35344954 DOI: 10.1159/000523714] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Yin T, Chen Y, Tang L, Yuan H, Zeng X, Fu P. Relationship between modifiable lifestyle factors and chronic kidney disease: a bibliometric analysis of top-cited publications from 2011 to 2020. BMC Nephrol 2022;23:120. [PMID: 35337272 DOI: 10.1186/s12882-022-02745-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Suh SH, Oh TR, Choi HS, Kim CS, Bae EH, Oh K, Choi KH, Oh YK, Ma SK, Kim SW. Association of Left Ventricular Diastolic Dysfunction With Cardiovascular Outcomes in Patients With Pre-dialysis Chronic Kidney Disease: Findings From KNOW-CKD Study. Front Cardiovasc Med 2022;9:844312. [DOI: 10.3389/fcvm.2022.844312] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Young HML, Ruddock N, Harrison M, Goodliffe S, Lightfoot CJ, Mayes J, Nixon AC, Greenwood SA, Conroy S, Singh SJ, Burton JO, Smith AC, Eborall H. The Impact of Falls: A Qualitative Study of the Experiences of People Receiving Haemodialysis. Int J Environ Res Public Health 2022;19:3873. [PMID: 35409557 DOI: 10.3390/ijerph19073873] [Reference Citation Analysis]
146 Yu X, Sun Q, Zhang Y, Zou L, Zhao Y. TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis. Front Pharmacol 2022;13:860588. [DOI: 10.3389/fphar.2022.860588] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
147 Li H, Wang Q, Ke J, Lin W, Luo Y, Yao J, Zhang W, Zhang L, Duan S, Dong Z, Chen X. Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China. Nutrients 2022;14:1334. [PMID: 35405947 DOI: 10.3390/nu14071334] [Reference Citation Analysis]
148 Chan KW, Chow TY, Yu KY, Feng Y, Lao L, Bian Z, Wong VT, Tang SC. Effectiveness of Integrative Chinese-Western Medicine for Chronic Kidney Disease and Diabetes: A Retrospective Cohort Study. Am J Chin Med 2022;50:371-88. [PMID: 35168474 DOI: 10.1142/S0192415X2250015X] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Galassi A, Fasulo EM, Ciceri P, Casazza R, Bonelli F, Zierold C, Calleri M, Blocki FA, Palmieri MA, Mastronardo C, Cozzolino MG. 1,25-dihydroxyvitamin D as Predictor of Renal Worsening Function in Chronic Kidney Disease. Results From the PASCaL-1,25D Study. Front Med (Lausanne) 2022;9:840801. [PMID: 35308556 DOI: 10.3389/fmed.2022.840801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Bawadi H, Al-Bayyari N, Tayyem R, Shi Z. Protein Intake Among Patients with Insulin-Treated Diabetes is Linked to Poor Glycemic Control: Findings of NHANES Data. Diabetes Metab Syndr Obes 2022;15:767-75. [PMID: 35300187 DOI: 10.2147/DMSO.S316953] [Reference Citation Analysis]
151 Irazabal MV, Chade AR, Eirin A. Renal mitochondrial injury in the pathogenesis of CKD: mtDNA and mitomiRs. Clin Sci (Lond) 2022;136:345-60. [PMID: 35260892 DOI: 10.1042/CS20210512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Huang Y, Xin W, Xiong J, Yao M, Zhang B, Zhao J. The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease. Front Pharmacol 2022;13:837500. [DOI: 10.3389/fphar.2022.837500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Shi J, Yang Y, Wang YN, Li Q, Xing X, Cheng AY, Zhan XN, Li J, Xu G, He F. Oxidative phosphorylation promotes vascular calcification in chronic kidney disease. Cell Death Dis 2022;13:229. [PMID: 35277475 DOI: 10.1038/s41419-022-04679-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
154 Shvartz V, Sokolskaya M, Petrosyan A, Ispiryan A, Donakanyan S, Bockeria L, Bockeria O. Predictors of Mortality Following Aortic Valve Replacement in Aortic Stenosis Patients. Pathophysiology 2022;29:106-17. [DOI: 10.3390/pathophysiology29010010] [Reference Citation Analysis]
155 Ouyang W, Chen H, Xu X, Zhang X, Fu L, Tang F, Wen Z, Marrone G, Liu L, Lin J, Liu X, Wu Y. Self-management program for patients with chronic kidney disease (SMP-CKD) in Southern China: protocol for an ambispective cohort study. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02700-2] [Reference Citation Analysis]
156 Liu M, Cardilla A, Ngeow J, Gong X, Xia Y. Studying Kidney Diseases Using Organoid Models. Front Cell Dev Biol 2022;10:845401. [DOI: 10.3389/fcell.2022.845401] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Pollock C, James G, Garcia Sanchez JJ, Arnold M, Carrero JJ, Lam CSP, Chen H, Nolan S, Pecoits-Filho R. Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort. Adv Ther 2022;39:1432-45. [PMID: 35112306 DOI: 10.1007/s12325-021-02010-3] [Reference Citation Analysis]
158 Tsai Y, Chen Y, Lin S, Chen Y, Chen C, Huang G. Lactobacillus rhamnosus GKLC1 ameliorates cisplatin-induced chronic nephrotoxicity by inhibiting cell inflammation and apoptosis. Biomedicine & Pharmacotherapy 2022;147:112701. [DOI: 10.1016/j.biopha.2022.112701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Tan Y, Wang Y, Feng H, Guo Z, Li X, Nie X, Zhao Y. Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.03.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
160 Mitrosz-Gołębiewska K, Rydzewska-Rosołowska A, Kakareko K, Zbroch E, Hryszko T. Water - A life-giving toxin - A nephrological oxymoron. Health consequences of water and sodium balance disorders. A review article. Adv Med Sci 2022;67:55-65. [PMID: 34979423 DOI: 10.1016/j.advms.2021.12.002] [Reference Citation Analysis]
161 Ji P, Zhu J, Feng J, Li H, Yu Q, Qin H, Wei L, Zhang J. Serum uric acid levels and diabetic kidney disease in patients with type 2 diabetes mellitus: A dose-response meta-analysis. Primary Care Diabetes 2022. [DOI: 10.1016/j.pcd.2022.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Campillo S, Bohorquez L, Gutiérrez-Calabrés E, García-Ayuso D, Miguel V, Griera M, Calle Y, de Frutos S, Rodríguez-Puyol M, Rodríguez-Puyol D, Calleros L. Indoxyl sulfate- and P-cresol-induced monocyte adhesion and migration is mediated by integrin-linked kinase-dependent podosome formation. Exp Mol Med 2022;54:226-38. [PMID: 35246616 DOI: 10.1038/s12276-022-00738-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Hong MS, Lee YH, Kong JM, Kwon OJ, Jung CW, Yang J, Kim MS, Han HW, Nam SM, Korean Organ Transplantation Registry Study Group. Personalized Prediction of Kidney Function Decline and Network Analysis of the Risk Factors after Kidney Transplantation Using Nationwide Cohort Data. J Clin Med 2022;11:1259. [PMID: 35268350 DOI: 10.3390/jcm11051259] [Reference Citation Analysis]
164 Flammia RS, Anceschi U, Tufano A, Tuderti G, Ferriero MC, Brassetti A, Mari A, Di Maida F, Minervini A, Derweesh IH, Capitanio U, Larcher A, Montorsi F, Eun DD, Lee J, Luciani LG, Cai T, Malossini G, Veccia A, Autorino R, Fiori C, Porpiglia F, Gallucci M, Leonardo C, Simone G. Is Hypertension Associated with Worse Renal Functional Outcomes after Minimally Invasive Partial Nephrectomy? Results from a Multi-Institutional Cohort. J Clin Med 2022;11:1243. [PMID: 35268334 DOI: 10.3390/jcm11051243] [Reference Citation Analysis]
165 Ma Y, Cai F, Huang X, Wang H, Yu B, Wang J, Nie W, Cai K, Yang Y, Chen J, Xiao L, Han F. Mannose-binding lectin activates the nuclear factor-κB and renal inflammation in the progression of diabetic nephropathy. FASEB J 2022;36:e22227. [PMID: 35195918 DOI: 10.1096/fj.202101852R] [Reference Citation Analysis]
166 Kang T, Hu Y, Huang X, Amoah AN, Lyu Q. Serum uric acid level and all-cause and cardiovascular mortality in peritoneal dialysis patients: A systematic review and dose-response meta-analysis of cohort studies. PLoS One 2022;17:e0264340. [PMID: 35192651 DOI: 10.1371/journal.pone.0264340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
167 Pillay Y, Nagiah S, Tiloke C, Phulukdaree A, Chuturgoon AA. miR-27b inhibition contributes to cytotoxicity in patulin-exposed HEK293 cells. Toxicon 2022;210:58-65. [PMID: 35217024 DOI: 10.1016/j.toxicon.2022.02.018] [Reference Citation Analysis]
168 Sharma S, Alexander KE, Green T, Wu MW, Bonner A. Energy conservation education intervention for people with end-stage kidney disease receiving haemodialysis (EVEREST): protocol for a cluster randomised control trial. BMJ Open 2022;12:e056544. [PMID: 35190440 DOI: 10.1136/bmjopen-2021-056544] [Reference Citation Analysis]
169 Vial R, Poitevin S, McKay N, Burtey S, Cerini C. Tryptophan Metabolites Regulate Neuropentraxin 1 Expression in Endothelial Cells. Int J Mol Sci 2022;23:2369. [PMID: 35216489 DOI: 10.3390/ijms23042369] [Reference Citation Analysis]
170 Zhang L, Zhang T, Li Y, Xiong W. Shenqi Yanshen Formula (SQYSF) protects against chronic kidney disease by modulating gut microbiota. Bioengineered 2022;13:5625-37. [DOI: 10.1080/21655979.2021.2023789] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Bučan Nenadić D, Radić J, Kolak E, Vučković M, Novak I, Selak M, Radić M. Mediterranean Diet Adherence and Nutritional Status in Dalmatian Diabetic Hypertensive Patients Regarding Presence of Chronic Kidney Disease—Is There Any Difference? IJERPH 2022;19:2293. [DOI: 10.3390/ijerph19042293] [Reference Citation Analysis]
172 Li N, Zhou G, Zheng Y, Lv D, Zhu X, Wei P, Zheng M, Liu S, Zhou E, Sun W, Zhang L. Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis. PLoS One 2022;17:e0261986. [PMID: 35020750 DOI: 10.1371/journal.pone.0261986] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
173 Tang PW, Wu P, Lin Y, Chiu C, Cheng T, Guan W, Lin HY, Lee K, Chen Y, Chiu C, Liu W. Zebrafish Model-Based Assessment of Indoxyl Sulfate-Induced Oxidative Stress and Its Impact on Renal and Cardiac Development. Antioxidants 2022;11:400. [DOI: 10.3390/antiox11020400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
174 Kulesza T, Typiak M, Rachubik P, Audzeyenka I, Rogacka D, Angielski S, Saleem MA, Piwkowska A. Hyperglycemic environment disrupts phosphate transporter function and promotes calcification processes in podocytes and isolated glomeruli. J Cell Physiol 2022. [PMID: 35150131 DOI: 10.1002/jcp.30700] [Reference Citation Analysis]
175 Aparicio-trejo OE, Aranda-rivera AK, Osorio-alonso H, Martínez-klimova E, Sánchez-lozada LG, Pedraza-chaverri J, Tapia E. Extracellular Vesicles in Redox Signaling and Metabolic Regulation in Chronic Kidney Disease. Antioxidants 2022;11:356. [DOI: 10.3390/antiox11020356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
176 Liang M, Zhang D, Zheng D, He W, Jin J. Exosomes from miR-374a-5p-modified mesenchymal stem cells inhibit the progression of renal fibrosis by regulating MAPK6/MK5/YAP axis. Bioengineered 2022;13:4517-27. [PMID: 35137672 DOI: 10.1080/21655979.2022.2033465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Tóth A, Csiki DM, Nagy B, Balogh E, Lente G, Ababneh H, Szöőr Á, Jeney V. Daprodustat Accelerates High Phosphate-Induced Calcification Through the Activation of HIF-1 Signaling. Front Pharmacol 2022;13:798053. [DOI: 10.3389/fphar.2022.798053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Zhang Z, Chen L, Tian H, Liu M, Jiang S, Shen J, Wang K, Cao Z. Discovery of pyridazinone analogs as potent transient receptor potential canonical channel 5 inhibitors. Bioorg Med Chem Lett 2022;:128612. [PMID: 35143983 DOI: 10.1016/j.bmcl.2022.128612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
179 Gao C, Zhang Q, Yang Y, Li Y, Lin W. Recent trends in therapeutic application of engineered blood purification materials for kidney disease. Biomater Res 2022;26:5. [PMID: 35120554 DOI: 10.1186/s40824-022-00250-0] [Reference Citation Analysis]
180 Bhagat N, Dawman L, Naganur S, Tiewsoh K, Kumar B, Pratyusha K, Sharawat IK, Gupta KL. Impact of anemia on the cardiovascular status in children with chronic kidney disease: A pilot study. Clinical Nutrition ESPEN 2022;47:283-7. [DOI: 10.1016/j.clnesp.2021.11.031] [Reference Citation Analysis]
181 Sonoda K, Harada M, Aomura D, Hara Y, Yamada Y, Yamaguchi A, Hashimoto K, Kamijo Y. Relationship between glomerular number in fresh kidney biopsy samples and light microscopy samples. Clin Exp Nephrol 2022. [PMID: 35103876 DOI: 10.1007/s10157-022-02179-z] [Reference Citation Analysis]
182 Jiang Y, Luo Y, Li J, Jiang Y, Zhao J, Gu S, Li P, Zhang L, Yin P, Lyu H, Tang P. Chronic kidney disease and risk of postoperative cardiovascular events in elderly patients receiving hip fracture surgery. Injury 2022;53:596-602. [PMID: 34974909 DOI: 10.1016/j.injury.2021.12.032] [Reference Citation Analysis]
183 Valim A, Carpes LS, Nicoletto BB. Effect of vegetarian diets on renal function in patients with chronic kidney disease under non-dialysis treatment: A scoping review. Braz J Nephrol . [DOI: 10.1590/2175-8239-jbn-2021-0126] [Reference Citation Analysis]
184 Su C, Wang T, Wang P, Lu X, Tang W. The estimation of protein equivalents of total nitrogen in Chinese CAPD patients: an explanatory study. Ren Fail 2022;44:14-22. [PMID: 35086422 DOI: 10.1080/0886022X.2021.2014886] [Reference Citation Analysis]
185 Guarneri M, Scola L, Giarratana RM, Bova M, Carollo C, Vaccarino L, Calandra L, Lio D, Balistreri CR, Cottone S. MIF rs755622 and IL6 rs1800795 Are Implied in Genetic Susceptibility to End-Stage Renal Disease (ESRD). Genes (Basel) 2022;13:226. [PMID: 35205271 DOI: 10.3390/genes13020226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
186 Ahmed MM, Tazyeen S, Haque S, Sulimani A, Ali R, Sajad M, Alam A, Ali S, Bagabir HA, Bagabir RA, Ishrat R. Network-Based Approach and IVI Methodologies, a Combined Data Investigation Identified Probable Key Genes in Cardiovascular Disease and Chronic Kidney Disease. Front Cardiovasc Med 2021;8:755321. [PMID: 35071341 DOI: 10.3389/fcvm.2021.755321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 He Y, Xue X, Terkeltaub R, Dalbeth N, Merriman TR, Mount DB, Feng Z, Li X, Cui L, Liu Z, Xu Y, Chen Y, Li H, Ji A, Ji X, Wang X, Lu J, Li C. Association of acidic urine pH with impaired renal function in primary gout patients: a Chinese population-based cross-sectional study. Arthritis Res Ther 2022;24. [DOI: 10.1186/s13075-022-02725-w] [Reference Citation Analysis]
188 Wada H, Shinozaki T, Suzuki M, Sakagami S, Ajiro Y, Funada J, Matsuda M, Shimizu M, Takenaka T, Morita Y, Yonezawa K, Matsubara H, Ono Y, Nakamura T, Fujimoto K, Ninomiya A, Kato T, Unoki T, Takagi D, Wada K, Wada M, Iguchi M, Yamakage H, Kusakabe T, Yasoda A, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; EXCEED‐J Study Investigators. Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study. J Am Heart Assoc 2022;11:e023464. [PMID: 35048713 DOI: 10.1161/JAHA.121.023464] [Reference Citation Analysis]
189 Allen A, Iqbal Z, Green-Saxena A, Hurtado M, Hoffman J, Mao Q, Das R. Prediction of diabetic kidney disease with machine learning algorithms, upon the initial diagnosis of type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2022;10:e002560. [PMID: 35046014 DOI: 10.1136/bmjdrc-2021-002560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
190 Gong P, Wang P, Pi S, Guo Y, Pei S, Yang W, Chang X, Wang L, Chen F. Proanthocyanidins Protect Against Cadmium-Induced Diabetic Nephropathy Through p38 MAPK and Keap1/Nrf2 Signaling Pathways. Front Pharmacol 2021;12:801048. [PMID: 35046823 DOI: 10.3389/fphar.2021.801048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
191 Long M, Zhu X, Wei X, Zhao D, Jiang L, Li C, Jin D, Miao C, Du Y. Magnesium in renal fibrosis. Int Urol Nephrol. [DOI: 10.1007/s11255-022-03118-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Anvarifard P, Anbari M, Ostadrahimi A, Ardalan M, Ghoreishi Z. A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review. Nutr Metab (Lond) 2022;19:6. [PMID: 35057819 DOI: 10.1186/s12986-021-00639-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Guo D, Li G, Miao J, Shen Y. A smartphone-based calibration-free portable urinalysis device. J Cent South Univ 2021;28:3829-37. [DOI: 10.1007/s11771-021-4883-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Stavas J, Gerber D, Coca SG, Silva AL, Johns A, Jain D, Bertram T, Díaz-González de Ferris M, Bakris G. Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design. Am J Nephrol 2022;53:50-8. [PMID: 35034024 DOI: 10.1159/000520231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
195 Dun R, Lan T, Tsai J, Mao J, Shao Y, Hu X, Zhu W, Qi G, Peng Y. Protective Effect of Melatonin for Renal Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis. Front Physiol 2022;12:791036. [DOI: 10.3389/fphys.2021.791036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Berglund S, Andreasson A, Rawshani A, Hirlekar G, Lundgren P, Angerås O, Mandalenakis Z, Redfors B, Holm A, Hagberg E, Ricksten SE, Friberg H, Gustafsson L, Dworeck C, Herlitz J, Rawshani A. Cardiorenal Function and Survival in In-Hospital Cardiac Arrest: A Nationwide Study of 22,819 Cases. Resuscitation 2022:S0300-9572(21)00545-1. [PMID: 35031390 DOI: 10.1016/j.resuscitation.2021.12.037] [Reference Citation Analysis]
197 Luo LP, Suo P, Ren LL, Liu HJ, Zhang Y, Zhao YY. Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways. Front Pharmacol 2021;12:800522. [PMID: 35002735 DOI: 10.3389/fphar.2021.800522] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
198 Mahallawi WH, Ibrahim NA, Mumena WA. Effectiveness of COVID-19 Vaccines in Patients Under Maintenance Hemodialysis. Risk Manag Healthc Policy 2021;14:5081-8. [PMID: 35002344 DOI: 10.2147/RMHP.S345686] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Niquini RP, Corrêa da Mota J, Bastos LS, da Costa Moreira Barbosa D, Falcão JDS, Palmieri P, Martins P, Melo Villar L, Bastos FI. Persistently high hepatitis C rates in haemodialysis patients in Brazil [a systematic review and meta-analysis]. Sci Rep 2022;12:330. [PMID: 35013390 DOI: 10.1038/s41598-021-03961-x] [Reference Citation Analysis]
200 Zhang X, Li X. Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential. Metabolites 2022;12:58. [PMID: 35050181 DOI: 10.3390/metabo12010058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
201 Geng T, Li X, Ma H, Heianza Y, Qi L. Adherence to a Healthy Sleep Pattern and Risk of Chronic Kidney Disease: The UK Biobank Study. Mayo Clin Proc 2022;97:68-77. [PMID: 34996567 DOI: 10.1016/j.mayocp.2021.08.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
202 Apel C, Hornig C, Maddux FW, Ketchersid T, Yeung J, Guinsburg A. Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability. Clin Kidney J 2021;14:i98-i113. [PMID: 34987789 DOI: 10.1093/ckj/sfab193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Podadera-Herreros A, Alcala-Diaz JF, Gutierrez-Mariscal FM, Jimenez-Torres J, Cruz-Ares S, Arenas-de Larriva AP, Cardelo MP, Torres-Peña JD, Luque RM, Ordovas JM, Delgado-Lista J, Lopez-Miranda J, Yubero-Serrano EM. Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial. Clin Nutr 2022;41:552-9. [PMID: 35030530 DOI: 10.1016/j.clnu.2021.12.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
204 Singh-Manoux A, Oumarou-Ibrahim A, Machado-Fragua MD, Dumurgier J, Brunner EJ, Kivimaki M, Fayosse A, Sabia S. Association between kidney function and incidence of dementia: 10-year follow-up of the Whitehall II cohort study. Age Ageing 2022;51:afab259. [PMID: 35061870 DOI: 10.1093/ageing/afab259] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
205 Gorisse L, Jaisson S, Piétrement C, Gillery P. Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers? Int J Mol Sci 2022;23:574. [PMID: 35008998 DOI: 10.3390/ijms23010574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Liu Y, Dong ZJ, Song JW, Liang LR, Sun LL, Liu XY, Miao R, Xu YL, Li XT, Zhang MW, Zhang ZZ, Zhong JC. MicroRNA-122-5p promotes renal fibrosis and injury in spontaneously hypertensive rats by targeting FOXO3. Exp Cell Res 2022;411:113017. [PMID: 34998813 DOI: 10.1016/j.yexcr.2022.113017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
207 Sahathevan S, Karupaiah T, Khor BH, Sadu Singh BK, Mat Daud ZA, Fiaccadori E, Sabatino A, Chinna K, Abdul Gafor AH, Bavanandan S, Visvanathan R, Yahya R, Wahab Z, Goh BL, Morad Z, Bee BC, Wong HS. Muscle Status Response to Oral Nutritional Supplementation in Hemodialysis Patients With Protein Energy Wasting: A Multi-Center Randomized, Open Label-Controlled Trial. Front Nutr 2021;8:743324. [PMID: 34977109 DOI: 10.3389/fnut.2021.743324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
208 Gomes MB, Conte D, Drummond KRG, Mallmann F, Pinheiro AA, Leal FSL, Morales PH, Negrato CA. Overweight/obesity in adolescents with type 1 diabetes belonging to an admixed population. A Brazilian multicenter study. Diabetol Metab Syndr 2022;14:1. [PMID: 34983637 DOI: 10.1186/s13098-021-00759-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
209 Khan MA, Kassianos AJ, Hoy WE, Alam AK, Healy HG, Gobe GC. Promoting Plant-Based Therapies for Chronic Kidney Disease. J Evid Based Integr Med 2022;27:2515690X221079688. [PMID: 35243916 DOI: 10.1177/2515690X221079688] [Reference Citation Analysis]
210 Silva EDO, Conde C, Machado DI, Ventura S, Couto SMF, Vattimo MDFF. Efeito da curcumina na doença renal crônica agudizada pela síndrome isquemia-reperfusão. Rev esc enferm USP 2022;56:e20210440. [DOI: 10.1590/1980-220x-reeusp-2021-0440pt] [Reference Citation Analysis]
211 Costa CFFA, Merino-Ribas A, Ferreira C, Campos C, Silva N, Pereira L, Garcia A, Azevedo Á, Mesquita RBR, Rangel AOSS, Manaia CM, Sampaio-Maia B. Characterization of Oral Enterobacteriaceae Prevalence and Resistance Profile in Chronic Kidney Disease Patients Undergoing Peritoneal Dialysis. Front Microbiol 2021;12:736685. [PMID: 34970231 DOI: 10.3389/fmicb.2021.736685] [Reference Citation Analysis]
212 Rahman MA, Shanjana Y, Ahmed MS, Dhama K, Hasan Fahim M, Mahmud T, Shuvo AA, Milan ZH, Rahman MS, Roy A, Bhuiyan MA, Islam MR. Hematological Abnormalities and Comorbidities Are Associated With the Severity of Kidney Disease: A Hospital-Based Cross-Sectional Study in Bangladesh. Clin Pathol 2022;15:2632010X221114807. [PMID: 35898700 DOI: 10.1177/2632010X221114807] [Reference Citation Analysis]
213 Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut 2022;71:156-62. [PMID: 33303564 DOI: 10.1136/gutjnl-2020-323082] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 43.0] [Reference Citation Analysis]
214 Sheer R, Nair R, Pasquale MK, Evers T, Cockrell M, Gay A, Singh R, Schmedt N. Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes. J Prim Care Community Health 2022;13:21501319211063726. [PMID: 35068244 DOI: 10.1177/21501319211063726] [Reference Citation Analysis]
215 Jiang Y, Gao Q, Liu Y, Gao B, Che Y, Lin L, Jiang J, Chang P, Song Q, Wang W, Wang N, Miao Y. Reduced White Matter Integrity in Patients With End-Stage and Non-end-Stage Chronic Kidney Disease: A Tract-Based Spatial Statistics Study. Front Hum Neurosci 2021;15:774236. [PMID: 34955791 DOI: 10.3389/fnhum.2021.774236] [Reference Citation Analysis]
216 Chen S, Chen J, Li S, Guo F, Li A, Wu H, Chen J, Pan Q, Liao S, Liu HF, Pan Q. High-Fat Diet-Induced Renal Proximal Tubular Inflammatory Injury: Emerging Risk Factor of Chronic Kidney Disease. Front Physiol 2021;12:786599. [PMID: 34950058 DOI: 10.3389/fphys.2021.786599] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
217 Day BA, Wilmer CE. Computational Design of MOF-Based Electronic Noses for Dilute Gas Species Detection: Application to Kidney Disease Detection. ACS Sens 2021;6:4425-34. [PMID: 34855364 DOI: 10.1021/acssensors.1c01808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Mrug M, Bloom MS, Seto C, Malhotra M, Tabriziani H, Gauthier P, Sidlow V, McKanna T, Billings PR. Genetic Testing for Chronic Kidney Diseases: Clinical Utility and Barriers Perceived by Nephrologists. Kidney Med 2021;3:1050-6. [PMID: 34939014 DOI: 10.1016/j.xkme.2021.08.006] [Reference Citation Analysis]
219 Ke G, Xie Z, Xiao J, Zhang Y, Hu Y, Li B, Jiang N, Chen X, Liu S, Shi W. Comparison of 6 equations for estimating glomerular filtration rate in a Chinese benign hypertensive nephrosclerosis population. Medicine (Baltimore) 2021;100:e28318. [PMID: 34941129 DOI: 10.1097/MD.0000000000028318] [Reference Citation Analysis]
220 Kawamura M, Hesaka A, Taniguchi A, Nakazawa S, Abe T, Hirata M, Sakate R, Horio M, Takahara S, Nonomura N, Isaka Y, Imamura R, Kimura T. Measurement of glomerular filtration rate using endogenous d-serine clearance in living kidney transplant donors and recipients. EClinicalMedicine 2022;43:101223. [PMID: 34934934 DOI: 10.1016/j.eclinm.2021.101223] [Reference Citation Analysis]
221 Liang P, Li S, Xu C, Li J, Tan F, Hu D, Kamel I, Li Z. Assessment of renal function using magnetic resonance quantitative histogram analysis based on spatial labeling with multiple inversion pulses. Ann Transl Med 2021;9:1614. [PMID: 34926658 DOI: 10.21037/atm-21-2299] [Reference Citation Analysis]
222 Wang HY, Meng Q, Yang C, Wang Y, Kong G, Zhao Y, Wang F, Zhang L. Association between pulse pressure, systolic blood pressure and the risk of rapid decline of kidney function among general population without hypertension: results from the China health and retirement longitudinal study (CHARLS). J Transl Med 2021;19:512. [PMID: 34930335 DOI: 10.1186/s12967-021-03176-8] [Reference Citation Analysis]
223 Akter T, Rahman MA, Moni A, Apu MAI, Fariha A, Hannan MA, Uddin MJ. Prospects for Protective Potential of Moringa oleifera against Kidney Diseases. Plants (Basel) 2021;10:2818. [PMID: 34961289 DOI: 10.3390/plants10122818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
224 Gunduz N, Buz A, Kabaalioglu A. Does Early Diabetic Kidney Damage Alter Renal Elasticity? An Ultrasound-Based, Two-Dimensional Shear Wave Elastography Study. Medeni Med J 2021;36:209-16. [PMID: 34915678 DOI: 10.5222/MMJ.2021.65021] [Reference Citation Analysis]
225 Sandokji I, Greenberg JH. Plasma and Urine Biomarkers of CKD: A Review of Findings in the CKiD Study. Semin Nephrol 2021;41:416-26. [PMID: 34916002 DOI: 10.1016/j.semnephrol.2021.09.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
226 Zhang F, Liao J, Zhang W, Wang H, Huang L, Shen Q, Zhang H. Effects of Baduanjin Exercise on Physical Function and Health-Related Quality of Life in Peritoneal Dialysis Patients: A Randomized Trial. Front Med (Lausanne) 2021;8:789521. [PMID: 34912835 DOI: 10.3389/fmed.2021.789521] [Reference Citation Analysis]
227 Wang P, Li Q, Guo X, Zhou Y, Li Z, Yang H, Yu S, Sun G, Zheng L, Sun Y, Zhang X. Usefulness of metabolic score for insulin resistance index in estimating the risk of mildly reduced estimate glomerular filtration rate: a cross-sectional study of rural population in China. BMJ Open 2021;11:e050907. [PMID: 34916312 DOI: 10.1136/bmjopen-2021-050907] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
228 Zhou TT, Hu B, Meng XL, Sun L, Li HB, Xu PR, Cheng BJ, Sheng J, Tao FB, Yang LS, Wu QS. The associations between urinary metals and metal mixtures and kidney function in Chinese community-dwelling older adults with diabetes mellitus. Ecotoxicol Environ Saf 2021;226:112829. [PMID: 34592520 DOI: 10.1016/j.ecoenv.2021.112829] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
229 Fukuma S, Sasaki S, Taguri M, Goto R, Misumi T, Saigusa Y, Tsugawa Y. Effect of Nudge-Based Intervention on Adherence to Physician Visit Recommendations and Early Health Outcomes among Individuals Identified with Chronic Kidney Disease in Screens. J Am Soc Nephrol 2022;33:175-85. [PMID: 34903568 DOI: 10.1681/ASN.2021050664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Di Lullo L, Lavalle C, Magnocavallo M, Mariani MV, Della Rocca DG, Severino P, Di Iorio BR, Russo D, Summaria F, Forleo GB, Ronco C, Mancone M, Chimenti C, Miraldi F, Natale A, Bellasi A. New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation. Int J Cardiol 2021;345:90-7. [PMID: 34688719 DOI: 10.1016/j.ijcard.2021.10.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
231 Gonzáles-Rubianes DZ, Figueroa-Osorio LK, Benites-Zapata VA, Pacheco-Mendoza J, Herrera-Añazco P. Utility of TG/HDL-c ratio as a predictor of mortality and cardiovascular disease in patients with chronic kidney disease undergoing hemodialysis: A systematic review. Hemodial Int 2021. [PMID: 34907634 DOI: 10.1111/hdi.12981] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
232 Yoshikawa M, Asaba K, Nakayama T. Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study. PLoS One 2021;16:e0261020. [PMID: 34898631 DOI: 10.1371/journal.pone.0261020] [Reference Citation Analysis]
233 Zou Y, Liu F, Cooper ME, Chai Z. Advances in Clinical Research in Chronic Kidney Disease. J Transl Int Med 2021;9:146-9. [PMID: 34900623 DOI: 10.2478/jtim-2021-0041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
234 Zeleke TK, Birhan TY, Abdela OA. Medicine Dose Adjustment Practice and Associated Factors among Renally Impaired Patients in Amhara Regional State, Ethiopia. Int J Nephrol 2021;2021:8238250. [PMID: 34900352 DOI: 10.1155/2021/8238250] [Reference Citation Analysis]
235 Ahn SS, Song JJ, Park YB, Lee SW. Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis. Korean J Intern Med 2021. [PMID: 34883552 DOI: 10.3904/kjim.2021.043] [Reference Citation Analysis]
236 Przybyciński J, Drożdżal S, Domański L, Dziedziejko V, Pawlik A. Role of Endothelial Glucocorticoid Receptor in the Pathogenesis of Kidney Diseases. Int J Mol Sci 2021;22:13295. [PMID: 34948091 DOI: 10.3390/ijms222413295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 de Cos M, Xipell M, García-Herrera A, Lledo GM, Guillen E, Blasco M, Espinosa G, Cervera R, Quintana LF. Assessing and counteracting fibrosis is a cornerstone of the treatment of CKD secondary to systemic and renal limited autoimmune disorders. Autoimmun Rev 2021;21:103014. [PMID: 34896651 DOI: 10.1016/j.autrev.2021.103014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
238 Booker R, Jones R, Galloway R, Holmes ME. Differences of Sedentary Behavior, Physical Activity, and Metabolic Syndrome Severity Among Metabolic Syndrome Clusters. American Journal of Lifestyle Medicine. [DOI: 10.1177/15598276211056874] [Reference Citation Analysis]
239 Clark AR, Marshall J, Zhou Y, Montesinos MS, Chen H, Nguyen L, Chen F, Greka A. Single-Cell Transcriptomics Reveal Disrupted Kidney Filter Cell-Cell Interactions after Early and Selective Podocyte Injury. Am J Pathol 2022;192:281-94. [PMID: 34861215 DOI: 10.1016/j.ajpath.2021.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
240 Levy RV, Reidy KJ, Le TH, David V, Winkler C, Xu Y, Warady B, Furth S, Kaskel F, Melamed ML. Association of GSTM1 Deletion With Progression of CKD in Children: Findings From the Chronic Kidney Disease in Children (CKiD) Study. Am J Kidney Dis 2021:S0272-6386(21)01009-X. [PMID: 34871703 DOI: 10.1053/j.ajkd.2021.10.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Liu T, Li R, Wang X, Gao X, Zhang X. Benefits of SGLT2 inhibitors combining with renin-angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis. Med Clin (Barc) 2021:S0025-7753(21)00647-3. [PMID: 34872768 DOI: 10.1016/j.medcli.2021.09.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Chowdhury NH, Reaz MBI, Haque F, Ahmad S, Ali SHM, A Bakar AA, Bhuiyan MAS. Performance Analysis of Conventional Machine Learning Algorithms for Identification of Chronic Kidney Disease in Type 1 Diabetes Mellitus Patients. Diagnostics (Basel) 2021;11:2267. [PMID: 34943504 DOI: 10.3390/diagnostics11122267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
243 You HS, Shin SJ, Kim J, Kang HT. Statin Use and Incidence of Chronic Kidney Disease in Hypercholesterolemia Patients with Normal Renal Function. Am J Nephrol 2021;52:940-8. [PMID: 34864729 DOI: 10.1159/000520532] [Reference Citation Analysis]
244 Maeda T, Yokota S, Nishi T, Funakoshi S, Tsuji M, Satoh A, Abe M, Kawazoe M, Yoshimura C, Tada K, Takahashi K, Ito K, Yasuno T, Yamanokuchi T, Iwanaga K, Morinaga A, Maki K, Ueno T, Masutani K, Mukoubara S, Arima H. Association between pulse pressure and progression of chronic kidney disease. Sci Rep 2021;11:23275. [PMID: 34857861 DOI: 10.1038/s41598-021-02809-8] [Reference Citation Analysis]
245 Tsai JW, Cerdeña JP, Goedel WC, Asch WS, Grubbs V, Mendu ML, Kaufman JS. Evaluating the Impact and Rationale of Race-Specific Estimations of Kidney Function: Estimations from U.S. NHANES, 2015-2018. EClinicalMedicine 2021;42:101197. [PMID: 34849475 DOI: 10.1016/j.eclinm.2021.101197] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
246 Rocha LCB, Nunes-Dos-Santos DL, Costa EM, Gomes SV, Rodrigues VP, Pereira ALA. A Cross-Sectional Study of the Association Between Chronic Oral Disease Burden and Serum Biomarkers in Kidney Transplant Recipients. Prog Transplant 2021;:15269248211064889. [PMID: 34851215 DOI: 10.1177/15269248211064889] [Reference Citation Analysis]
247 Safdar O, Alaydarous SA, Arafsha Y, Arafsha L, Almaimani N, Bahomeed R, Al Beiruty M, Norah A, Kari JA, Shalaby M. Incidence and Outcome of Community-Acquired Acute Kidney Injury in Pediatric Patients Seen at an Emergency Department: A Retrospective Cohort Study. Pediatr Emerg Care 2021;37:e1429-33. [PMID: 32118838 DOI: 10.1097/PEC.0000000000002065] [Reference Citation Analysis]
248 Wu H, Zhang R, Hu B, He Y, Zhang Y, Cai L, Wang L, Wang G, Hou H, Qiu X. A porous hydrogel scaffold mimicking the extracellular matrix with swim bladder derived collagen for renal tissue regeneration. Chinese Chemical Letters 2021;32:3940-7. [DOI: 10.1016/j.cclet.2021.04.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Bellocchio F, Lonati C, Ion Titapiccolo J, Nadal J, Meiselbach H, Schmid M, Baerthlein B, Tschulena U, Schneider M, Schultheiss UT, Barbieri C, Moore C, Steppan S, Eckardt KU, Stuard S, Neri L. Validation of a Novel Predictive Algorithm for Kidney Failure in Patients Suffering from Chronic Kidney Disease: The Prognostic Reasoning System for Chronic Kidney Disease (PROGRES-CKD). Int J Environ Res Public Health 2021;18:12649. [PMID: 34886378 DOI: 10.3390/ijerph182312649] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
250 Chang Y, Lee JS, Woo HG, Ryu DR, Kim JW, Song TJ. Improved oral hygiene care and chronic kidney disease occurrence: A nationwide population-based retrospective cohort study. Medicine (Baltimore) 2021;100:e27845. [PMID: 34964752 DOI: 10.1097/MD.0000000000027845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
251 Jabbar A, Qureshi R, Dhrolia M, Nasir K, Ahmad A. Variety of Cardiac Events in Hospitalized Chronic Kidney Disease Patients. Cureus 2021;13:e18801. [PMID: 34804663 DOI: 10.7759/cureus.18801] [Reference Citation Analysis]
252 Du Y, Ma J, Fan Y, Wang X, Zheng S, Feng J, Li J, Fan Z, Li G, Ye Q. Naringenin: A Promising Therapeutic Agent against Organ Fibrosis. Oxid Med Cell Longev 2021;2021:1210675. [PMID: 34804359 DOI: 10.1155/2021/1210675] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
253 Fotheringham AK, Solon-Biet SM, Bielefeldt-Ohmann H, McCarthy DA, McMahon AC, Ruohonen K, Li I, Sullivan MA, Whiddett RO, Borg DJ, Cogger VC, Ballard WO, Turner N, Melvin RG, Raubenheimer D, Le Couteur DG, Simpson SJ, Forbes JM. Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structure. iScience 2021;24:103308. [PMID: 34820603 DOI: 10.1016/j.isci.2021.103308] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
254 Li N, Lv D, Zhu X, Wei P, Gui Y, Liu S, Zhou E, Zheng M, Zhou D, Zhang L. Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis. Front Med (Lausanne) 2021;8:728089. [PMID: 34790672 DOI: 10.3389/fmed.2021.728089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
255 Swift O, Sharma S, Ramanarayanan S, Umar H, Laws KR, Vilar E, Farrington K. Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis. Clinical Kidney Journal 2021. [DOI: 10.1093/ckj/sfab230] [Reference Citation Analysis]
256 Sanz-Corbalán I, Tardáguila-García A, García-Álvarez Y, López-Moral M, Álvaro-Afonso FJ, Lázaro-Martínez JL. Evaluation of Adherence to the Oral Antibiotic Treatment in Patients With Diabetic Foot Infection. Int J Low Extrem Wounds 2021;:15347346211057342. [PMID: 34779665 DOI: 10.1177/15347346211057342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
257 Ojakäär T, Koychev I. Secondary Prevention of Dementia: Combining Risk Factors and Scalable Screening Technology. Front Neurol 2021;12:772836. [DOI: 10.3389/fneur.2021.772836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Grundmann D, Linder M, Goßling A, Voigtländer L, Ludwig S, Waldschmidt L, Demal T, Bhadra OD, Schäfer A, Schirmer J, Reichenspurner H, Blankenberg S, Westermann D, Schofer N, Conradi L, Seiffert M. End-stage renal disease, calcification patterns and clinical outcomes after TAVI. Clin Res Cardiol 2021. [PMID: 34773135 DOI: 10.1007/s00392-021-01968-y] [Reference Citation Analysis]
259 Zhang Q, Zhang J, Lei L, Liang H, Li Y, Lu J, Zhou S, Li G, Zhang X, Chen Y, Pan J, Lu X, Chen Y, Lin X, Li X, An S, Xiu J. Nomogram to predict risk of incident chronic kidney disease in high-risk population of cardiovascular disease in China: community-based cohort study. BMJ Open 2021;11:e047774. [PMID: 34772745 DOI: 10.1136/bmjopen-2020-047774] [Reference Citation Analysis]
260 Soppert J, Frisch J, Wirth J, Hemmers C, Boor P, Kramann R, Vondenhoff S, Moellmann J, Lehrke M, Hohl M, van der Vorst EPC, Werner C, Speer T, Maack C, Marx N, Jankowski J, Roma LP, Noels H. A systematic review and meta-analysis of murine models of uremic cardiomyopathy. Kidney Int 2021:S0085-2538(21)01052-8. [PMID: 34774555 DOI: 10.1016/j.kint.2021.10.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Drake I, Fryk E, Strindberg L, Lundqvist A, Rosengren AH, Groop L, Ahlqvist E, Borén J, Orho-Melander M, Jansson PA. The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation analyses. Diabetologia 2021. [PMID: 34743218 DOI: 10.1007/s00125-021-05594-1] [Reference Citation Analysis]
262 Qu G, He T, Dai A, Zhao Y, Guan D, Li S, Shi H, Gan W, Zhang A. miR-199b-5p mediates adriamycin-induced podocyte apoptosis by inhibiting the expression of RGS10. Exp Ther Med 2021;22:1469. [PMID: 34737809 DOI: 10.3892/etm.2021.10904] [Reference Citation Analysis]
263 Poret F, Nacher M, Pujo J, Cauvin JM, Demar M, Massicard M, Sabbah N. Risk factors for hypoglycaemia in people with diabetes admitted to the Emergency Department of a Hospital in French Guiana. Diabet Med 2021;:e14736. [PMID: 34738244 DOI: 10.1111/dme.14736] [Reference Citation Analysis]
264 Seufert L, Benzing T, Ignarski M, Müller RU. RNA-binding proteins and their role in kidney disease. Nat Rev Nephrol 2021. [PMID: 34732838 DOI: 10.1038/s41581-021-00497-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
265 Chen Y, Ou W, Lin D, Lin M, Huang X, Ni S, Chen S, Yong J, O'Gara MC, Tan X, Liu R. Increased Uric Acid, Gamma-Glutamyl Transpeptidase and Alkaline Phosphatase in Early-Pregnancy Associated With the Development of Gestational Hypertension and Preeclampsia. Front Cardiovasc Med 2021;8:756140. [PMID: 34722684 DOI: 10.3389/fcvm.2021.756140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
266 Yuan D, Kuan T, Ling H, Wang H, Feng L, Zhao Q, Li J, Ran J. Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis. Ren Fail 2021;43:1479-91. [PMID: 34723750 DOI: 10.1080/0886022X.2021.1994995] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
267 Tran Ngoc C, Barango P, Harrison R, Jones A, Shongwe SV, Tuyishime A, Uwinkindi F, Xu H, Shoop-Worrall S. Risk factors associated with albuminuria in Rwanda: results from a STEPS survey. BMC Nephrol 2021;22:361. [PMID: 34724916 DOI: 10.1186/s12882-021-02574-w] [Reference Citation Analysis]
268 Escobar C, Aranda U, Palacios B, Capel M, Sicras A, Sicras A, Hormigo A, Alcázar R, Manito N, Botana M. Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain. Nefrología (English Edition) 2021;41:670-88. [DOI: 10.1016/j.nefroe.2022.01.008] [Reference Citation Analysis]
269 Brotzer L, Nickler M, Kim MJ, Mueller B, Blum CA. Adrenal function testing in dialysis patients - a review of the literature. BMC Nephrol 2021;22:360. [PMID: 34724905 DOI: 10.1186/s12882-021-02541-5] [Reference Citation Analysis]
270 Huang S, Jiang X, Chen Q, Hu Z, Wang F, Zhao Y, Xin G, Chen J. Jujube polysaccharides mitigated anemia in rats with chronic kidney disease: Regulation of short chain fatty acids release and erythropoietin production. Journal of Functional Foods 2021;86:104673. [DOI: 10.1016/j.jff.2021.104673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
271 Dong L, Li J, Zhao M, Ren J. Application of B-ultrasound information image in Renal Puncture Biopsy treatment and Nursing. Pak J Med Sci 2021;37:1564-8. [PMID: 34712283 DOI: 10.12669/pjms.37.6-WIT.4831] [Reference Citation Analysis]
272 Kavishe BB, Kweka BV, Nitsch D, PrayGod G, Jeremiah K, Faurholt-Jepsen D, Filteau S, Olsen MF, Kitilya BW, Krogh-Madsen R, Friis H, Peck R. Risk factors for impaired renal function in HIV-infected and HIV-uninfected adults: cross-sectional study in North-Western Tanzania. BMC Nephrol 2021;22:355. [PMID: 34715799 DOI: 10.1186/s12882-021-02563-z] [Reference Citation Analysis]
273 Hsieh CC, Chan MJ, Su YJ, Fu JF, Wang IK, Chen CY, Weng CH, Huang WH, Hsu CW, Yen TH. Bone Marrow Hypocellularity in Patients with End-Stage Kidney Disease. Healthcare (Basel) 2021;9:1452. [PMID: 34828498 DOI: 10.3390/healthcare9111452] [Reference Citation Analysis]
274 Caneparo C, Sorroza-Martinez L, Chabaud S, Fradette J, Bolduc S. Considerations for the clinical use of stem cells in genitourinary regenerative medicine. World J Stem Cells 2021; 13(10): 1480-1512 [PMID: 34786154 DOI: 10.4252/wjsc.v13.i10.1480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Amoabeng KA, Laurila S, Juárez-orozco LE, Marthinsen ABL, Moczulski D, Rebelos E, Dadson P. The utilization of positron emission tomography in the evaluation of renal health and disease. Clin Transl Imaging. [DOI: 10.1007/s40336-021-00469-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
276 Chung CY, Wu PH, Chiu YW, Hwang SJ, Lin MY. Effect of Nephrology Care on Mortality in Incident Dialysis Patients: A Population-Based Cohort Study. J Pers Med 2021;11:1071. [PMID: 34834424 DOI: 10.3390/jpm11111071] [Reference Citation Analysis]
277 Kjaergaard AD, Johannesen BR, Sørensen HT, Henderson VW, Christiansen CF. Kidney disease and risk of dementia: a Danish nationwide cohort study. BMJ Open 2021;11:e052652. [PMID: 34686557 DOI: 10.1136/bmjopen-2021-052652] [Reference Citation Analysis]
278 Haugnes HS, Negaard HF, Jensvoll H, Wilsgaard T, Tandstad T, Solberg A. Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study. Eur Urol Open Sci 2021;32:19-27. [PMID: 34667955 DOI: 10.1016/j.euros.2021.07.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
279 Zheng J, Zhang Y, Rasheed H, Walker V, Sugawara Y, Li J, Leng Y, Elsworth B, Wootton RE, Fang S, Yang Q, Burgess S, Haycock PC, Borges MC, Cho Y, Carnegie R, Howell A, Robinson J, Thomas LF, Brumpton BM, Hveem K, Hallan S, Franceschini N, Morris AP, Köttgen A, Pattaro C, Wuttke M, Yamamoto M, Kashihara N, Akiyama M, Kanai M, Matsuda K, Kamatani Y, Okada Y, Walters R, Millwood IY, Chen Z, Davey Smith G, Barbour S, Yu C, Åsvold BO, Zhang H, Gaunt TR. Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease. Int J Epidemiol 2021:dyab203. [PMID: 34669934 DOI: 10.1093/ije/dyab203] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
280 Wu N, Xia J, Chen S, Yu C, Xu Y, Xu C, Yan T, Li N, Liu Y, Pan XF. Serum uric acid and risk of incident chronic kidney disease: a national cohort study and updated meta-analysis. Nutr Metab (Lond) 2021;18:94. [PMID: 34666784 DOI: 10.1186/s12986-021-00618-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
281 Zhang X, Agborbesong E, Li X. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential. Int J Mol Sci 2021;22:11253. [PMID: 34681922 DOI: 10.3390/ijms222011253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
282 Bin Zarah A, Feraudo MC, Andrade JM. Development and Relative Validity of the Chronic Kidney Disease Short Food Frequency Questionnaire (CKD SFFQ) to Determine Diet Quality and Dietary Habits among Adults with Chronic Kidney Disease. Nutrients 2021;13:3610. [PMID: 34684611 DOI: 10.3390/nu13103610] [Reference Citation Analysis]
283 Wu B, Zhao Q, Li Z, Min Z, Shi M, Nie X, He Q, Gui R. Environmental level bisphenol A accelerates alterations of the reno-cardiac axis by the MAPK cascades in male diabetic rats: An analysis based on transcriptomic profiling and bioinformatics. Environ Pollut 2021;287:117671. [PMID: 34435562 DOI: 10.1016/j.envpol.2021.117671] [Reference Citation Analysis]
284 Kim JY, Lee S, Cha J, Son G, Kim DK. Chronic kidney disease is associated with increased risk of sudden sensorineural hearing loss and Ménière's disease: a nationwide cohort study. Sci Rep 2021;11:20194. [PMID: 34642430 DOI: 10.1038/s41598-021-99792-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
285 Avila-Carrasco L, García-Mayorga EA, Díaz-Avila DL, Garza-Veloz I, Martinez-Fierro ML, González-Mateo GT. Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease. Molecules 2021;26:6096. [PMID: 34684678 DOI: 10.3390/molecules26206096] [Reference Citation Analysis]
286 Laucyte-Cibulskiene A, Sharma S, Christensson A, Nilsson PM. Early life factors in relation to albuminuria and estimated glomerular filtration rate based on cystatin C and creatinine in adults from a Swedish population-based cohort study. J Nephrol 2021. [PMID: 34623630 DOI: 10.1007/s40620-021-01159-y] [Reference Citation Analysis]
287 Miao H, Wu XQ, Wang YN, Chen DQ, Chen L, Vaziri ND, Zhuang S, Guo Y, Su W, Ma SX, Zhang HQ, Shang YQ, Yu XY, Zhao YL, Mao JR, Gao M, Zhang JH, Zhao J, Zhang Y, Zhang L, Zhao YY, Cao G. 1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway. Br J Pharmacol 2021. [PMID: 34625952 DOI: 10.1111/bph.15705] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
288 Melekoglu E, Cetinkaya MA, Kepekci-Tekkeli SE, Kul O, Samur G. Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease. PLoS One 2021;16:e0258145. [PMID: 34614017 DOI: 10.1371/journal.pone.0258145] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
289 Yang M, Geng CA, Liu X, Guan M. Lipid Disorders in NAFLD and Chronic Kidney Disease. Biomedicines 2021;9:1405. [PMID: 34680522 DOI: 10.3390/biomedicines9101405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
290 Cases A, Gomez P, Broseta JJ, Perez Bernat E, Arjona Barrionuevo JD, Portolés JM, Gorriz JL. Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review. Front Med (Lausanne) 2021;8:654620. [PMID: 34604247 DOI: 10.3389/fmed.2021.654620] [Reference Citation Analysis]
291 Jiang X, Zhang F, Li Y, Ren J, Xu D, Cai R, Yi Z, Li C, Liu T, Zhang X, Yao H, Zhu T, Mu R. Clinical assessment of cardiac impairment favored by two-dimensional speckle tracking echocardiology in patients with systemic sclerosis. Rheumatology (Oxford) 2021:keab724. [PMID: 34599809 DOI: 10.1093/rheumatology/keab724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Auer J, Lamm G. The role of aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease. Eur J Prev Cardiol 2021:zwab149. [PMID: 34599597 DOI: 10.1093/eurjpc/zwab149] [Reference Citation Analysis]
293 Wallace DM, Alcaide ML, Wohlgemuth WK, Jones Weiss DL, Uribe Starita C, Patel SR, Stosor V, Levine A, Skvarca C, Long DM, Rubtsova A, Adimora AA, Gange SJ, Spence AB, Anastos K, Aouizerat BE, Anziska Y, Punjabi NM. Prevalence and correlates of restless legs syndrome in men living with HIV. PLoS One 2021;16:e0258139. [PMID: 34597340 DOI: 10.1371/journal.pone.0258139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
294 Shimoni Z, Froom P, Benbassat J. Proteinuria in hospitalised internal medicine adult patients. Postgrad Med J 2021:postgradmedj-2021-141002. [PMID: 34593627 DOI: 10.1136/postgradmedj-2021-141002] [Reference Citation Analysis]
295 Tran NK, Lea RA, Holland S, Nguyen Q, Raghubar AM, Sutherland HG, Benton MC, Haupt LM, Blackburn NB, Curran JE, Blangero J, Mallett AJ, Griffiths LR. Multi-phenotype genome-wide association studies of the Norfolk Island isolate implicate pleiotropic loci involved in chronic kidney disease. Sci Rep 2021;11:19425. [PMID: 34593906 DOI: 10.1038/s41598-021-98935-4] [Reference Citation Analysis]
296 Li L, Luo R, Yang Y, Cheng Y, Ge S, Xu G. Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A. Ren Fail 2020;42:1173-83. [PMID: 33213229 DOI: 10.1080/0886022X.2020.1847145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
297 Qiu Y, Cao Y, Tu G, Li J, Su Y, Fang F, Zhang X, Cang J, Rong R, Luo Z. Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis. Front Immunol 2021;12:698894. [PMID: 34566958 DOI: 10.3389/fimmu.2021.698894] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
298 Gollie JM, Harris-Love MO, Patel SS, Shara NM, Blackman MR. Rate of Force Development Is Related to Maximal Force and Sit-to-Stand Performance in Men With Stages 3b and 4 Chronic Kidney Disease. Front Rehabilit Sci 2021;2. [PMID: 34708217 DOI: 10.3389/fresc.2021.734705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
299 Ye H, Chen Y, Ye P, Zhang Y, Liu X, Xiao G, Zhang Z, Kong Y, Liang G. Nomogram predicting the risk of three-year chronic kidney disease adverse outcomes among East Asian patients with CKD. BMC Nephrol 2021;22:322. [PMID: 34579654 DOI: 10.1186/s12882-021-02496-7] [Reference Citation Analysis]
300 Mok Y, Ballew SH, Matsushita K. Chronic kidney disease measures for cardiovascular risk prediction. Atherosclerosis 2021;335:110-8. [PMID: 34556333 DOI: 10.1016/j.atherosclerosis.2021.09.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
301 Xu Q, Li B, Wang Y, Wang C, Feng S, Xue L, Chen J, Jiang H. Identification of VCAN as Hub Gene for Diabetic Kidney Disease Immune Injury Using Integrated Bioinformatics Analysis. Front Physiol 2021;12:651690. [PMID: 34557107 DOI: 10.3389/fphys.2021.651690] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
302 Meng X, Zou H, Li D, Yu P, Huang L, Zhang J, Li W, Yu X. Association of Circulating ANGPTL8 Levels With Renal Dysfunction: A Case-Control Study. Front Public Health 2021;9:710504. [PMID: 34557469 DOI: 10.3389/fpubh.2021.710504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
303 Heerspink HJL, Xie D, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Perkovic V, Rossing P, Parving HH, de Zeeuw D; on behalf on the SONAR Investigators. Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial. J Am Soc Nephrol 2021;32:2900-11. [PMID: 34551995 DOI: 10.1681/ASN.2021030391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Yan MT, Chao CT, Lin SH. Chronic Kidney Disease: Strategies to Retard Progression. Int J Mol Sci 2021;22:10084. [PMID: 34576247 DOI: 10.3390/ijms221810084] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
305 Zhang L, Wang Y, Zhang Z, Liang H, Wu L, Ni L, Gao G, Yang D, Zhao H, Xiao J. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord 2021;21:438. [PMID: 34525967 DOI: 10.1186/s12872-021-02245-6] [Reference Citation Analysis]
306 Harambat J, Madden I, Hogan J. [Epidemiology of pediatric chronic kidney disease]. Nephrol Ther 2021;17:476-84. [PMID: 34518130 DOI: 10.1016/j.nephro.2021.06.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Jin, Zhang Y, Zhang Y, Duan L, Zhou R, Duan Y, Sun Y, Lian F, Tong X. Panax Ginseng C.A.Mey. as Medicine: The Potential Use of Panax Ginseng C.A.Mey. as a Remedy for Kidney Protection from a Pharmacological Perspective. Front Pharmacol 2021;12:734151. [PMID: 34512359 DOI: 10.3389/fphar.2021.734151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
308 Li X, Shan Y, Gao Y, Jiang X, Wang H, Yang X, Ding Y. The Cross-Cultural Adaptation and the Reliability Test for the Chinese-Version Dietary Behavior and Psychological Series Scales in Maintenance Hemodialysis Patients. Patient Prefer Adherence 2021;15:1903-12. [PMID: 34511886 DOI: 10.2147/PPA.S322868] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
309 Zhang Y, Wen P, Luo J, Ding H, Cao H, He W, Zen K, Zhou Y, Yang J, Jiang L. Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis. Cell Death Dis 2021;12:847. [PMID: 34518519 DOI: 10.1038/s41419-021-04134-4] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
310 Li Y, Ma K, Han Z, Chi M, Sai X, Zhu P, Ding Z, Song L, Liu C. Immunomodulatory Effects of Heme Oxygenase-1 in Kidney Disease. Front Med (Lausanne) 2021;8:708453. [PMID: 34504854 DOI: 10.3389/fmed.2021.708453] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
311 Urbanellis P, Mazilescu L, Kollmann D, Linares-Cervantes I, Kaths JM, Ganesh S, Oquendo F, Sharma M, Goto T, Noguchi Y, John R, Konvalinka A, Mucsi I, Ghanekar A, Bagli D, Robinson LA, Selzner M. Prolonged warm ischemia time leads to severe renal dysfunction of donation-after-cardiac death kidney grafts. Sci Rep 2021;11:17930. [PMID: 34504136 DOI: 10.1038/s41598-021-97078-w] [Reference Citation Analysis]
312 Walbaum M, Scholes S, Rojas R, Mindell JS, Pizzo E. Projection of the health and economic impacts of Chronic kidney disease in the Chilean population. PLoS One 2021;16:e0256680. [PMID: 34495980 DOI: 10.1371/journal.pone.0256680] [Reference Citation Analysis]
313 Evangelidis N, Sautenet B, Madero M, Tong A, Ashuntantang G, Sanabria LC, de Boer IH, Fung S, Gallego D, Levey AS, Levin A, Lorca E, Okpechi IG, Rossignol P, Sola L, Usherwood T, Wheeler DC, Cho Y, Howell M, Guha C, Scholes-Robertson N, Widders K, Gonzalez AM, Teixeira-Pinto A, Viecelli AK, Bernier-Jean A, Anumudu S, Dunn L, Wilkie M, Craig JC; SONG-CKD Investigators. Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy. Trials 2021;22:612. [PMID: 34503563 DOI: 10.1186/s13063-021-05574-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
314 Hossain A, Chowdhury SI, Sarker S, Ahsan MS. Artificial neural network for the prediction model of glomerular filtration rate to estimate the normal or abnormal stages of kidney using gamma camera. Ann Nucl Med 2021;35:1342-52. [PMID: 34491539 DOI: 10.1007/s12149-021-01676-7] [Reference Citation Analysis]
315 Vu LN, Nghia NQ, Tuan TM, Phuong TH, Vo HL, Viet KN, Giang TB. Measuring Health-Related Quality of Life in Vietnamese Patients After Kidney Transplantation. Front Surg 2021;8:646629. [PMID: 34490335 DOI: 10.3389/fsurg.2021.646629] [Reference Citation Analysis]
316 Li SS, Sun Q, Hua MR, Suo P, Chen JR, Yu XY, Zhao YY. Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis. Front Pharmacol 2021;12:719880. [PMID: 34483931 DOI: 10.3389/fphar.2021.719880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
317 Hunegnaw A, Mekonnen HS, Techane MA, Agegnehu CD. Prevalence and Associated Factors of Chronic Kidney Disease among Adult Hypertensive Patients at Northwest Amhara Referral Hospitals, Northwest Ethiopia, 2020. Int J Hypertens 2021;2021:5515832. [PMID: 34484816 DOI: 10.1155/2021/5515832] [Reference Citation Analysis]
318 Castro-Porras LV, Rojas-Martínez R, Aguilar-Salinas CA, Bello-Chavolla OY, Becerril-Gutierrez C, Escamilla-Nuñez C. Trends and age-period-cohort effects on hypertension mortality rates from 1998 to 2018 in Mexico. Sci Rep 2021;11:17553. [PMID: 34475436 DOI: 10.1038/s41598-021-96175-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
319 Nikagolla C, Dawes LA, Millar GJ, Meredith KT, Banati RB. Using isotopes to determine the natural and anthropogenic processes influencing water quality in household wells of Chronic kidney disease of unknown origin (CKDu) endemic Medawachchiya area, Sri Lanka. Journal of Hydrology 2021;600:126623. [DOI: 10.1016/j.jhydrol.2021.126623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
320 Cai Q, Dekker LH, Vinke PC, Corpeleijn E, Bakker SJL, de Borst MH, Navis GJ. Diet quality and incident chronic kidney disease in the general population: The Lifelines Cohort Study. Clin Nutr 2021;40:5099-105. [PMID: 34461583 DOI: 10.1016/j.clnu.2021.07.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
321 Costa NA, Pereira AG, Dorna MS, Rodrigues HCN, Azevedo PS, Paiva SAR, Polegato BF, Balbi AL, Zornoff LAM, Ponce D, Minicucci MF. Meal timing and frequency implications in the development and prognosis of chronic kidney disease. Nutrition 2021;91-92:111427. [PMID: 34461602 DOI: 10.1016/j.nut.2021.111427] [Reference Citation Analysis]
322 Laheij A, Rooijers W, Bidar L, Haidari L, Neradova A, de Vries R, Rozema F. Oral health in patients with end-stage renal disease: A scoping review. Clin Exp Dent Res 2021. [PMID: 34459147 DOI: 10.1002/cre2.479] [Reference Citation Analysis]
323 Chen Y, Cao F, Xiao JP, Fang XY, Wang XR, Ding LH, Wang DG, Pan HF. Emerging role of air pollution in chronic kidney disease. Environ Sci Pollut Res Int 2021;28:52610-24. [PMID: 34448134 DOI: 10.1007/s11356-021-16031-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
324 Wang Y, Zheng Y, Chen P, Liang S, He P, Shao X, Cai G, Chen X. The weak correlation between serum vitamin levels and chronic kidney disease in hospitalized patients: a cross-sectional study. BMC Nephrol 2021;22:292. [PMID: 34445968 DOI: 10.1186/s12882-021-02498-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
325 van de Wouw J, Sorop O, van Drie RWA, Joles JA, Danser AHJ, Verhaar MC, Merkus D, Duncker DJ. Reduced nitric oxide bioavailability impairs myocardial oxygen balance during exercise in swine with multiple risk factors. Basic Res Cardiol 2021;116:50. [PMID: 34435256 DOI: 10.1007/s00395-021-00890-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
326 Li LL, Yang YQ, Qiu M, Wang L, Yuan HL, Zou RC. The clinical significance of neutrophil-lymphocyte ratio in patients treated with hemodialysis complicated with lung infection. Medicine (Baltimore) 2021;100:e26591. [PMID: 34398014 DOI: 10.1097/MD.0000000000026591] [Reference Citation Analysis]
327 Ciarambino T, Ciaburri F, Paoli VD, Caruso G, Giordano M, D'Avino M. Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences? J Clin Med 2021;10:3740. [PMID: 34442038 DOI: 10.3390/jcm10163740] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
328 Bi J, Barry V, Weil EJ, Chang HH, Ebelt S. Short-term exposure to fine particulate air pollution and emergency department visits for kidney diseases in the Atlanta metropolitan area. Environ Epidemiol 2021;5:e164. [PMID: 34414347 DOI: 10.1097/EE9.0000000000000164] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
329 Hammoud SH, AlZaim I, Al-Dhaheri Y, Eid AH, El-Yazbi AF. Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases. Front Endocrinol (Lausanne) 2021;12:707126. [PMID: 34408726 DOI: 10.3389/fendo.2021.707126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
330 Lin YL, Chang IC, Liou HH, Wang CH, Lai YH, Kuo CH, Hsu BG. Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease. Sci Rep 2021;11:16863. [PMID: 34413438 DOI: 10.1038/s41598-021-96447-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
331 Shamshirgaran Y, Jonebring A, Svensson A, Leefa I, Bohlooly-Y M, Firth M, Woollard KJ, Hofherr A, Rogers IM, Hicks R. Rapid target validation in a Cas9-inducible hiPSC derived kidney model. Sci Rep 2021;11:16532. [PMID: 34400685 DOI: 10.1038/s41598-021-95986-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
332 Shiizaki K, Tsubouchi A, Miura Y, Seo K, Kuchimaru T, Hayashi H, Iwazu Y, Miura M, Battulga B, Ohno N, Hara T, Kunishige R, Masutani M, Negishi K, Kario K, Kotani K, Yamada T, Nagata D, Komuro I, Itoh H, Kurosu H, Murata M, Kuro-O M. Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression. J Clin Invest 2021;131:145693. [PMID: 34185705 DOI: 10.1172/JCI145693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
333 Chapman FA, Nyimanu D, Maguire JJ, Davenport AP, Newby DE, Dhaun N. The therapeutic potential of apelin in kidney disease. Nat Rev Nephrol 2021. [PMID: 34389827 DOI: 10.1038/s41581-021-00461-z] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
334 Sheng X, Guan Y, Ma Z, Wu J, Liu H, Qiu C, Vitale S, Miao Z, Seasock MJ, Palmer M, Shin MK, Duffin KL, Pullen SS, Edwards TL, Hellwege JN, Hung AM, Li M, Voight BF, Coffman TM, Brown CD, Susztak K. Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments. Nat Genet 2021. [PMID: 34385711 DOI: 10.1038/s41588-021-00909-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
335 Su WY, Chu NS, Huang JC, Wu PY, Lee WH, Liu YH, Chen SC, Su HM. Low Albumin, Low Bilirubin, and High Alfa-Fetoprotein Are Associated with a Rapid Renal Function Decline in a Large Population Follow-Up Study. J Pers Med 2021;11:781. [PMID: 34442425 DOI: 10.3390/jpm11080781] [Reference Citation Analysis]
336 Alvand S, Abolnezhadian F, Alatab S, Mohammadi Z, Hayati F, Noori M, Danehchin L, Paridar Y, Cheraghian B, Rahimi Z, Hariri S, Masoudi S, Mard SA, Shayesteh AA, Poustchi H. Prevalence of impaired renal function and determinants in the southwest of Iran. BMC Nephrol 2021;22:276. [PMID: 34376157 DOI: 10.1186/s12882-021-02484-x] [Reference Citation Analysis]
337 Kuro-O M. Klotho and calciprotein particles as therapeutic targets against accelerated ageing. Clin Sci (Lond) 2021;135:1915-27. [PMID: 34374422 DOI: 10.1042/CS20201453] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
338 Del Vecchio L, Beretta A, Jovane C, Peiti S, Genovesi S. A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease. Drugs 2021;81:1491-511. [PMID: 34363606 DOI: 10.1007/s40265-021-01573-3] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
339 Balkanski S. Dapagliflozin – structure, synthesis, and new indications. PHAR 2021;68:591-6. [DOI: 10.3897/pharmacia.68.e70626] [Reference Citation Analysis]
340 Dunn AN, Huded C, Raymond R, Lincoff AM, Bajzer C, Kapadia S, Ellis SG. Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents. Catheter Cardiovasc Interv 2021;98:208-14. [PMID: 33913614 DOI: 10.1002/ccd.29707] [Reference Citation Analysis]
341 Wang Q, Liu L, Jonas JB, Gao B, Wu SL, Chen SH, Yan YN, Yang JY, Zhou WJ, Yang MC, Chan SY, Zhang L, Wei WB, Wang YX. Albuminuria and retinal vessel density in diabetes without diabetic retinopathy: the Kailuan Eye Study. Acta Ophthalmol 2021;99:e669-78. [PMID: 33354932 DOI: 10.1111/aos.14670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
342 Goffredo G, Barone R, Di Terlizzi V, Correale M, Brunetti ND, Iacoviello M. Biomarkers in Cardiorenal Syndrome. J Clin Med 2021;10:3433. [PMID: 34362216 DOI: 10.3390/jcm10153433] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
343 Uddin MJ, Farjana M, Moni A, Hossain KS, Hannan MA, Ha H. Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging. Int J Mol Sci 2021;22:8258. [PMID: 34361023 DOI: 10.3390/ijms22158258] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
344 Kao CC, Wang SY, Chuang YK, Lee WY, Chang WC, Wu MS, Kuo TC, Tsai IL. Clinical Mass Spectrometry Discovered Human IgG Sialylation as a Potential Biosignature for Kidney Function. J Pers Med 2021;11:761. [PMID: 34442405 DOI: 10.3390/jpm11080761] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
345 Figuer A, Bodega G, Tato P, Valera G, Serroukh N, Ceprian N, de Sequera P, Morales E, Carracedo J, Ramírez R, Alique M. Premature Aging in Chronic Kidney Disease: The Outcome of Persistent Inflammation beyond the Bounds. Int J Environ Res Public Health 2021;18:8044. [PMID: 34360333 DOI: 10.3390/ijerph18158044] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
346 Hansrivijit P, Chen YJ, Lnu K, Trongtorsak A, Puthenpura MM, Thongprayoon C, Bathini T, Mao MA, Cheungpasitporn W. Prediction of mortality among patients with chronic kidney disease: A systematic review. World J Nephrol 2021; 10(4): 59-75 [PMID: 34430385 DOI: 10.5527/wjn.v10.i4.59] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
347 Cho HB, Kim MG, Park SY, Song S, Jang YS, Park S, Lee HK, Yoo JH, Chung JW, Kim SH. The influence of propofol-based total intravenous anesthesia on postoperative outcomes in end-stage renal disease patients: A retrospective observation study. PLoS One 2021;16:e0254014. [PMID: 34292982 DOI: 10.1371/journal.pone.0254014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
348 Chen J, Wu Z, Liu Y, Wang L, Li T, Dong Y, Qin Q, Ding S. Prevalence, Association Relation, and Dynamic Evolution Analysis of Critical Values in Health Checkup in China: A Retrospective Study. Front Public Health 2021;9:630356. [PMID: 34368036 DOI: 10.3389/fpubh.2021.630356] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Namba T, Ichii O, Nakamura T, Masum MA, Otani Y, Hosotani M, Elewa YHA, Kon Y. Compartmentalization of interleukin 36 subfamily according to inducible and constitutive expression in the kidneys of a murine autoimmune nephritis model. Cell Tissue Res 2021. [PMID: 34287716 DOI: 10.1007/s00441-021-03495-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
350 Provenzano M, Serra R, Michael A, Bolignano D, Coppolino G, Ielapi N, Serraino GF, Mastroroberto P, Locatelli F, De Nicola L, Andreucci M. Smoking habit as a risk amplifier in chronic kidney disease patients. Sci Rep 2021;11:14778. [PMID: 34285279 DOI: 10.1038/s41598-021-94270-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
351 Yang Y, Kozel Z, Sharma P, Yaskiv O, Torres J, Pandya S, Jhaveri KD, Bhaskaran M, Vira M, Bijol V. Identifying patients with CKD risk at the time of nephrectomy: When to initiate nephrology consult. Journal of Onco-Nephrology 2021;5:105-13. [DOI: 10.1177/23993693211031918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
352 Bao Y, Liang W, Ye Y, Yi B. PERK-Dependent Activation of the JAK2/STAT3 Pathway Contributes to High Glucose-Induced Extracellular Matrix Deposition in Renal Tubular Epithelial Cells. Int J Endocrinol 2021;2021:8475868. [PMID: 34335747 DOI: 10.1155/2021/8475868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Sung PS, Han JW, Seo C, Ahn J, Lee SK, Nam HC, Choi HJ, You YK, Jang JW, Choi JY, Yoon SK. Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant. Front Pharmacol 2021;12:685176. [PMID: 34326770 DOI: 10.3389/fphar.2021.685176] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
354 Tracz J, Luczak M. Applying Proteomics and Integrative "Omics" Strategies to Decipher the Chronic Kidney Disease-Related Atherosclerosis. Int J Mol Sci 2021;22:7492. [PMID: 34299112 DOI: 10.3390/ijms22147492] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
355 Lu P, Xia G, Tong S, Bell M, Li S, Guo Y. Ambient temperature and hospitalizations for acute kidney injury in Queensland, Australia, 1995–2016. Environ Res Lett 2021;16:075007. [DOI: 10.1088/1748-9326/ac0c44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Huang X, Chen L, Lan L, Ren P, Ni A, Ma Y, Wang Y, Zhu Y, Xu Y, Chen J, Han F. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome. Front Immunol 2021;12:641655. [PMID: 34305886 DOI: 10.3389/fimmu.2021.641655] [Reference Citation Analysis]
357 Goudis C, Daios S, Korantzopoulos P, Liu T. Does CHA2DS2-VASc score predict mortality in chronic kidney disease? Intern Emerg Med 2021. [PMID: 34232486 DOI: 10.1007/s11739-021-02799-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
358 Jankauskas SS, Gambardella J, Sardu C, Lombardi A, Santulli G. Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications. Noncoding RNA 2021;7:39. [PMID: 34287359 DOI: 10.3390/ncrna7030039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
359 Tang M, Zhu C, Yan T, Zhou Y, Lv Q, Chuan J. Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat. Front Pharmacol 2021;12:658079. [PMID: 34276361 DOI: 10.3389/fphar.2021.658079] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
360 Rojas-morales P, Pedraza-chaverri J, Tapia E. Ketone bodies for kidney injury and disease. Advances in Redox Research 2021;2:100009. [DOI: 10.1016/j.arres.2021.100009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
361 Sobreiro-Almeida R, Quinteira R, Neves NM. Renal Regeneration: The Role of Extracellular Matrix and Current ECM-Based Tissue Engineered Strategies. Adv Healthc Mater 2021;10:e2100160. [PMID: 34137210 DOI: 10.1002/adhm.202100160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
362 Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
363 Rhee JJ, Jardine MJ, Chertow GM, Mahaffey KW. Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY. Diabetes Obes Metab 2020;22 Suppl 1:46-54. [PMID: 32267076 DOI: 10.1111/dom.13987] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
364 MacRae C, Mercer S, Guthrie B. Potentially inappropriate primary care prescribing in people with chronic kidney disease: a cross-sectional analysis of a large population cohort. Br J Gen Pract 2021;71:e483-90. [PMID: 33947664 DOI: 10.3399/BJGP.2020.0871] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
365 Zou H, Xu Y, Meng X, Li D, Chen X, Du T, Yang Y, Chen Y, Shao S, Yuan G, Zhou X, Hu S, He W, Ma D, Xie J, Zhang B, Zhang J, Li W, Liu Z, Yu X. Circulating ANGPTL8 levels and risk of kidney function decline: Results from the 4C Study. Cardiovasc Diabetol 2021;20:127. [PMID: 34167540 DOI: 10.1186/s12933-021-01317-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
366 Flythe JE, Karlsson N, Sundgren A, Cordero P, Grandinetti A, Cremisi H, Rydén A. Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis. BMC Nephrol 2021;22:233. [PMID: 34162354 DOI: 10.1186/s12882-021-02440-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
367 Ceravolo G, Macchia T, Cuppari C, Dipasquale V, Gambadauro A, Casto C, Ceravolo MD, Cutrupi M, Calabrò MP, Borgia P, Piccolo G, Mancuso A, Albiero R, Chimenz R. Update on the Classification and Pathophysiological Mechanisms of Pediatric Cardiorenal Syndromes. Children (Basel) 2021;8:528. [PMID: 34206173 DOI: 10.3390/children8070528] [Reference Citation Analysis]
368 Menezes HF, Camacho ACLF, Lins SMSB, Campos TDS, Lima FR, Jales AKFA, Silva RARD. Terms of specialized nursing language for chronic renal patients undergoing conservative treatment. Rev Bras Enferm 2020;73:e20190820. [PMID: 33338153 DOI: 10.1590/0034-7167-2019-0820] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
369 Wakasugi S, Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, Nishida K, Shiraiwa T, Torimoto K, Kurozumi A, Gosho M, Shimomura I, Watada H. Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes. BMJ Open Diabetes Res Care 2021;9:e001923. [PMID: 33879513 DOI: 10.1136/bmjdrc-2020-001923] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
370 Huang JC, Huang YC, Wu PY, Lee WH, Tsai YC, Chen YP, Chen SC, Su HM, Chiu YW, Chang JM. Association between Reduced Serum Zinc and Diastolic Dysfunction in Maintenance Hemodialysis Patients. Nutrients 2021;13:2077. [PMID: 34204555 DOI: 10.3390/nu13062077] [Reference Citation Analysis]
371 Wang X, Copmans D, de Witte PAM. Using Zebrafish as a Disease Model to Study Fibrotic Disease. Int J Mol Sci 2021;22:6404. [PMID: 34203824 DOI: 10.3390/ijms22126404] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
372 Griffin TP, O'shea PM, Smyth A, Islam MN, Wall D, Ferguson J, O'sullivan E, Finucane FM, Dinneen SF, Dunne FP, Lappin DW, Reddan DN, Bell M, O'brien T, Griffin DG, Griffin MD. Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe. BMJ Open Diab Res Care 2021;9:e002125. [DOI: 10.1136/bmjdrc-2021-002125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
373 Kim K, Anderson EM, Thome T, Lu G, Salyers ZR, Cort TA, O'Malley KA, Scali ST, Ryan TE. Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice. Am J Physiol Renal Physiol 2021;321:F106-19. [PMID: 34121452 DOI: 10.1152/ajprenal.00117.2021] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
374 Frater JL. The Top 100 Cited Papers in the Field of Iron Deficiency in Humans: A Bibliometric Study. Biomed Res Int 2021;2021:5573790. [PMID: 34235219 DOI: 10.1155/2021/5573790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
375 Yamamoto S, Inoue Y, Kuwahara K, Miki T, Nakagawa T, Honda T, Yamamoto S, Hayashi T, Mizoue T. Leisure-time, occupational, and commuting physical activity and the risk of chronic kidney disease in a working population. Sci Rep 2021;11:12308. [PMID: 34112832 DOI: 10.1038/s41598-021-91525-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
376 Maksimowski NA, Scholey JW, Williams VR; Nephrotic Syndrome Study Network (NEPTUNE). Sex and kidney ACE2 expression in primary focal segmental glomerulosclerosis: A NEPTUNE study. PLoS One 2021;16:e0252758. [PMID: 34097714 DOI: 10.1371/journal.pone.0252758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
377 Yang J, Chen T, Zhu Y, Bai M, Li X. Causal Inference Between Chronic Periodontitis and Chronic Kidney Disease: A Bidirectional Mendelian Randomization Analysis in a European Population. Front Genet 2021;12:676136. [PMID: 34163528 DOI: 10.3389/fgene.2021.676136] [Reference Citation Analysis]
378 Furukawa M, Onoue T, Kato K, Wada T, Shinohara Y, Kinoshita F, Goto M, Arima H, Tsushita K. Prediabetes is associated with proteinuria development but not with glomerular filtration rate decline: A longitudinal observational study. Diabet Med 2021;38:e14607. [PMID: 34031914 DOI: 10.1111/dme.14607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
379 Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K; World Kidney Day Steering Committee. Kidney health for everyone everywhere: from prevention to detection and equitable access to care. J Nephrol 2020;33:201-10. [PMID: 32232774 DOI: 10.1007/s40620-020-00728-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
380 Bowden K, Gray NA, Swanepoel E, Wright HH. A Mediterranean lifestyle is associated with favourable cardiometabolic markers in people with non-dialysis dependent chronic kidney disease. J Nutr Sci 2021;10:e42. [PMID: 34164121 DOI: 10.1017/jns.2021.33] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
381 Chen Y, Dai Y, Song K, Huang Y, Zhang L, Zhang C, Yan Q, Gao H. Pre-emptive pharmacological inhibition of fatty acid-binding protein 4 attenuates kidney fibrosis by reprogramming tubular lipid metabolism. Cell Death Dis 2021;12:572. [PMID: 34083513 DOI: 10.1038/s41419-021-03850-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
382 Escobar C, Palacios B, Aranda U, Capel M, Sicras A, Sicras A, Hormigo A, Alcázar R, Manito N, Botana M. Costs and healthcare utilisation of patients with chronic kidney disease in Spain. BMC Health Serv Res 2021;21:536. [PMID: 34074269 DOI: 10.1186/s12913-021-06566-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
383 Duman NB, Dogan I, Yildirim F, Kayadibi H. Sexual Dysfunctıons in Predialysis and Hemodıalysıs Patıents and Affectıng Factors: Corum Provınce, Turkey. Sex Disabil 2021;39:609-19. [DOI: 10.1007/s11195-021-09696-x] [Reference Citation Analysis]
384 Huang X, Ma Y, Li Y, Han F, Lin W. Targeted Drug Delivery Systems for Kidney Diseases. Front Bioeng Biotechnol 2021;9:683247. [PMID: 34124026 DOI: 10.3389/fbioe.2021.683247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
385 Šalamon Š, Bevc S, Ekart R, Hojs R, Potočnik U. Polymorphism in the GATM Locus Associated with Dialysis-Independent Chronic Kidney Disease but Not Dialysis-Dependent Kidney Failure. Genes (Basel) 2021;12:834. [PMID: 34071541 DOI: 10.3390/genes12060834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Sekulic S, Mijailovic Z, Petrovic D, Lukic R, Jovanovic M, Jovanovic I. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021;0:000010247820210010. [DOI: 10.2478/sjecr-2021-0010] [Reference Citation Analysis]
387 Filipska A, Bohdan B, Wieczorek PP, Hudz N. Chronic kidney disease and dialysis therapy: incidence and prevalence in the world. PHAR 2021;68:463-70. [DOI: 10.3897/pharmacia.68.e65501] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
388 Zhang BL, Yang XH, Jin HM, Zhan XL. Identification of differentially expressed genes in diabetic kidney disease by RNA-Seq analysis of venous blood platelets. FEBS Open Bio 2021. [PMID: 34029013 DOI: 10.1002/2211-5463.13199] [Reference Citation Analysis]
389 Mallis P, Oikonomidis C, Dimou Z, Stavropoulos-Giokas C, Michalopoulos E, Katsimpoulas M. Optimizing Decellularization Strategies for the Efficient Production of Whole Rat Kidney Scaffolds. Tissue Eng Regen Med 2021;18:623-40. [PMID: 34014553 DOI: 10.1007/s13770-021-00339-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
390 Domínguez-Vías G, Segarra AB, Ramírez-Sánchez M, Prieto I. Effects of Virgin Olive Oil on Blood Pressure and Renal Aminopeptidase Activities in Male Wistar Rats. Int J Mol Sci 2021;22:5388. [PMID: 34065436 DOI: 10.3390/ijms22105388] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
391 He P, Zhou C, Shen H. Diagnostic value of phosphatidylethanolamine binding protein 4 levels in patients receiving nursing interventions for advanced chronic kidney disease. J Int Med Res 2021;49:300060521996179. [PMID: 33752499 DOI: 10.1177/0300060521996179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
392 Hasegawa T, Nishikawa K, Tamura Y, Oka T, Urawa A, Watanabe S, Mizuno S, Okada M. Impacts of Interaction of Mental Condition and Quality of Life between Donors and Recipients at Decision-Making of Preemptive and Post-Dialysis Living-Donor Kidney Transplantation. J Pers Med 2021;11:414. [PMID: 34069298 DOI: 10.3390/jpm11050414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
393 Aycart DF, Acevedo S, Eguiguren-Jimenez L, Andrade JM. Influence of Plant and Animal Proteins on Inflammation Markers among Adults with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Nutrients 2021;13:1660. [PMID: 34068841 DOI: 10.3390/nu13051660] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
394 Tirichen H, Yaigoub H, Xu W, Wu C, Li R, Li Y. Mitochondrial Reactive Oxygen Species and Their Contribution in Chronic Kidney Disease Progression Through Oxidative Stress. Front Physiol 2021;12:627837. [PMID: 33967820 DOI: 10.3389/fphys.2021.627837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
395 Haines RW, Powell-Tuck J, Leonard H, Crichton S, Ostermann M. Long-term kidney function of patients discharged from hospital after an intensive care admission: observational cohort study. Sci Rep 2021;11:9928. [PMID: 33976354 DOI: 10.1038/s41598-021-89454-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
396 Wang YL, Lee YH, Hsu YH, Chiu IJ, Huang CC, Huang CC, Chia ZC, Lee CP, Lin YF, Chiu HW. The Kidney-Related Effects of Polystyrene Microplastics on Human Kidney Proximal Tubular Epithelial Cells HK-2 and Male C57BL/6 Mice. Environ Health Perspect 2021;129:57003. [PMID: 33956507 DOI: 10.1289/EHP7612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
397 Arai H, Sato Y, Yanagita M. Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney. Immunol Rev 2021;302:196-210. [PMID: 33951198 DOI: 10.1111/imr.12969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
398 McCullough K, Bolisetty S. Ferritins in Kidney Disease. Semin Nephrol 2020;40:160-72. [PMID: 32303279 DOI: 10.1016/j.semnephrol.2020.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
399 Forbes JM, Le Bagge S, Righi S, Fotheringham AK, Gallo LA, McCarthy DA, Leung S, Baskerville T, Nisbett J, Morton A, Teasdale S, D'Silva N, Barrett H, Jones T, Couper J, Donaghue K, Isbel N, Johnson DW, Donnellan L, Deo P, Akison LK, Moritz KM, O'Moore-Sullivan T. Advanced glycation end products as predictors of renal function in youth with type 1 diabetes. Sci Rep 2021;11:9422. [PMID: 33941808 DOI: 10.1038/s41598-021-88786-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
400 Liu R, Jian W, Zhao Y, Lu X, Wu Y, Duan J. Retinal oxygen saturation and vessel diameter in patients with chronic kidney disease. Acta Ophthalmol 2021;99:e352-9. [PMID: 32529722 DOI: 10.1111/aos.14398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
401 Álvarez JC, Cuervo SI, Silva E, Díaz JA, Jiménez LL, Parra DS, Gómez JC, Sánchez R, Cortés JA. Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy. Antibiotics (Basel) 2021;10:504. [PMID: 33946665 DOI: 10.3390/antibiotics10050504] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
402 Ghaith N, Malaeb B, Itani R, Alnafea M, Al Faraj A. Correlation of Kidney Size on Computed Tomography with GFR, Creatinine and HbA1C for an Accurate Diagnosis of Patients with Diabetes and/or Chronic Kidney Disease. Diagnostics (Basel) 2021;11:789. [PMID: 33925666 DOI: 10.3390/diagnostics11050789] [Reference Citation Analysis]
403 Bo Y, Brook JR, Lin C, Chang LY, Guo C, Zeng Y, Yu Z, Tam T, Lau AKH, Lao XQ. Reduced Ambient PM2.5 Was Associated with a Decreased Risk of Chronic Kidney Disease: A Longitudinal Cohort Study. Environ Sci Technol 2021;55:6876-83. [PMID: 33904723 DOI: 10.1021/acs.est.1c00552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
404 Xia H, Zhang B, Yang D, Zhu C, Zhang J, Chen H, Ma H, Hu S, Xu C, Shi C, Lu K, Zhang P. Yi-Qi-Jian-Pi-Xiao-Yu-Xie-Zhuo Formula Improves Muscle Atrophy via Modulating the IGF-1/PI3K/Akt Signaling Pathway in 5/6 Nephrectomized Rats. Front Pharmacol 2021;12:624303. [PMID: 33986663 DOI: 10.3389/fphar.2021.624303] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
405 Goh KLS, Lee CS, Koh CHG, Ling NL, Ang SB, Oh C, Lin Y, Yuan W, Zheng QC, Tan NC. Evaluating the effectiveness and utility of a novel culturally-adapted telemonitoring system in improving the glycaemic control of Asians with type-2 diabetes mellitus: a mixed method study protocol. Trials 2021;22:305. [PMID: 33902656 DOI: 10.1186/s13063-021-05240-6] [Reference Citation Analysis]
406 Jiang Z, Qin J, Liang K, Zhao R, Yan F, Hou X, Wang C, Chen L. Self-reported snoring is associated with chronic kidney disease in obese but not in normal-weight Chinese adults. Ren Fail 2021;43:709-17. [PMID: 33896382 DOI: 10.1080/0886022X.2021.1915332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
407 Wilkinson TJ, Nixon DGD, Palmer J, Lightfoot CJ, Smith AC. Differences in physical symptoms between those with and without kidney disease: a comparative study across disease stages in a UK population. BMC Nephrol 2021;22:147. [PMID: 33888089 DOI: 10.1186/s12882-021-02355-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
408 Alvarado M, Schaubel DE, Reddy KR, Bittermann T. Black Race Is Associated With Higher Rates of Early-Onset End-Stage Renal Disease and Increased Mortality Following Liver Transplantation. Liver Transpl 2021;27:1154-64. [PMID: 33733570 DOI: 10.1002/lt.26054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
409 Balogh E, Chowdhury A, Ababneh H, Csiki DM, Tóth A, Jeney V. Heme-Mediated Activation of the Nrf2/HO-1 Axis Attenuates Calcification of Valve Interstitial Cells. Biomedicines 2021;9:427. [PMID: 33920891 DOI: 10.3390/biomedicines9040427] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
410 Arad M, Goli R, Parizad N, Vahabzadeh D, Baghaei R. Do the patient education program and nurse-led telephone follow-up improve treatment adherence in hemodialysis patients? A randomized controlled trial. BMC Nephrol 2021;22:119. [PMID: 33827478 DOI: 10.1186/s12882-021-02319-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
411 Morooka H, Yamamoto J, Tanaka A, Inaguma D, Maruyama S. Relationship between mortality and use of sodium bicarbonate at the time of dialysis initiation: a prospective observational study. BMC Nephrol 2021;22:118. [PMID: 33823813 DOI: 10.1186/s12882-021-02330-0] [Reference Citation Analysis]
412 Saeki C, Saito M, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease. PLoS One 2021;16:e0249728. [PMID: 33798236 DOI: 10.1371/journal.pone.0249728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
413 Xie L, Guo K, Lu S, Wang N, Wang Y, Chen H, Liu J, Jia W. Diabetic nephropathy in mice is aggravated by the absence of podocyte IRE1 and is correlated with reduced kidney ADH1 expression. Ann Transl Med 2021;9:636. [PMID: 33987334 DOI: 10.21037/atm-20-6356] [Reference Citation Analysis]
414 Zhang G, Liu Y, Sun H, Xu L, Sun J, An J, Zhou H, Liu Y, Chen L, Jin Z. Texture analysis based on quantitative magnetic resonance imaging to assess kidney function: a preliminary study. Quant Imaging Med Surg 2021;11:1256-70. [PMID: 33816165 DOI: 10.21037/qims-20-842] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
415 Van Wynsberghe M, Flejeo J, Sakhi H, Ollero M, Sahali D, Izzedine H, Henique C. Nephrotoxicity of Anti-Angiogenic Therapies. Diagnostics (Basel) 2021;11:640. [PMID: 33916159 DOI: 10.3390/diagnostics11040640] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
416 Dos Santos MS, Canale D, Bernardo DRD, Shimizu MHM, Seguro AC, Volpini RA, de Bragança AC. The Restoration of Vitamin D Levels Slows the Progression of Renal Ischemic Injury in Rats Previously Deficient in Vitamin D. Front Med (Lausanne) 2021;8:625647. [PMID: 33869246 DOI: 10.3389/fmed.2021.625647] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
417 Potter JA, Price GW, Cliff CL, Green CR, Squires PE, Hills CE. Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells. Int J Mol Sci 2021;22:3644. [PMID: 33807408 DOI: 10.3390/ijms22073644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
418 Bai L, Xie Q, Xia M, Gong K, Wang N, Chen Y, Zhao M. The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H. J Cell Mol Med 2021;25:4316-25. [PMID: 33788378 DOI: 10.1111/jcmm.16492] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
419 Bae JH, Park EG, Kim S, Kim SG, Hahn S, Kim NH. Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Endocrinol Metab (Seoul) 2021;36:388-400. [PMID: 33789035 DOI: 10.3803/EnM.2020.912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
420 Zhao M, Yu Y, Wang R, Chang M, Ma S, Qu H, Zhang Y. Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease. Front Pharmacol 2020;11:619201. [PMID: 33854427 DOI: 10.3389/fphar.2020.619201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
421 Zhou F, Zou X, Zhang J, Wang Z, Yang Y, Wang D. Jian-Pi-Yi-Shen Formula Ameliorates Oxidative Stress, Inflammation, and Apoptosis by Activating the Nrf2 Signaling in 5/6 Nephrectomized Rats. Front Pharmacol 2021;12:630210. [PMID: 33841151 DOI: 10.3389/fphar.2021.630210] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
422 Zhou K, Zhu X, Ma K, Liu J, Nürnberg B, Gawaz M, Lang F. Effect of MgCl2 and GdCl3 on ORAI1 Expression and Store-Operated Ca2+ Entry in Megakaryocytes. Int J Mol Sci 2021;22:3292. [PMID: 33804889 DOI: 10.3390/ijms22073292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
423 Li P, Liu Y, Qin X, Chen K, Wang R, Yuan L, Chen X, Hao C, Huang X. SIRT1 attenuates renal fibrosis by repressing HIF-2α. Cell Death Discov 2021;7:59. [PMID: 33758176 DOI: 10.1038/s41420-021-00443-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
424 Basile DP, Ullah MM, Collet JA, Mehrotra P. T helper 17 cells in the pathophysiology of acute and chronic kidney disease. Kidney Res Clin Pract 2021;40:12-28. [PMID: 33789382 DOI: 10.23876/j.krcp.20.185] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
425 Luo D, Zhao W, Lin Z, Wu J, Lin H, Li Y, Song J, Zhang J, Peng H. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses. Front Cell Infect Microbiol 2021;11:579386. [PMID: 33834002 DOI: 10.3389/fcimb.2021.579386] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
426 Hu S, Hu H, Wang R, He H, Shui H. microRNA-29b prevents renal fibrosis by attenuating renal tubular epithelial cell-mesenchymal transition through targeting the PI3K/AKT pathway. Int Urol Nephrol 2021;53:1941-50. [PMID: 33742315 DOI: 10.1007/s11255-021-02836-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
427 Geng TT, Jafar TH, Neelakantan N, Yuan JM, van Dam RM, Koh WP. Healthful dietary patterns and risk of end-stage kidney disease: the Singapore Chinese Health Study. Am J Clin Nutr 2021;113:675-83. [PMID: 33381807 DOI: 10.1093/ajcn/nqaa348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
428 Bandach I, Segev Y, Landau D. Experimental modulation of Interleukin 1 shows its key role in chronic kidney disease progression and anemia. Sci Rep 2021;11:6288. [PMID: 33737665 DOI: 10.1038/s41598-021-85778-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
429 Zhou LT, Zhang ZJ, Cao JY, Chen H, Zhu YS, Wu X, Nawabi AQ, Liu X, Shan W, Zhang Y, Zhang XR, Xue J, Hu L, Wang SS, Wang L, Sun ZX. The unique molecular mechanism of diabetic nephropathy: a bioinformatics analysis of over 250 microarray datasets. Clin Kidney J 2021;14:1626-38. [PMID: 34084458 DOI: 10.1093/ckj/sfaa190] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
430 Palmerini C, Piscitani L, Bologna G, Riganti C, Lanuti P, Mandatori D, Di Liberato L, Di Fulvio G, Sirolli V, Renda G, Pipino C, Marchisio M, Bonomini M, Pandolfi A, Di Pietro N. Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis. Int J Mol Sci 2021;22:3049. [PMID: 33802652 DOI: 10.3390/ijms22063049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
431 Wu Y, Zhang C, Guo R, Wu D, Shi J, Li L, Chu Y, Yuan X, Gao J. Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy. Stem Cells Int 2021;2021:6620811. [PMID: 33815509 DOI: 10.1155/2021/6620811] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
432 Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation 2021;143:1157-72. [PMID: 33720773 DOI: 10.1161/CIRCULATIONAHA.120.050686] [Cited by in Crossref: 12] [Cited by in F6Publishing: 117] [Article Influence: 12.0] [Reference Citation Analysis]
433 Li N, Huang H, Linsheng L, Lu H, Liu X. Improving glomerular filtration rate estimation by semi-supervised learning: a development and external validation study. Int Urol Nephrol 2021;53:1649-58. [PMID: 33710531 DOI: 10.1007/s11255-020-02771-w] [Reference Citation Analysis]
434 Xu H, Peng W, Yang Z, Zhang Y, Xia C, Li Z, Xu R, Guo Y. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping. J Cardiovasc Magn Reson 2021;23:23. [PMID: 33691727 DOI: 10.1186/s12968-021-00713-8] [Reference Citation Analysis]
435 Liu M, Legault V, Fülöp T, Côté AM, Gravel D, Blanchet FG, Leung DL, Lee SJ, Nakazato Y, Cohen AA. Prediction of Mortality in Hemodialysis Patients Using Moving Multivariate Distance. Front Physiol 2021;12:612494. [PMID: 33776784 DOI: 10.3389/fphys.2021.612494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
436 Chuang YH, Lin IF, Lao XQ, Lin C, Chan TC. The Association Between Renal Function Decline and the Incidence of Urothelial Carcinoma: A 16-year Retrospective Cohort Study in Taiwan. Eur Urol Open Sci 2021;27:1-9. [PMID: 34337511 DOI: 10.1016/j.euros.2021.02.004] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
437 Jung HW, Choi IY, Shin DW, Han K, Yoo JE, Chun S, Yi Y. Association between physical performance and incidence of end-stage renal disease in older adults: a national wide cohort study. BMC Nephrol 2021;22:85. [PMID: 33691641 DOI: 10.1186/s12882-021-02291-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
438 Figueroa SM, Araos P, Reyes J, Gravez B, Barrera-Chimal J, Amador CA. Oxidized Albumin as a Mediator of Kidney Disease. Antioxidants (Basel) 2021;10:404. [PMID: 33800425 DOI: 10.3390/antiox10030404] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
439 Chen H, You Z, Zhang S, He C, He H, Luo M, Lin X, Zhang L, Lin K, Guo Y. Predictive value of preprocedural albuminuria for contrast-induced nephropathy non-recovery in patients undergoing percutaneous coronary intervention. Int Urol Nephrol 2021. [PMID: 33675474 DOI: 10.1007/s11255-021-02818-6] [Reference Citation Analysis]
440 Rizikalo A, Coric S, Matetic A, Vasilj M, Tocilj Z, Bozic J. Association of Glomerular Filtration Rate and Carotid Intima-Media Thickness in Non-Diabetic Chronic Kidney Disease Patients over a 4-Year Follow-Up. Life (Basel) 2021;11:204. [PMID: 33807694 DOI: 10.3390/life11030204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
441 Kannenkeril D, Janka R, Bosch A, Jung S, Kolwelter J, Striepe K, Ott C, Martirosian P, Schiffer M, Uder M, Schmieder RE. Detection of Changes in Renal Blood Flow Using Arterial Spin Labeling MRI. Am J Nephrol 2021;52:69-75. [PMID: 33677438 DOI: 10.1159/000513665] [Reference Citation Analysis]
442 Shen H, van der Kleij RMJJ, van der Boog PJM, Wang W, Song X, Li Z, Lou X, Chavannes N. Patients' and healthcare professionals' beliefs, perceptions and needs towards chronic kidney disease self-management in China: a qualitative study. BMJ Open 2021;11:e044059. [PMID: 33664078 DOI: 10.1136/bmjopen-2020-044059] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
443 Fleischmann D, Harloff M, Maslanka Figueroa S, Schlossmann J, Goepferich A. Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β Pathway. Int J Mol Sci 2021;22:2557. [PMID: 33806499 DOI: 10.3390/ijms22052557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
444 Ning M, Luo D, Ye G, Zhang T, Liu L, Peng F. Integrated management to reduce fistula-related long-term complications and improve the quality of life after arteriovenous fistula surgery: A retrospective cohort study. Nurs Open 2021;8:1856-62. [PMID: 33665975 DOI: 10.1002/nop2.839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Buendía-Martínez J, Barreda-Sánchez M, Rodríguez-Peña L, Ballesta-Martínez MJ, López-González V, Sánchez-Soler MJ, Serrano-Antón AT, Pérez-Tomás ME, Gil-Ferrer R, Avilés-Plaza F, Glover-López G, Carazo-Díaz C, Guillén-Navarro E. Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients. Orphanet J Rare Dis 2021;16:106. [PMID: 33639982 DOI: 10.1186/s13023-021-01742-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
446 Klaus R, Niyazi M, Lange-Sperandio B. Radiation-induced kidney toxicity: molecular and cellular pathogenesis. Radiat Oncol 2021;16:43. [PMID: 33632272 DOI: 10.1186/s13014-021-01764-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
447 Chang M, Chen B, Shaffner J, Dworkin LD, Gong R. Melanocortin System in Kidney Homeostasis and Disease: Novel Therapeutic Opportunities. Front Physiol 2021;12:651236. [PMID: 33716796 DOI: 10.3389/fphys.2021.651236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
448 Mousapour P, Barzin M, Valizadeh M, Mahdavi M, Azizi F, Hosseinpanah F. Comparison of the Modification of Diet in Renal Disease Study and Chronic Kidney Disease Epidemiology Collaboration Equations for Detection of Cardiovascular Risk: Tehran Lipid and Glucose Study. Int J Endocrinol Metab 2020;18:e101977. [PMID: 33613676 DOI: 10.5812/ijem.101977] [Reference Citation Analysis]
449 Wang YN, Hu HH, Zhang DD, Wu XQ, Liu JL, Guo Y, Miao H, Zhao YY. The Dysregulation of Eicosanoids and Bile Acids Correlates with Impaired Kidney Function and Renal Fibrosis in Chronic Renal Failure. Metabolites 2021;11:127. [PMID: 33672315 DOI: 10.3390/metabo11020127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
450 Yun JS, Park YM, Han K, Kim HW, Cha SA, Ahn YB, Ko SH. Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes. Sci Rep 2021;11:4305. [PMID: 33619302 DOI: 10.1038/s41598-021-82838-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
451 Yan Y, Zheng W, Ma Q, Chu C, Hu J, Wang K, Liao Y, Chen C, Yuan Y, Lv Y, Xu X, Wang Y, Mu J. Child-to-adult body mass index trajectories and the risk of subclinical renal damage in middle age. Int J Obes (Lond) 2021;45:1095-104. [PMID: 33608649 DOI: 10.1038/s41366-021-00779-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
452 Wang YN, Wu XQ, Zhang DD, Hu HH, Liu JL, Vaziri ND, Guo Y, Zhao YY, Miao H. Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites. Front Pharmacol 2021;12:633566. [PMID: 33679418 DOI: 10.3389/fphar.2021.633566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
453 Ishii T, Tanaka T, Nangaku M. Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease. Ther Clin Risk Manag 2021;17:155-63. [PMID: 33628028 DOI: 10.2147/TCRM.S293879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
454 Wu L, Rong C, Zhou Q, Zhao X, Zhuansun XM, Wan S, Sun MM, Wang SL. Bone Marrow Mesenchymal Stem Cells Ameliorate Cisplatin-Induced Renal Fibrosis via miR-146a-5p/Tfdp2 Axis in Renal Tubular Epithelial Cells. Front Immunol 2020;11:623693. [PMID: 33664736 DOI: 10.3389/fimmu.2020.623693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
455 Suzuki S, Kanaji S, Urakawa N, Takiguchi G, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Kakeji Y. Impact of chronic kidney disease stage on morbidity after gastrectomy for gastric cancer. Ann Gastroenterol Surg 2021;5:519-27. [PMID: 34337301 DOI: 10.1002/ags3.12441] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
456 Tsai HJ, Hung CH, Wang CW, Tu HP, Li CH, Tsai CC, Lin WY, Chen SC, Kuo CH. Associations among Heavy Metals and Proteinuria and Chronic Kidney Disease. Diagnostics (Basel) 2021;11:282. [PMID: 33670331 DOI: 10.3390/diagnostics11020282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
457 Petreski T, Piko N, Ekart R, Hojs R, Bevc S. Review on Inflammation Markers in Chronic Kidney Disease. Biomedicines 2021;9:182. [PMID: 33670423 DOI: 10.3390/biomedicines9020182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
458 Rinaldi L, Pafundi PC, Galiero R, Caturano A, Morone MV, Silvestri C, Giordano M, Salvatore T, Sasso FC. Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review. Antioxidants (Basel) 2021;10:270. [PMID: 33578702 DOI: 10.3390/antiox10020270] [Cited by in Crossref: 8] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
459 Wang L, Luo J, Liu W, Huang X, Xu J, Zhou Y, Jiang L, Yang J. Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic kidney disease patients. Ren Fail 2021;43:340-6. [PMID: 33567936 DOI: 10.1080/0886022X.2021.1880938] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
460 Ding B, Sun G, Liu S, Peng E, Wan M, Chen L, Jackson J, Atala A. Three-Dimensional Renal Organoids from Whole Kidney Cells: Generation, Optimization, and Potential Application in Nephrotoxicology In Vitro. Cell Transplant 2020;29:963689719897066. [PMID: 32166969 DOI: 10.1177/0963689719897066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
461 Sinusi R, Hargono A. Diabetes, Hypertension, Obesity, and Smoking as Risk Factors for Chronic Kidney Disease in Productive Age. JBE 2021;9:88. [DOI: 10.20473/jbe.v9i12021.88-95] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Li L, Zhou G, Fu R, He Y, Xiao L, Peng F, Yuan C. Polysaccharides extracted from balanophora polyandra Griff (BPP) ameliorate renal Fibrosis and EMT via inhibiting the Hedgehog pathway. J Cell Mol Med 2021;25:2828-40. [PMID: 33507617 DOI: 10.1111/jcmm.16313] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
463 Guo G, Huang A, Huang X, Xu T, Yao L. Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis. Dis Markers 2021;2021:8881393. [PMID: 33574967 DOI: 10.1155/2021/8881393] [Reference Citation Analysis]
464 Düsing P, Zietzer A, Goody PR, Hosen MR, Kurts C, Nickenig G, Jansen F. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J Mol Med (Berl) 2021;99:335-48. [PMID: 33481059 DOI: 10.1007/s00109-021-02037-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
465 Restivo I, Attanzio A, Tesoriere L, Allegra M. Suicidal Erythrocyte Death in Metabolic Syndrome. Antioxidants (Basel) 2021;10:154. [PMID: 33494379 DOI: 10.3390/antiox10020154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
466 Zhang Y, Zhang C, Li L, Liang X, Cheng P, Li Q, Chang X, Wang K, Huang S, Li Y, Liu Y, Xu G. Lymphangiogenesis in renal fibrosis arises from macrophages via VEGF-C/VEGFR3-dependent autophagy and polarization. Cell Death Dis 2021;12:109. [PMID: 33479195 DOI: 10.1038/s41419-020-03385-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
467 Krajewski PK, Olczyk P, Krajewska M, Krajewski W, Szepietowski JC. Clinical Characteristics of Itch in Renal Transplant Recipients. Front Med (Lausanne) 2020;7:615334. [PMID: 33553209 DOI: 10.3389/fmed.2020.615334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
468 Lanthier L, Plourde MÉ, Cauchon M. [In patients with type 2 diabetes, chronic kidney disease and albuminuria, is finerenone, a selective minerocorticoid receptor antagonist, effective and safe for lowering CKD progression?]. Rev Med Interne 2021;42:144-5. [PMID: 33455835 DOI: 10.1016/j.revmed.2020.12.013] [Reference Citation Analysis]
469 Niu SF, Wu CK, Chuang NC, Yang YB, Chang TH. Early Chronic Kidney Disease Care Programme delays kidney function deterioration in patients with stage I-IIIa chronic kidney disease: an observational cohort study in Taiwan. BMJ Open 2021;11:e041210. [PMID: 33468527 DOI: 10.1136/bmjopen-2020-041210] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
470 Limdi NA, Beasley TM, Sun J, Stockbridge N, Pacanowski M, Florian J. Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function. Clin Pharmacol Ther 2021;109:1593-605. [PMID: 33278832 DOI: 10.1002/cpt.2131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
471 Kim JY, Joo YS, Jhee JH, Han SH, Yoo TH, Kang SW, Park JT. Effect of Psychosocial Distress on the Rate of Kidney Function Decline. J Gen Intern Med 2021. [PMID: 33469756 DOI: 10.1007/s11606-020-06573-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
472 Wilson S, Mone P, Jankauskas SS, Gambardella J, Santulli G. Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk. J Clin Hypertens (Greenwich) 2021;23:831-4. [PMID: 33455061 DOI: 10.1111/jch.14186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
473 Han P, Cai Y, Wang Y, Weng W, Chen Y, Wang M, Zhan H, Yu X, Wang T, Shao M, Sun H. Artemether ameliorates kidney injury by restoring redox imbalance and improving mitochondrial function in Adriamycin nephropathy in mice. Sci Rep 2021;11:1266. [PMID: 33446820 DOI: 10.1038/s41598-020-80298-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
474 Khalil E. Mid-term results of tunneled brachial venous hemodialysis catheter placement: Our single-center experience with 21 patients. Turk Gogus Kalp Damar Cerrahisi Derg 2021;29:13-9. [PMID: 33768976 DOI: 10.5606/tgkdc.dergisi.2021.20398] [Reference Citation Analysis]
475 Xiong J, He T, Yu Z, Yang K, Chen F, Cheng J, Shi Y, Huang Y, Qiao Y, Li H, Shen Y, Zhao J. Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial. Trials 2021;22:37. [PMID: 33413594 DOI: 10.1186/s13063-020-04992-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
476 Hodel NC, Hamad A, Reither K, Kasella IM, Abdulla S, Schoetzau A, Hatz CFR, Mayr M. Comparison of Two Different Semiquantitative Urinary Dipstick Tests with Albumin-to-Creatinine Ratio for Screening and Classification of Albuminuria According to KDIGO. A Diagnostic Test Study. Diagnostics (Basel) 2021;11:81. [PMID: 33419091 DOI: 10.3390/diagnostics11010081] [Reference Citation Analysis]
477 Pan B, Zhang F, Sun J, Chen D, Huang W, Zhang H, Cao C, Wan X. Correlation of Indoleamine-2,3-Dioxygenase and Chronic Kidney Disease: A Pilot Study. J Immunol Res 2021;2021:8132569. [PMID: 33506062 DOI: 10.1155/2021/8132569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
478 Gonçalves JG, Canale D, de Bragança AC, Seguro AC, Shimizu MHM, Volpini RA. The Blockade of TACE-Dependent EGF Receptor Activation by Losartan-Erlotinib Combination Attenuates Renal Fibrosis Formation in 5/6-Nephrectomized Rats Under Vitamin D Deficiency. Front Med (Lausanne) 2020;7:609158. [PMID: 33469545 DOI: 10.3389/fmed.2020.609158] [Reference Citation Analysis]
479 Qin S, Wang A, Gu S, Wang W, Gao Z, Tang X, Yan L, Wan Q, Luo Z, Qin G, Chen L, Ning G, Mu Y. Association between obesity and urinary albumin-creatinine ratio in the middle-aged and elderly population of Southern and Northern China: a cross-sectional study. BMJ Open 2021;11:e040214. [PMID: 33402405 DOI: 10.1136/bmjopen-2020-040214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
480 Zhang J, Song K, Ping J, Du J, Sun Y, Zhang J, Qi M, Miao Y, Li Y. A biodegradable bismuth–gadolinium-based nano contrast agent for accurate identification and imaging of renal insufficiency in vivo. Inorg Chem Front 2021;8:4720-9. [DOI: 10.1039/d1qi00878a] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
481 Al-absi HRH, Refaee MA, Rehman AU, Islam MT, Belhaouari SB, Alam T. Risk Factors and Comorbidities Associated to Cardiovascular Disease in Qatar: A Machine Learning Based Case-Control Study. IEEE Access 2021;9:29929-41. [DOI: 10.1109/access.2021.3059469] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
482 Jia L, Dong X, Li X, Jia R, Zhang HL. Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis. Int J Med Sci 2021;18:811-20. [PMID: 33437217 DOI: 10.7150/ijms.51484] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
483 Kamprom W, Tawonsawatruk T, Mas-Oodi S, Anansilp K, Rattanasompattikul M, Supokawej A. P-cresol and Indoxyl Sulfate Impair Osteogenic Differentiation by Triggering Mesenchymal Stem Cell Senescence. Int J Med Sci 2021;18:744-55. [PMID: 33437209 DOI: 10.7150/ijms.48492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
484 Song X, Ji H, Zhao W, Sun S, Zhao C. Hemocompatibility enhancement of polyethersulfone membranes: Strategies and challenges. Advanced Membranes 2021;1:100013. [DOI: 10.1016/j.advmem.2021.100013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
485 Guerrero-Hue M, Rayego-Mateos S, Vázquez-Carballo C, Palomino-Antolín A, García-Caballero C, Opazo-Rios L, Morgado-Pascual JL, Herencia C, Mas S, Ortiz A, Rubio-Navarro A, Egea J, Villalba JM, Egido J, Moreno JA. Protective Role of Nrf2 in Renal Disease. Antioxidants (Basel) 2020;10:E39. [PMID: 33396350 DOI: 10.3390/antiox10010039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
486 Batiushin MM. Chronic Kidney Disease: Current State of the Problem. Racionalʹnaâ farmakoterapiâ v kardiologii 2020;16:938-47. [DOI: 10.20996/1819-6446-2020-11-06] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
487 Abdissa D. Purposeful Review to Identify Risk Factors, Epidemiology, Clinical Features, Treatment and Prevention of Chronic Kidney Disease of Unknown Etiology. Int J Nephrol Renovasc Dis 2020;13:367-77. [PMID: 33363397 DOI: 10.2147/IJNRD.S283161] [Reference Citation Analysis]
488 Igari K, Kudo T, Katsui S, Nishizawa M, Uetake H. The Comparison of Long-Term Results between Aortofemoral and Axillofemoral Bypass for Patients with Aortoiliac Occlusive Disease. Ann Thorac Cardiovasc Surg 2020;26:352-8. [PMID: 32321900 DOI: 10.5761/atcs.oa.19-00300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
489 Behrens F, Holle J, Kuebler WM, Simmons S. Extracellular vesicles as regulators of kidney function and disease. Intensive Care Med Exp 2020;8:22. [PMID: 33336297 DOI: 10.1186/s40635-020-00306-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
490 Gollie JM, Patel SS, Scholten JD, Harris-Love MO. Preliminary Study of the Effects of Eccentric-Overload Resistance Exercise on Physical Function and Torque Capacity in Chronic Kidney Disease. J Funct Morphol Kinesiol 2020;5:E97. [PMID: 33467312 DOI: 10.3390/jfmk5040097] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
491 Chen T, Wang X, Wang X, Chen H, Xiao H, Tang H, Feng L, Xiang Z, Zou H, Shao X. Comparison of Novel Metabolic Indices in Estimation of Chronic Kidney Diseases in a Southern Chinese Population. Diabetes Metab Syndr Obes 2020;13:4919-27. [PMID: 33328750 DOI: 10.2147/DMSO.S286565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
492 Li G, Huang J, Wang J, Zhao M, Liu Y, Guo X, Wu S, Zhang L. Long-Term Exposure to Ambient PM2.5 and Increased Risk of CKD Prevalence in China. J Am Soc Nephrol 2021;32:448-58. [PMID: 33334736 DOI: 10.1681/ASN.2020040517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
493 Lázaro-Martínez JL, Álvaro-Afonso FJ, Sevillano-Fernández D, García-Álvarez Y, Sanz-Corbalan I, García-Morales E. Cellular Proliferation, Dermal Repair, and Microbiological Effectiveness of Ultrasound-Assisted Wound Debridement (UAW) Versus Standard Wound Treatment in Complicated Diabetic Foot Ulcers (DFU): An Open-Label Randomized Controlled Trial. J Clin Med 2020;9:E4032. [PMID: 33322200 DOI: 10.3390/jcm9124032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
494 Hu R, Gao L, Chen P, Wu B, Wu X, Xu H. How Do You Feel Now? The Salience Network Functional Connectivity in End-Stage Renal Disease. Front Neurosci 2020;14:533910. [PMID: 33304233 DOI: 10.3389/fnins.2020.533910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
495 Xu J, Zhou L, Liu Y. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies. Front Pharmacol 2020;11:601325. [PMID: 33362554 DOI: 10.3389/fphar.2020.601325] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
496 de Boer ECW, van Mourik AG, Jongerius I. Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease. Front Immunol 2020;11:578069. [PMID: 33362763 DOI: 10.3389/fimmu.2020.578069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
497 Ribeiro PC, Lojudice FH, Fernandes-Charpiot IMM, Baptista MASF, de Almeida Araújo S, Mendes GEF, Sogayar MC, Abbud-Filho M, Caldas HC. Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease. Stem Cell Res Ther 2020;11:530. [PMID: 33298161 DOI: 10.1186/s13287-020-02060-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
498 Chacar FC, Kogika MM, Zafalon RVA, Brunetto MA. Vitamin D Metabolism and Its Role in Mineral and Bone Disorders in Chronic Kidney Disease in Humans, Dogs and Cats. Metabolites 2020;10:E499. [PMID: 33291777 DOI: 10.3390/metabo10120499] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
499 Zhang S, Wang Y, Zhu Y, Li X, Song Y, Yuan J. Rotating Night Shift Work, Exposure to Light at Night, and Glomerular Filtration Rate: Baseline Results from a Chinese Occupational Cohort. Int J Environ Res Public Health 2020;17:E9035. [PMID: 33291553 DOI: 10.3390/ijerph17239035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
500 Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, Zhang L, Zhang C, Bian W, Zuo L, Gao X, Zhu B, Lei XG, Gu Z, Cui W, Xu X, Li Z, Zhu B, Li Y, Chen S, Guo H, Zhang H, Sun J, Zhang M, Hui Y, Zhang X, Liu X, Sun B, Wang L, Qiu Q, Zhang Y, Li X, Liu W, Xue R, Wu H, Shao D, Li J, Zhou Y, Li S, Yang R, Pedersen OB, Yu Z, Ehrlich SD, Ren F. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 2020;69:2131-42. [PMID: 32241904 DOI: 10.1136/gutjnl-2019-319766] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 40.5] [Reference Citation Analysis]
501 Tuttle KR, Knight R, Appelbaum PS, Arora T, Bansal S, Bebiak J, Brown K, Campbell C, Cooperman L, Corona-Villalobos CP, Dighe A, de Boer IH, Hall DE, Jefferson N, Jolly S, Kermani A, Lee SC, Mehl K, Murugan R, Roberts GV, Rosas SE, Himmelfarb J, Miller RT; Kidney Precision Medicine Project. Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project. Clin J Am Soc Nephrol 2021;16:660-8. [PMID: 33257411 DOI: 10.2215/CJN.10270620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
502 Jin H, Yu J, Lin S, Gao S, Yang H, Haick H, Hua C, Deng S, Yang T, Liu Y, Shen W, Zhang X, Zhang X, Shan S, Ren T, Wang L, Cheung W, Kam W, Miao J, Chen D, Cui D. Nanosensor-Based Flexible Electronic Assisted with Light Fidelity Communicating Technology for Volatolomics-Based Telemedicine. ACS Nano 2020;14:15517-32. [PMID: 33141556 DOI: 10.1021/acsnano.0c06137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
503 Akamine S, Marutani N, Kanayama D, Gotoh S, Maruyama R, Yanagida K, Sakagami Y, Mori K, Adachi H, Kozawa J, Maeda N, Otsuki M, Matsuoka T, Iwahashi H, Shimomura I, Ikeda M, Kudo T. Renal function is associated with blood neurofilament light chain level in older adults. Sci Rep 2020;10:20350. [PMID: 33230211 DOI: 10.1038/s41598-020-76990-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
504 Chen Y, Yan Q, Lv M, Song K, Dai Y, Huang Y, Zhang L, Zhang C, Gao H. Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis. Cell Death Dis 2020;11:994. [PMID: 33219209 DOI: 10.1038/s41419-020-03199-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
505 Ning Y, Chen J, Shi Y, Song N, Yu X, Fang Y, Ding X. Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5. Front Pharmacol 2020;11:579265. [PMID: 33364952 DOI: 10.3389/fphar.2020.579265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
506 Qiu X, Xu Q, Xu T, Wan P, Sheng Z, Han Y, Yao L. Metformin alleviates β-glycerophosphate-induced calcification of vascular smooth muscle cells via AMPK/mTOR-activated autophagy. Exp Ther Med 2021;21:58. [PMID: 33365058 DOI: 10.3892/etm.2020.9490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
507 Shen H, van der Kleij R, van der Boog PJM, Song X, Wang W, Zhang T, Li Z, Lou X, Chavannes N. Development and evaluation of an eHealth self-management intervention for patients with chronic kidney disease in China: protocol for a mixed-method hybrid type 2 trial. BMC Nephrol 2020;21:495. [PMID: 33213398 DOI: 10.1186/s12882-020-02160-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
508 Zhang NH, Luo R, Cheng YC, Ge SW, Xu G. Leisure-Time Physical Activity and Mortality in CKD: A 1999-2012 NHANES Analysis. Am J Nephrol 2020;51:919-29. [PMID: 33207339 DOI: 10.1159/000511685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
509 Pillay Y, Nagiah S, Phulukdaree A, Krishnan A, Chuturgoon AA. Patulin suppresses α1-adrenergic receptor expression in HEK293 cells. Sci Rep 2020;10:20115. [PMID: 33208818 DOI: 10.1038/s41598-020-77157-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
510 Molla MD, Degef M, Bekele A, Geto Z, Challa F, Lejisa T, Getahun T, Sileshi M, Tolcha Y, Ashebir G, Seifu D. Assessment of serum electrolytes and kidney function test for screening of chronic kidney disease among Ethiopian Public Health Institute staff members, Addis Ababa, Ethiopia. BMC Nephrol 2020;21:494. [PMID: 33208123 DOI: 10.1186/s12882-020-02166-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
511 Huang JF, Zheng XQ, Sun XL, Zhou X, Liu J, Li YM, Wang XY, Zhang XL, Wu AM. Association between Bone Mineral Density and Severity of Chronic Kidney Disease. Int J Endocrinol 2020;2020:8852690. [PMID: 33193760 DOI: 10.1155/2020/8852690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
512 Kalayci M, Hassan IA, Keinan IA, Cetinkaya E, Suren E, Tahtabasi M, Sumbul HE. The Effect of Hemodialysis on Axial Length, Ocular Surface, and Intraocular Pressure in Patients with End-Stage Renal Failure. Int J Gen Med 2020;13:1035-42. [PMID: 33192087 DOI: 10.2147/IJGM.S281546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
513 Sass R, Finlay J, Rossum K, Soroka KV, McCormick M, Desjarlais A, Vorster H, Fontaine G, Ferreira Da Silva P, James M, Sood MM, Tong A, Pannu N, Tennankore K, Thompson S, Tonelli M, Bohm C. Patient, Caregiver, and Provider Perspectives on Challenges and Solutions to Individualization of Care in Hemodialysis: A Qualitative Study. Can J Kidney Health Dis 2020;7:2054358120970715. [PMID: 33240519 DOI: 10.1177/2054358120970715] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
514 Hu Y, Wen X, Ni L, Wang F, Hu S, Fang F. Effects of telemedicine intervention on the management of diabetic complications in type 2 diabetes. Int J Diabetes Dev Ctries 2021;41:322-8. [DOI: 10.1007/s13410-020-00893-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
515 Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Watanabe A, Sakamoto K, Kokaze A. Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study. BMC Nephrol 2020;21:471. [PMID: 33172399 DOI: 10.1186/s12882-020-02144-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
516 Arman T, Lynch KD, Goedken M, Clarke JD. Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol diet. Chemosphere 2021;269:128773. [PMID: 33143886 DOI: 10.1016/j.chemosphere.2020.128773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
517 Zhao J, Sun W, Chen J, Sun Z, Chen D, Cao C, Yang M, Ma J, Wang L, Xing C, Chen Y, Sheng M, Zhou E, Xu L, Gao K, Liu L, Liu Q, Yi L, He W, Zhu Y. Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Evid Based Complement Alternat Med 2020;2020:4073901. [PMID: 33144869 DOI: 10.1155/2020/4073901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
518 Dorotea D, Ha H. Activation of β2 adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases. Arch Pharm Res 2021;44:49-62. [PMID: 33155167 DOI: 10.1007/s12272-020-01280-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
519 Zhou S, Yin X, Mayr M, Noor M, Hylands PJ, Xu Q. Proteomic landscape of TGF-β1-induced fibrogenesis in renal fibroblasts. Sci Rep 2020;10:19054. [PMID: 33149203 DOI: 10.1038/s41598-020-75989-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
520 Michna M, Kovarova L, Valerianova A, Malikova H, Weichet J, Malik J. Review of the structural and functional brain changes associated with chronic kidney disease. Physiol Res 2020;69:1013-28. [PMID: 33129242 DOI: 10.33549/physiolres.934420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
521 Cordero-pérez P, Sánchez-martínez C, García-hernández PA, Saucedo AL. Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators. Nefrología (English Edition) 2020;40:585-96. [DOI: 10.1016/j.nefroe.2020.12.002] [Reference Citation Analysis]
522 Cordero-Pérez P, Sánchez-Martínez C, García-Hernández PA, Saucedo AL. Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators. Nefrologia (Engl Ed) 2020;40:585-96. [PMID: 33036786 DOI: 10.1016/j.nefro.2020.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Silva Junior GB, Fraser SDS, Néri AKM, Xavier RMF, Mota RMS, Lopes AA, Mill JG, Barreto SM, Luft VC, Chor D, Santos CAST, Lotufo PA, Matos SMA. Association between dietary patterns and renal function in a cross-sectional study using baseline data from the ELSA-Brasil cohort. Braz J Med Biol Res 2020;53:e10230. [PMID: 33146283 DOI: 10.1590/1414-431X202010230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
524 Molokhia M, Okoli GN, Redmond P, Asgari E, Shaw C, Schofield P, Ashworth M, Durbaba S, Nitsch D. Uncoded chronic kidney disease in primary care: a cross-sectional study of inequalities and cardiovascular disease risk management. Br J Gen Pract 2020;70:e785-92. [PMID: 33077509 DOI: 10.3399/bjgp20X713105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
525 Kamath CC, Dobler CC, McCoy RG, Lampman MA, Pajouhi A, Erwin PJ, Matulis J, Elrashidi M, Darcel J, Alsawas M, Wang Z, Shah ND, Murad MH, Thorsteinsdottir B. Improving Blood Pressure Management in Primary Care Patients with Chronic Kidney Disease: a Systematic Review of Interventions and Implementation Strategies. J Gen Intern Med 2020;35:849-69. [PMID: 33107008 DOI: 10.1007/s11606-020-06103-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
526 Basturk T, Ojalvo D, Mazi EE, Hasbal NB, Ozagari AA, Ahbap E, Sakaci T, Koc Y, Sevinc M, Unsal A. Pentraxin-2 is Associated with Renal Fibrosis in Patients Undergoing Renal Biopsy. Clinics (Sao Paulo) 2020;75:e1809. [PMID: 33146353 DOI: 10.6061/clinics/2020/e1809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
527 Glenn DA, Denburg MR. Bone Health in Glomerular Kidney Disease. Curr Osteoporos Rep 2019;17:570-9. [PMID: 31734906 DOI: 10.1007/s11914-019-00531-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
528 Wang Y, Kong W, Wang L, Zhang T, Huang B, Meng J, Yang B, Xie Z, Zhou H. Multiple-Purpose Connectivity Map Analysis Reveals the Benefits of Esculetin to Hyperuricemia and Renal Fibrosis. Int J Mol Sci 2020;21:E7695. [PMID: 33080936 DOI: 10.3390/ijms21207695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
529 Hwang SJ, Tan NC, Yoon S, Ramakrishnan C, Paulpandi M, Gun S, Lee JY, Chang ZY, Jafar TH. Perceived barriers and facilitators to chronic kidney disease care among patients in Singapore: a qualitative study. BMJ Open 2020;10:e041788. [PMID: 33067304 DOI: 10.1136/bmjopen-2020-041788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
530 Stanimirova I, Banasik M, Ząbek A, Dawiskiba T, Kościelska-Kasprzak K, Wojtowicz W, Krajewska M, Janczak D, Młynarz P. Serum metabolomics approach to monitor the changes in metabolite profiles following renal transplantation. Sci Rep 2020;10:17223. [PMID: 33057167 DOI: 10.1038/s41598-020-74245-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
531 Aitekenov S, Gaipov A, Bukasov R. Review: Detection and quantification of proteins in human urine. Talanta 2021;223:121718. [PMID: 33303164 DOI: 10.1016/j.talanta.2020.121718] [Cited by in Crossref: 9] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
532 Sorensen CJ, Butler-Dawson J, Dally M, Krisher L, Griffin BR, Johnson RJ, Lemery J, Asensio C, Tenney L, Newman LS. Risk Factors and Mechanisms Underlying Cross-Shift Decline in Kidney Function in Guatemalan Sugarcane Workers. J Occup Environ Med 2019;61:239-50. [PMID: 30575695 DOI: 10.1097/JOM.0000000000001529] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 12.5] [Reference Citation Analysis]
533 Papadimitriou A, Romagnani P, Angelotti ML, Noor M, Corcoran J, Raby K, Wilson PD, Li J, Fraser D, Piedagnel R, Hendry BM, Xu Q. Collecting duct cells show differential retinoic acid responses to acute versus chronic kidney injury stimuli. Sci Rep 2020;10:16683. [PMID: 33028882 DOI: 10.1038/s41598-020-73099-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
534 Roy A, Maiti A, Sinha A, Baidya A, Basu AK, Sarkar D, Sanyal D, Biswas D, Maisnam I, Pandit K, Raychaudhuri M, Sengupta N, Chakraborty PP, Mukhopadhyay P, Raychaudhuri P, Sahana PK, Chatterjee P, Bhattacharjee R, Dasgupta R, Saraogi RK, Pal SK, Mukhopadhyay S, Mukhopadhyay S, Goswami S, Chowdhury S, Ghosh S; Working Group of the Endocrine Society of Bengal . Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement. Diabetes Ther 2020;11:2791-827. [PMID: 33025397 DOI: 10.1007/s13300-020-00921-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
535 Gomes MB, Pizarro MH, Muniz LH, Barros BSV, Melo LGN, Santos DC, Negrato CA. Prevalence of chronic kidney disease in an admixed population of patients with type 1 diabetes. A multicenter study in Brazil. Diabetes Res Clin Pract 2020;170:108490. [PMID: 33010359 DOI: 10.1016/j.diabres.2020.108490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
536 Corsonello A, Fabbietti P, Formiga F, Moreno-Gonzalez R, Tap L, Mattace-Raso F, Roller-Wirnsberger R, Wirnsberger G, Ärnlöv J, Carlsson AC, Weingart C, Freiberger E, Kostka T, Guligowska A, Gil P, Martinez SL, Melzer I, Yehoshua I, Lattanzio F; SCOPE investigators. Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) study. BMC Geriatr 2020;20:350. [PMID: 33008303 DOI: 10.1186/s12877-020-01696-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
537 Shi Y, Peng H, Chen Y, Deng J, Li W, He J, Xiong J. Implementation of Cluster-Based Management Strategies for Patients With Chronic Kidney Disease. The Journal for Nurse Practitioners 2020;16:689-94. [DOI: 10.1016/j.nurpra.2020.07.003] [Reference Citation Analysis]
538 Magee LA, Sharma S, Sevene E, Qureshi RN, Mallapur A, Macuácua SE, Goudar S, Bellad MB, Adetoro OO, Payne BA, Sotunsa J, Valá A, Bone J, Shennan AH, Vidler M, Bhutta ZA, von Dadelszen P; & the Community-Level Interventions for Pre-eclampsia Study Group. Population-level data on antenatal screening for proteinuria; India, Mozambique, Nigeria, Pakistan. Bull World Health Organ 2020;98:661-70. [PMID: 33177756 DOI: 10.2471/BLT.19.248898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
539 Wilkinson TJ, Watson EL, Vadaszy N, Baker LA, Viana JL, Smith AC. Response of the oxygen uptake efficiency slope to exercise training in patients with chronic kidney disease. Kidney Res Clin Pract 2020;39:305-17. [PMID: 32550710 DOI: 10.23876/j.krcp.20.032] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
540 Coluzzi F, Caputi FF, Billeci D, Pastore AL, Candeletti S, Rocco M, Romualdi P. Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists. Ther Clin Risk Manag 2020;16:821-37. [PMID: 32982255 DOI: 10.2147/TCRM.S262843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
541 Banik SD, Cardoza RH, González RMM, Solis ALG. Fasting plasma glucose, lipid ratios, and atherogenic coefficient are the risk factors for hypertension in chronic kidney disease patients on hemodialysis: A report from the Regional High Speciality Hospital of Peninsular Yucatan, Mexico. Anthropological Review 2020;83:251-60. [DOI: 10.2478/anre-2020-0019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
542 Sun J, Su H, Lou Y, Wang M. Association Between Serum Albumin Level and All-Cause Mortality in Patients With Chronic Kidney Disease: A Retrospective Cohort Study. Am J Med Sci 2021;361:451-60. [PMID: 32958160 DOI: 10.1016/j.amjms.2020.07.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
543 Huang Y, Wang S, Zhou J, Liu Y, Du C, Yang K, Bi X, Liu M, Han W, Wang K, Xiong J, Wang S, Wang Y, Nie L, Liu C, Zhang D, Gu J, Zeng C, Zhao J. IRF1-mediated downregulation of PGC1α contributes to cardiorenal syndrome type 4. Nat Commun 2020;11:4664. [PMID: 32938919 DOI: 10.1038/s41467-020-18519-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
544 Alves ADR, Langella BB, Barbosa JR, Lima DM, Colares JKB, Garcia RCNC, Pinto MA, Villar LM, Amado LA. High prevalence of parvovirus B19 infection in patients with chronic kidney disease under hemodialysis: A multicenter study. Int J Infect Dis 2020;100:350-6. [PMID: 32927082 DOI: 10.1016/j.ijid.2020.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
545 Mertowski S, Lipa P, Morawska I, Niedźwiedzka-Rystwej P, Bębnowska D, Hrynkiewicz R, Grywalska E, Roliński J, Załuska W. Toll-Like Receptor as a Potential Biomarker in Renal Diseases. Int J Mol Sci 2020;21:E6712. [PMID: 32933213 DOI: 10.3390/ijms21186712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
546 Walbaum M, Scholes S, Pizzo E, Paccot M, Mindell JS. Chronic kidney disease in adults aged 18 years and older in Chile: findings from the cross-sectional Chilean National Health Surveys 2009-2010 and 2016-2017. BMJ Open 2020;10:e037720. [PMID: 32883732 DOI: 10.1136/bmjopen-2020-037720] [Reference Citation Analysis]
547 Bonezi V, Genvigir FDV, Salgado PC, Felipe CR, Tedesco-Silva H Jr, Medina-Pestana JO, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy. Ann Transl Med 2020;8:1051. [PMID: 33145270 DOI: 10.21037/atm-20-1757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
548 Pan Y, Lee CY, Lee LM, Wen YC, Huang JY, Yang SF, Hsiao CH. Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study. Medicina (Kaunas) 2020;56:E441. [PMID: 32878139 DOI: 10.3390/medicina56090441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
549 Buchanan S, Combet E, Stenvinkel P, Shiels PG. Klotho, Aging, and the Failing Kidney. Front Endocrinol (Lausanne) 2020;11:560. [PMID: 32982966 DOI: 10.3389/fendo.2020.00560] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
550 Liu KL, Tsai WC, Tu HP, Lee CH. Statin use and the risk of chronic kidney disease in patients with psoriasis: A nationwide cohort study in Taiwan. PLoS One 2020;15:e0237816. [PMID: 32841265 DOI: 10.1371/journal.pone.0237816] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
551 Haas Pizarro M, Conte Santos D, Gomes Nunes Melo L, Senger Vasconcelos Barros B, Harcar Muniz L, Porto LC, Silva DA, Bregman R, Brito Gomes M. Glomerular filtration rate estimated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in type 1 diabetes based on genomic ancestry. Diabetol Metab Syndr 2020;12:71. [PMID: 32821292 DOI: 10.1186/s13098-020-00578-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
552 Rocha KTD, Figueiredo AE. Letramento funcional em saúde na terapia renal substitutiva: revisão integrativa. Acta Paulista de Enfermagem 2020;33:eAPE20180124. [DOI: 10.37689/actaape/2020ri0124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
553 Saminathan TA, Hooi LS, Mohd Yusoff MF, Ong LM, Bavanandan S, Rodzlan Hasani WS, Tan EZZ, Wong I, Rifin HM, Robert TG, Ismail H, Wong NI, Ahmad G, Ambak R, Othman F, Abd Hamid HA, Aris T. Prevalence of chronic kidney disease and its associated factors in Malaysia; findings from a nationwide population-based cross-sectional study. BMC Nephrol 2020;21:344. [PMID: 32795256 DOI: 10.1186/s12882-020-01966-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
554 Olivera LM, Okuno MFP, Barbosa DA, Sesso RCC, Scherrer Júnior G, Pessoa JLE, Fonseca CDD, Belasco AGS. Quality of life and spirituality of patients with chronic kidney disease: pre- and post-transplant analysis. Rev Bras Enferm 2020;73 Suppl 5:e20190408. [PMID: 32785446 DOI: 10.1590/0034-7167-2019-0408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
555 Pinar U, Rod X, Mageau A, Renard Y, Lebacle C, Barrou B, Drouin S, Irani J, Bessede T. Surgical complications risk in obese and overweight recipients for kidney transplantation: a predictive morphometric model based on sarcopenia and vessel-to-skin distance. World J Urol 2021;39:2223-30. [PMID: 32785765 DOI: 10.1007/s00345-020-03407-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
556 Mendrinou E, Mashaly ME, Al Okily AM, Mohamed ME, Refaie AF, Elsawy EM, Saleh HH, Sheashaa H, Patrinos GP. CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients. Front Pharmacol 2020;11:1218. [PMID: 32848803 DOI: 10.3389/fphar.2020.01218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
557 Cardoso DF, Marques EA, Leal DV, Ferreira A, Baker LA, Smith AC, Viana JL. Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies. BMC Nephrol 2020;21:334. [PMID: 32770949 DOI: 10.1186/s12882-020-01999-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
558 Chen X, Wang Y, Wang W, Yuan L, Qi Z, Song D. Assessment of left ventricular energy loss using vector flow mapping in patients with stages 1-3 chronic kidney disease. BMC Cardiovasc Disord 2020;20:355. [PMID: 32741356 DOI: 10.1186/s12872-020-01640-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
559 Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K; World Kidney Day Steering Committee. Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care. Kidney Med 2020;2:5-11. [PMID: 32734223 DOI: 10.1016/j.xkme.2020.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
560 Kim SH, Jhee JH, Choi HY, Lee SH, Shin SK, Lee SY, Yang DH, Yi JH, Han SW, Jo YI, Park HC. New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study. BMC Nephrol 2020;21:317. [PMID: 32736531 DOI: 10.1186/s12882-020-01971-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
561 Santos-Díaz G, Pérez-Pico AM, Suárez-Santisteban MÁ, García-Bernalt V, Mayordomo R, Dorado P. Prevalence of Potential Drug-Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital. Pharmaceutics 2020;12:E713. [PMID: 32751436 DOI: 10.3390/pharmaceutics12080713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
562 Liljedahl Prytz K, Prag M, Fredlund H, Magnuson A, Sundqvist M, Källman J. Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis. PLoS One 2020;15:e0236864. [PMID: 32730359 DOI: 10.1371/journal.pone.0236864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
563 Yang Y, Wang Y, He Z, Liu Y, Chen C, Wang Y, Wang DW, Wang H. Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1. Front Pharmacol 2020;11:1136. [PMID: 32848753 DOI: 10.3389/fphar.2020.01136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
564 Sui W, Calvert JK, Kavoussi NL, Gould ER, Miller NL, Bejan CA, Hsi RS. Association of Chronic Kidney Disease Stage with 24-Hour Urine Values Among Patients with Nephrolithiasis. J Endourol 2020;34:1263-71. [PMID: 32578450 DOI: 10.1089/end.2020.0403] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
565 Li N, Tang H, Wu L, Ge H, Wang Y, Yu H, Zhang X, Ma J, Gu HF. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases. Phytother Res 2021;35:198-206. [PMID: 32716080 DOI: 10.1002/ptr.6818] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
566 Chen L, Wang Y, Li S, Zuo B, Zhang X, Wang F, Sun D. Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1/eNOS signaling pathway. Theranostics 2020;10:9425-42. [PMID: 32802201 DOI: 10.7150/thno.43315] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
567 Ingrosso D, Perna AF. DNA Methylation Dysfunction in Chronic Kidney Disease. Genes (Basel) 2020;11:E811. [PMID: 32708735 DOI: 10.3390/genes11070811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
568 Pretto CR, Winkelmann ER, Hildebrandt LM, Barbosa DA, Colet CF, Stumm EMF. Quality of life of chronic kidney patients on hemodialysis and related factors. Rev Lat Am Enfermagem 2020;28:e3327. [PMID: 32696925 DOI: 10.1590/1518-8345.3641.3327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
569 Di Rosa M, D'Alia S, Guarasci F, Soraci L, Pierpaoli E, Lenci F, Ricci M, Onder G, Volpato S, Ruggiero C, Cherubini A, Corsonello A, Lattanzio F. Cognitive Impairment, Chronic Kidney Disease, and 1-Year Mortality in Older Patients Discharged from Acute Care Hospital. J Clin Med 2020;9:E2202. [PMID: 32664677 DOI: 10.3390/jcm9072202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
570 Pedersen ML. Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken. Int J Circumpolar Health 2019;78:1709257. [PMID: 31996108 DOI: 10.1080/22423982.2019.1709257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
571 Cohen G. Immune Dysfunction in Uremia 2020. Toxins (Basel) 2020;12:E439. [PMID: 32635646 DOI: 10.3390/toxins12070439] [Cited by in Crossref: 14] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
572 Feng Z, Liu W, Jiang HX, Dai H, Gao C, Dong Z, Gao Y, Liu F, Zhang Z, Zhao Q, Zhang L, Liu B. How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy? Front Pharmacol 2020;11:994. [PMID: 32719601 DOI: 10.3389/fphar.2020.00994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
573 Jiang Y, Zhu Y, Zhen T, Li J, Xing K, He L, Zhu S. Transcriptomic analysis of the mechanisms of alleviating renal interstitial fibrosis using the traditional Chinese medicine Kangxianling in a rat model. Sci Rep 2020;10:10682. [PMID: 32606425 DOI: 10.1038/s41598-020-67690-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
574 Daimon M, Fujita T, Murabayashi M, Mizushiri S, Murakami H, Nishiya Y, Tanabe J, Matsuhashi Y, Yanagimachi M, Tokuda I, Sawada K, Ihara K. Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency. Front Med (Lausanne) 2020;7:221. [PMID: 32582730 DOI: 10.3389/fmed.2020.00221] [Reference Citation Analysis]
575 Atthakomol P, Manosroi W, Phinyo P, Pipanmekaporn T, Vaseenon T, Rojanasthien S. Prognostic Factors for All-Cause Mortality in Thai Patients with Fragility Fracture of Hip: Comorbidities and Laboratory Evaluations. Medicina (Kaunas) 2020;56:E311. [PMID: 32599880 DOI: 10.3390/medicina56060311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
576 Li J, Wu X, Luo M, Yan M, Wang Q, Li P, Niu W. Association of Serum Thyroid Hormones with the Risk and Severity of Chronic Kidney Disease Among 3563 Chinese Adults. Med Sci Monit 2020;26:e922910. [PMID: 32569261 DOI: 10.12659/MSM.922910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
577 Scinicariello F, Buser MC, Balluz L, Gehle K, Murray HE, Abadin HG, Attanasio R. Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009-2014. Chemosphere 2020;259:127446. [PMID: 32590180 DOI: 10.1016/j.chemosphere.2020.127446] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
578 Hu Y, Wang M, Pan Y, Li Q, Xu L. Salvianolic acid B attenuates renal interstitial fibrosis by regulating the HPSE/SDC1 axis. Mol Med Rep 2020;22:1325-34. [PMID: 32626974 DOI: 10.3892/mmr.2020.11229] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
579 Wang Q, Wang Y, Wang J, Zhang L, Zhao MH; Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). White-coat hypertension and incident end-stage renal disease in patients with non-dialysis chronic kidney disease: results from the C-STRIDE Study. J Transl Med 2020;18:238. [PMID: 32539728 DOI: 10.1186/s12967-020-02413-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
580 Sitjar-Suñer M, Suñer-Soler R, Masià-Plana A, Chirveches-Pérez E, Bertran-Noguer C, Fuentes-Pumarola C. Quality of Life and Social Support of People on Peritoneal Dialysis: Mixed Methods Research. Int J Environ Res Public Health 2020;17:E4240. [PMID: 32545857 DOI: 10.3390/ijerph17124240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
581 Shi FH, Shen L, Pan MM, Ma LL, Zhang C, Gu ZC, Ma J, Li H. The Successful Rapid Adjustment of Blood Glucose in a Patient With Acute Coronary Syndrome, Renal Insufficiency, and Diabetes: A Case Report of Management Coordinated by Clinical Pharmacists and Clinicians. Front Pharmacol 2020;11:756. [PMID: 32528289 DOI: 10.3389/fphar.2020.00756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
582 Wang Z, Zhou C, Sun Y, Chen Y, Xue D. Let-7c-5p Is Involved in Chronic Kidney Disease by Targeting TGF-β Signaling. Biomed Res Int 2020;2020:6960941. [PMID: 32626757 DOI: 10.1155/2020/6960941] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
583 Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K. Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care. Kidney Dis (Basel) 2020;6:136-43. [PMID: 32523955 DOI: 10.1159/000506528] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
584 Frainey BT, Fascelli M, Wood HM. Complications of Pediatric Bladder Reconstruction in the Adult Patient. Curr Bladder Dysfunct Rep 2020;15:173-81. [DOI: 10.1007/s11884-020-00584-2] [Reference Citation Analysis]
585 Huang Y, Zhou J, Wang S, Xiong J, Chen Y, Liu Y, Xiao T, Li Y, He T, Li Y, Bi X, Yang K, Han W, Qiao Y, Yu Y, Zhao J. Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment. Theranostics 2020;10:7384-400. [PMID: 32641998 DOI: 10.7150/thno.45455] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
586 Yu CS, Lin YJ, Lin CH, Lin SY, Wu JL, Chang SS. Development of an Online Health Care Assessment for Preventive Medicine: A Machine Learning Approach. J Med Internet Res 2020;22:e18585. [PMID: 32501272 DOI: 10.2196/18585] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
587 Stern-Zimmer M, Calderon-Margalit R, Skorecki K, Vivante A. Childhood risk factors for adulthood chronic kidney disease. Pediatr Nephrol 2021;36:1387-96. [PMID: 32500249 DOI: 10.1007/s00467-020-04611-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
588 Vieira ALS, Pazeli Júnior JM, Bastos MG. Role of point-of-care ultrasound during the COVID-19 pandemic: our recommendations in the management of dialytic patients. Ultrasound J 2020;12:30. [PMID: 32488686 DOI: 10.1186/s13089-020-00177-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
589 Tod P, Bukosza EN, Róka B, Kaucsár T, Fintha A, Krenács T, Szénási G, Hamar P. Post-Ischemic Renal Fibrosis Progression Is Halted by Delayed Contralateral Nephrectomy: The Involvement of Macrophage Activation. Int J Mol Sci 2020;21:E3825. [PMID: 32481551 DOI: 10.3390/ijms21113825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
590 Aleksic S, Eisenberg R, Tsomos E, Zahedpour Anaraki S, Japp E, Upadhyay L, Mowrey WB, Akalin E, Zonszein J. Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective study. Diabetes Res Clin Pract 2020;165:108221. [PMID: 32442553 DOI: 10.1016/j.diabres.2020.108221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
591 Mongaret C, Aubert L, Lestrille A, Albaut V, Kreit P, Herlem E, Noel N, Touré F, Lallier F, Slimano F, MIRPhO Investigators Study T. The Role of Community Pharmacists in the Detection of Clinically Relevant Drug-Related Problems in Chronic Kidney Disease Patients. Pharmacy (Basel) 2020;8:E89. [PMID: 32456115 DOI: 10.3390/pharmacy8020089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
592 Xi Y, Lu X, Zhu L, Sun X, Jiang Y, He W, Wei M. Clinical trial for conventional medicine integrated with traditional Chinese medicine (TCM) in the treatment of patients with chronic kidney disease. Medicine (Baltimore) 2020;99:e20234. [PMID: 32481298 DOI: 10.1097/MD.0000000000020234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
593 Chang J, Hou WW, Wang YF, Sun QM. Main Risk Factors Related to Activities of Daily Living in Non-Dialysis Patients with Chronic Kidney Disease Stage 3-5: A Case-Control Study. Clin Interv Aging 2020;15:609-18. [PMID: 32431494 DOI: 10.2147/CIA.S249137] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
594 Volaklis K, Mamadjanov T, Meisinger C. Sedentary behavior and kidney function in adults: a narrative review. Wien Klin Wochenschr 2021;133:144-52. [PMID: 32435869 DOI: 10.1007/s00508-020-01673-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
595 Wang Y, Xing QQ, Tu JK, Tang WB, Yuan XN, Xie YY, Wang W, Peng ZZ, Huang L, Xu H, Qin J, Xiao XC, Tao LJ, Yuan QJ. Involvement of hydrogen sulfide in the progression of renal fibrosis. Chin Med J (Engl) 2019;132:2872-80. [PMID: 31856060 DOI: 10.1097/CM9.0000000000000537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
596 Yeh SJ, Tang SC, Tsai LK, Chen CH, Hsu SP, Sun Y, Lien LM, Wei CY, Lai TC, Chen PL, Chen CC, Huang PH, Lin CH, Liu CH, Lin HJ, Hu CJ, Lin CL, Jeng JS, Hsu CY; and Taiwan Stroke Registry Investigators. Renal Function-Dependent Associations of Statins with Outcomes of Ischemic Stroke. J Atheroscler Thromb 2021;28:146-56. [PMID: 32418948 DOI: 10.5551/jat.55210] [Reference Citation Analysis]
597 Zaidan M, Burtin M, Zhang JD, Blanc T, Barre P, Garbay S, Nguyen C, Vasseur F, Yammine L, Germano S, Badi L, Gubler MC, Gallazzini M, Friedlander G, Pontoglio M, Terzi F. Signaling pathways predisposing to chronic kidney disease progression. JCI Insight 2020;5:126183. [PMID: 32376805 DOI: 10.1172/jci.insight.126183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
598 Espi M, Koppe L, Fouque D, Thaunat O. Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells. Toxins (Basel) 2020;12:E300. [PMID: 32384617 DOI: 10.3390/toxins12050300] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
599 Van den Bulck SA, Vankrunkelsven P, Goderis G, Van Pottelbergh G, Swerts J, Panis K, Hermens R. Developing quality indicators for Chronic Kidney Disease in primary care, extractable from the Electronic Medical Record. A Rand-modified Delphi method. BMC Nephrol 2020;21:161. [PMID: 32370742 DOI: 10.1186/s12882-020-01788-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
600 Chang J, Gao Y, Fang XY, Zhao SM, Hou YP, Sun QM. Individualized intervention for frail non-dialysis elderly patients with chronic kidney disease: protocol for a randomized controlled trial. BMC Geriatr 2020;20:159. [PMID: 32366214 DOI: 10.1186/s12877-020-1491-6] [Reference Citation Analysis]
601 Geng XQ, Ma A, He JZ, Wang L, Jia YL, Shao GY, Li M, Zhou H, Lin SQ, Ran JH, Yang BX. Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways. Acta Pharmacol Sin 2020;41:670-7. [PMID: 31804606 DOI: 10.1038/s41401-019-0324-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
602 Pan Q, Lu X, Zhao C, Liao S, Chen X, Guo F, Yang C, Liu HF. Metformin: the updated protective property in kidney disease. Aging (Albany NY) 2020;12:8742-59. [PMID: 32364526 DOI: 10.18632/aging.103095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
603 Gouya L, Ventura P, Balwani M, Bissell DM, Rees DC, Stölzel U, Phillips JD, Kauppinen R, Langendonk JG, Desnick RJ, Deybach JC, Bonkovsky HL, Parker C, Naik H, Badminton M, Stein PE, Minder E, Windyga J, Bruha R, Cappellini MD, Sardh E, Harper P, Sandberg S, Aarsand AK, Andersen J, Alegre F, Ivanova A, Talbi N, Chan A, Querbes W, Ko J, Penz C, Liu S, Lin T, Simon A, Anderson KE. EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks. Hepatology 2020;71:1546-58. [PMID: 31512765 DOI: 10.1002/hep.30936] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 25.5] [Reference Citation Analysis]
604 Pierpaoli E, Fabi K, Lenci FF, Ricci M, Di Rosa M, Onder G, Volpato S, Ruggiero C, Cherubini A, Corsonello A, Lattanzio F. Kidney function and cognitive impairment among older hospitalized patients: a comparison of four glomerular filtration rate equations. Aging Clin Exp Res 2020;32:841-50. [PMID: 31732959 DOI: 10.1007/s40520-019-01405-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
605 Su WY, Wu PY, Huang JC, Chen SC, Chang JM. Increased Proteinuria is Associated with Increased Aortic Arch Calcification, Cardio-Thoracic Ratio, Rapid Renal Progression and Increased Overall and Cardiovascular Mortality in Chronic Kidney Disease. Int J Med Sci 2020;17:1102-11. [PMID: 32410840 DOI: 10.7150/ijms.45470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
606 Korbut AI, Taskaeva IS, Bgatova NP, Muraleva NA, Orlov NB, Dashkin MV, Khotskina AS, Zavyalov EL, Konenkov VI, Klein T, Klimontov VV. SGLT2 inhibitor empagliflozin and DPP4 inhibitor linagliptin reactivate glomerular autophagy in db/db mice, a model of type 2 diabetes. Int J Mol Sci. 2020;21. [PMID: 32340263 DOI: 10.3390/ijms21082987] [Cited by in Crossref: 10] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
607 Yang K, Li W, Bai T, Xiao Y, Yu W, Luo P, Cheng F. Mindin deficiency alleviates renal fibrosis through inhibiting NF-κB and TGF-β/Smad pathways. J Cell Mol Med 2020;24:5740-50. [PMID: 32253812 DOI: 10.1111/jcmm.15236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
608 Lano G, Burtey S, Sallée M. Indoxyl Sulfate, a Uremic Endotheliotoxin. Toxins (Basel) 2020;12:E229. [PMID: 32260489 DOI: 10.3390/toxins12040229] [Cited by in Crossref: 22] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
609 Ren J, Crowley SD. A complex role for Bcl10 in kidney injury. Cardiovasc Res 2020;116:882-4. [PMID: 31808815 DOI: 10.1093/cvr/cvz320] [Reference Citation Analysis]
610 Chang TI, Lim H, Park CH, Rhee CM, Kalantar-Zadeh K, Kang EW, Kang SW, Han SH. Association Between Income Disparities and Risk of Chronic Kidney Disease: A Nationwide Cohort Study of Seven Million Adults in Korea. Mayo Clin Proc 2020;95:231-42. [PMID: 32029084 DOI: 10.1016/j.mayocp.2019.09.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
611 Malik AO, Spertus JA, Grantham JA, Peri-Okonny P, Gosch K, Sapontis J, Moses J, Lombardi W, Karmpaliotis D, Nicholson WJ, Al Badarin F, Salisbury AC. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Renal Dysfunction. Am J Cardiol 2020;125:1046-53. [PMID: 31955832 DOI: 10.1016/j.amjcard.2019.12.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
612 Nome RV, Cvancarova Småstuen M, Bjøro T, Kiserud CE, Fosså SD. Longitudinal kidney function outcome in aging testicular cancer survivors. Acta Oncol 2020;59:467-74. [PMID: 32043400 DOI: 10.1080/0284186X.2020.1724328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
613 Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K. Kidney Health for Everyone Everywhere: From Prevention to Detection and Equitable Access to Care. Can J Kidney Health Dis 2020;7:2054358120910569. [PMID: 32215213 DOI: 10.1177/2054358120910569] [Reference Citation Analysis]
614 Krajewska Wojciechowska J, Krajewski W, Zatoński T. Otorhinolaryngological dysfunctions induced by chronic kidney disease in pre- and post-transplant stages. Eur Arch Otorhinolaryngol 2020;277:1575-91. [PMID: 32222803 DOI: 10.1007/s00405-020-05925-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
615 Zang X, Du X, Li L, Mei C. Complications and outcomes of urgent-start peritoneal dialysis in elderly patients with end-stage renal disease in China: a retrospective cohort study. BMJ Open 2020;10:e032849. [PMID: 32205371 DOI: 10.1136/bmjopen-2019-032849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
616 Dorotea D, Koya D, Ha H. Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways. Front Pharmacol 2020;11:265. [PMID: 32256356 DOI: 10.3389/fphar.2020.00265] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
617 Liabeuf S, Laville SM, Glorieux G, Cheddani L, Brazier F, Titeca Beauport D, Valholder R, Choukroun G, Massy ZA. Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease. Int J Mol Sci 2020;21:E2031. [PMID: 32188143 DOI: 10.3390/ijms21062031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
618 Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K; World Kidney Day Steering Committee. Kidney Health for Everyone Everywhere: From Prevention to Detection and Equitable Access to Care. Am J Hypertens 2020;33:282-9. [PMID: 32168375 DOI: 10.1093/ajh/hpz184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
619 Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K; World Kidney Day 2020 Steering Committee. Kidney health for everyone everywhere - from prevention to detection and equitable access to care. Braz J Med Biol Res 2020;53:e9614. [PMID: 32159613 DOI: 10.1590/1414-431X20209614] [Reference Citation Analysis]
620 Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K; World Kidney Day Steering Committee. Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care. Kidney Int Rep 2020;5:245-51. [PMID: 32154446 DOI: 10.1016/j.ekir.2020.01.023] [Reference Citation Analysis]
621 Tanabe K, Wada J, Sato Y. Targeting angiogenesis and lymphangiogenesis in kidney disease. Nat Rev Nephrol 2020;16:289-303. [PMID: 32144398 DOI: 10.1038/s41581-020-0260-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
622 Qi R, Zhang W, Zheng L, Xu M, Rong R, Zhu T, Yang C. Cyclic helix B peptide ameliorates renal tubulointerstitial fibrosis induced by unilateral ureter obstruction via inhibiting NLRP3 pathway. Ann Transl Med 2020;8:167. [PMID: 32309314 DOI: 10.21037/atm.2020.02.12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
623 Mantovani A, Zusi C. PNPLA3 gene and kidney disease. Exploration of Medicine 2020;1:42-50. [DOI: 10.37349/emed.2020.00004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
624 Mai M, Jiang Y, Wu X, Liu G, Zhu Y, Zhu W. Association of TGF-β1, IL-4, and IL-10 Polymorphisms With Chronic Kidney Disease Susceptibility: A Meta-Analysis. Front Genet 2020;11:79. [PMID: 32174964 DOI: 10.3389/fgene.2020.00079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
625 You NN, Jiang WH, Lin MY, Li XG, Wu YY, Li JY, Zhou XY, Ding ZW, Wang JW, Zhao XX, Chen HL, Tang HT. The role of urinary renalase on early-stage renal damage in Chinese adults with primary hypertension. Exp Biol Med (Maywood) 2020;245:576-82. [PMID: 32102561 DOI: 10.1177/1535370220909311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
626 Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K; World Kidney Day Steering Committee. Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care. Indian J Nephrol 2020;30:63-71. [PMID: 32269428 DOI: 10.4103/ijn.IJN_50_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
627 Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno JM, Monsalve M, Ramos AM, Sanchez-Niño MD, Ruiz-Ortega M, Ortiz A, Sanz AB. The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases. Biomolecules 2020;10:E347. [PMID: 32102312 DOI: 10.3390/biom10020347] [Cited by in Crossref: 20] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
628 Hallan SI, Rifkin DE, Potok OA, Langlo KA, Dekker FW, Ix JH. Physicians' Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System. Kidney Med 2020;2:258-66. [PMID: 32734245 DOI: 10.1016/j.xkme.2019.12.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
629 Tonelli M, Nkunu V, Varghese C, Abu-Alfa AK, Alrukhaimi MN, Fox L, Gill J, Harris DCH, Hou FF, O'Connell PJ, Rashid HU, Niang A, Ossareh S, Tesar V, Zakharova E, Yang CW. Framework for establishing integrated kidney care programs in low- and middle-income countries. Kidney Int Suppl (2011) 2020;10:e19-23. [PMID: 32149006 DOI: 10.1016/j.kisu.2019.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
630 Moss RF, George HS, Nijhara S, Orr SE, Joshee L, Barkin JL, Bridges CC. Chronic kidney disease in pregnant mothers affects maternal and fetal disposition of mercury. Reprod Toxicol 2020;93:137-45. [PMID: 32084500 DOI: 10.1016/j.reprotox.2020.02.005] [Reference Citation Analysis]
631 Rukavina Mikusic NL, Kouyoumdzian NM, Choi MR. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Pflugers Arch 2020;472:303-20. [PMID: 32064574 DOI: 10.1007/s00424-020-02352-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
632 Shu CC, Wei YF, Yeh YC, Lin HH, Chen CY, Wang PH, Cheng SL, Wang JY, Yu CJ. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res 2020;21:51. [PMID: 32050967 DOI: 10.1186/s12931-020-1294-5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
633 Garcia-Fernandez N, Jacobs-Cachá C, Mora-Gutiérrez JM, Vergara A, Orbe J, Soler MJ. Matrix Metalloproteinases in Diabetic Kidney Disease. J Clin Med 2020;9:E472. [PMID: 32046355 DOI: 10.3390/jcm9020472] [Cited by in Crossref: 17] [Cited by in F6Publishing: 26] [Article Influence: 8.5] [Reference Citation Analysis]
634 Zhou C, Liu J, Ge Y, Zhu Y, Zhou L, Xu L, Xu Z, Wu R, Jia R. Remote Ischemic Preconditioning Ameliorates Renal Fibrosis After Ischemia-Reperfusion Injury via Transforming Growth Factor beta1 (TGF-β1) Signalling Pathway in Rats. Med Sci Monit 2020;26:e919185. [PMID: 32024811 DOI: 10.12659/MSM.919185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
635 Pelzl L, Sahu I, Ma K, Heinzmann D, Bhuyan AAM, Al-Maghout T, Sukkar B, Sharma Y, Marini I, Rigoni F, Artunc F, Cao H, Gutti R, Voelkl J, Pieske B, Gawaz M, Bakchoul T, Lang F. Beta-Glycerophosphate-Induced ORAI1 Expression and Store Operated Ca2+ Entry in Megakaryocytes. Sci Rep 2020;10:1728. [PMID: 32015442 DOI: 10.1038/s41598-020-58384-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
636 Kim JY, Steingroever J, Lee KH, Oh J, Choi MJ, Lee J, Larkins NG, Schaefer F, Hong SH, Jeong GH, Shin JI, Kronbichler A. Clinical Interventions and All-Cause Mortality of Patients with Chronic Kidney Disease: An Umbrella Systematic Review of Meta-Analyses. J Clin Med 2020;9:E394. [PMID: 32024136 DOI: 10.3390/jcm9020394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
637 Becker M, Gnirck AC, Turner JE. Innate Lymphoid Cells in Renal Inflammation. Front Immunol 2020;11:72. [PMID: 32063905 DOI: 10.3389/fimmu.2020.00072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
638 Marino C, Ferraro PM, Bargagli M, Cascini S, Agabiti N, Gambaro G, Davoli M. Prevalence of chronic kidney disease in the Lazio region, Italy: a classification algorithm based on health information systems. BMC Nephrol 2020;21:23. [PMID: 31992222 DOI: 10.1186/s12882-020-1689-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
639 Kim YJ, Yoon JH, Choi HS, Kim CS, Bae EH, Ma SK, Kim SW. Meal Frequency and Skipping Breakfast Are Associated with Chronic Kidney Disease. Nutrients 2020;12:E331. [PMID: 32012653 DOI: 10.3390/nu12020331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
640 Xia P, Gao K, Xie J, Sun W, Shi M, Li W, Zhao J, Yan J, Liu Q, Zheng M, Wang X, Wu Q, Zhou E, Chen J, Xv L, He W. Data Mining-Based Analysis of Chinese Medicinal Herb Formulae in Chronic Kidney Disease Treatment. Evid Based Complement Alternat Med 2020;2020:9719872. [PMID: 32047530 DOI: 10.1155/2020/9719872] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
641 Afkari R, Feizabadi MM, Ansari-Moghadam A, Safari T, Bokaeian M. Simultaneous use of oxalate-degrading bacteria and herbal extract to reduce the urinary oxalate in a rat model: A new strategy. Int Braz J Urol 2019;45:1249-59. [PMID: 31808414 DOI: 10.1590/S1677-5538.IBJU.2019.0167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
642 Xia CH, Han XT, Zhang X, Zhu ZB, Guo J, Cui HL, Jiang HX, Huang WJ, Chen GZ, Liu YN, Liu WJ. Yiqihuoxue Formula Activates Autophagy and Offers Renoprotection in a Rat Model of Adenine-Induced Kidney Disease. Evid Based Complement Alternat Med 2019;2019:3423981. [PMID: 31949466 DOI: 10.1155/2019/3423981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
643 Nagy A, Pethő D, Gáll T, Zavaczki E, Nyitrai M, Posta J, Zarjou A, Agarwal A, Balla G, Balla J. Zinc Inhibits HIF-Prolyl Hydroxylase Inhibitor-Aggravated VSMC Calcification Induced by High Phosphate. Front Physiol 2019;10:1584. [PMID: 32009983 DOI: 10.3389/fphys.2019.01584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
644 Li W, Lu Y, Lou Y, Zhao S, Cui W, Wang Y, Luo M, Sun J, Miao L. FFNT25 ameliorates unilateral ureteral obstruction-induced renal fibrosis. Ren Fail 2019;41:419-26. [PMID: 31140898 DOI: 10.1080/0886022X.2019.1612430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
645 Xu HY, Yang ZG, Zhang Y, Peng WL, Xia CC, Li ZL, He Y, Xu R, Rao L, Peng Y, Li YM, Gao HL, Guo YK. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging. BMC Cardiovasc Disord 2020;20:12. [PMID: 31924159 DOI: 10.1186/s12872-019-01313-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
646 Feng P, Wang G, Yu Q, Zhu W, Zhong C. First-trimester blood urea nitrogen and risk of gestational diabetes mellitus. J Cell Mol Med 2020;24:2416-22. [PMID: 31925909 DOI: 10.1111/jcmm.14924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
647 Mohanty NK, Sahoo KC, Pati S, Sahu AK, Mohanty R. Prevalence of Chronic Kidney Disease in Cuttack District of Odisha, India. Int J Environ Res Public Health 2020;17:E456. [PMID: 31936746 DOI: 10.3390/ijerph17020456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
648 Renczés E, Marônek M, Gaál Kovalčíková A, Vavrincová-Yaghi D, Tóthová L, Hodosy J. Behavioral Changes During Development of Chronic Kidney Disease in Rats. Front Med (Lausanne) 2019;6:311. [PMID: 31998731 DOI: 10.3389/fmed.2019.00311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
649 Ma X, Yu M, Hao C, Yang W. Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach. Evid Based Complement Alternat Med 2020;2020:1027271. [PMID: 32025234 DOI: 10.1155/2020/1027271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
650 Khamis SSA, Yassein YS, Zorkany KMAE, Mousa WA, Kora ASA, Ragheb A. Study the Role of Lung Ultrasound in Assessment of Subclinical Fluid Overload in Maintenance Hemodialysis Patients with Intra-Dialytic Hypertension. OJNeph 2020;10:199-211. [DOI: 10.4236/ojneph.2020.103019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
651 Liu P, Quinn RR, Karim ME, Bello A, Tam-Tham H, Weaver R, Ronksley PE, Quan H, Strippoli GFM, Manns B, Hemmelgarn BR, Tonelli M, Ravani P. Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study. CMAJ 2019;191:E274-82. [PMID: 30858183 DOI: 10.1503/cmaj.181372] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
652 Kaito S, Taniguchi Y, Kitamura A, Seino S, Amano H, Yokoyama Y, Fukuda H, Yokokawa H, Fujiwara Y, Shinkai S, Naito T. Trajectories of kidney function and associated factors among community-dwelling older Japanese: a 16-year longitudinal study. Clin Exp Nephrol 2020;24:330-8. [PMID: 31875938 DOI: 10.1007/s10157-019-01837-z] [Reference Citation Analysis]
653 Van JAD, Clotet-Freixas S, Zhou J, Batruch I, Sun C, Glogauer M, Rampoldi L, Elia Y, Mahmud FH, Sochett E, Diamandis EP, Scholey JW, Konvalinka A. Peptidomic Analysis of Urine from Youths with Early Type 1 Diabetes Reveals Novel Bioactivity of Uromodulin Peptides In Vitro. Mol Cell Proteomics 2020;19:501-17. [PMID: 31879271 DOI: 10.1074/mcp.RA119.001858] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
654 Smilowitz NR, Bhandari N, Berger JS. Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease. Atherosclerosis 2020;297:149-56. [PMID: 31948675 DOI: 10.1016/j.atherosclerosis.2019.12.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
655 Wu D, Zhou Y, Pan Y, Li C, Wang Y, Chen F, Chen X, Yang S, Zhou Z, Liao Y, Qiu Z. Vaccine Against PCSK9 Improved Renal Fibrosis by Regulating Fatty Acid β-Oxidation. J Am Heart Assoc 2020;9:e014358. [PMID: 31870234 DOI: 10.1161/JAHA.119.014358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
656 Sirolli V, Pieroni L, Di Liberato L, Urbani A, Bonomini M. Urinary Peptidomic Biomarkers in Kidney Diseases. Int J Mol Sci 2019;21:E96. [PMID: 31877774 DOI: 10.3390/ijms21010096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
657 Kakitapalli Y, Ampolu J, Madasu SD, Sai Kumar MLS. Detailed Review of Chronic Kidney Disease. Kidney Dis (Basel) 2020;6:85-91. [PMID: 32309290 DOI: 10.1159/000504622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
658 Zhao J, Hinton P, Chen J, Jiang J. Causal inference for the effect of environmental chemicals on chronic kidney disease. Comput Struct Biotechnol J 2020;18:93-9. [PMID: 31934310 DOI: 10.1016/j.csbj.2019.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
659 Duong TV, Wu PY, Yang E, Lin YF, Chiou HY, Yang SH. Associations of Waist Circumference, Socioeconomic, Environmental, and Behavioral Factors with Chronic Kidney Disease in Normal Weight, Overweight, and Obese People. Int J Environ Res Public Health 2019;16:E5093. [PMID: 31847161 DOI: 10.3390/ijerph16245093] [Reference Citation Analysis]
660 de Haan A, Eijgelsheim M, Vogt L, Knoers NVAM, de Borst MH. Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown Etiology. Front Genet 2019;10:1264. [PMID: 31921302 DOI: 10.3389/fgene.2019.01264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
661 Lanthier L, Huard G, Plourde MÉ, Cauchon M. [In patients with type 2 diabetes and diabetic nephropathy with albuminuria, what is the effect of SGLT2 inhibitor canagliflozin on renal and cardiovascular outcomes?]. Rev Med Interne 2020;41:67-8. [PMID: 31812446 DOI: 10.1016/j.revmed.2019.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
662 Peng S, Shen F, Wen A, Wang L, Fan Y, Liu X, Liu H. Detecting Lifestyle Risk Factors for Chronic Kidney Disease With Comorbidities: Association Rule Mining Analysis of Web-Based Survey Data. J Med Internet Res 2019;21:e14204. [PMID: 31821152 DOI: 10.2196/14204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
663 Hendriks FK, Smeets JSJ, van der Sande FM, Kooman JP, van Loon LJC. Dietary Protein and Physical Activity Interventions to Support Muscle Maintenance in End-Stage Renal Disease Patients on Hemodialysis. Nutrients 2019;11:E2972. [PMID: 31817402 DOI: 10.3390/nu11122972] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
664 Shi Z, Zhang M, Liu J. Chili Intake Is Inversely Associated with Chronic Kidney Disease among Adults: A Population-Based Study. Nutrients 2019;11:E2949. [PMID: 31817083 DOI: 10.3390/nu11122949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
665 Geng TT, Talaei M, Jafar TH, Yuan JM, Koh WP. Pulse Pressure and the Risk of End-Stage Renal Disease Among Chinese Adults in Singapore: The Singapore Chinese Health Study. J Am Heart Assoc 2019;8:e013282. [PMID: 31766974 DOI: 10.1161/JAHA.119.013282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
666 Da Rocha KT, Figueiredo AE. Letramento em saúde: avaliação de pacientes em terapia renal substitutiva. Enferm Nefrol 2019;22:388-97. [DOI: 10.4321/s2254-28842019000400005] [Reference Citation Analysis]
667 Anand A, Aoyagi H. A High Throughput Isolation Method for Phosphate-Accumulating Organisms. Sci Rep 2019;9:18083. [PMID: 31792245 DOI: 10.1038/s41598-019-53429-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
668 Rosiello G, Capitanio U, Larcher A. Acute kidney injury after partial nephrectomy: transient or permanent kidney damage?-Impact on long-term renal function. Ann Transl Med 2019;7:S317. [PMID: 32016035 DOI: 10.21037/atm.2019.09.156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
669 Kopić V, Barbić J, Petrović S, Šahinović I, Mihaljević D, Kopić A, Bošnjak A. PERIODONTAL DISEASE IN DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE. Acta Clin Croat 2019;58:709-15. [PMID: 32595256 DOI: 10.20471/acc.2019.58.04.18] [Reference Citation Analysis]
670 Tang S, Xiao X. Ferroptosis and kidney diseases. Int Urol Nephrol 2020;52:497-503. [PMID: 31768804 DOI: 10.1007/s11255-019-02335-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
671 Zhao L, Hu C, Zhang P, Jiang H, Chen J. Melatonin preconditioning is an effective strategy for mesenchymal stem cell-based therapy for kidney disease. J Cell Mol Med. 2020;24:25-33. [PMID: 31747719 DOI: 10.1111/jcmm.14769] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
672 O'Sullivan J, Finnie SL, Teenan O, Cairns C, Boyd A, Bailey MA, Thomson A, Hughes J, Bénézech C, Conway BR, Denby L. Refining the Mouse Subtotal Nephrectomy in Male 129S2/SV Mice for Consistent Modeling of Progressive Kidney Disease With Renal Inflammation and Cardiac Dysfunction. Front Physiol 2019;10:1365. [PMID: 31803059 DOI: 10.3389/fphys.2019.01365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
673 Zhou D, Fu H, Han Y, Zhang L, Liu S, Lin L, Stolz DB, Liu Y. Sonic hedgehog connects podocyte injury to mesangial activation and glomerulosclerosis. JCI Insight 2019;4:130515. [PMID: 31647783 DOI: 10.1172/jci.insight.130515] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
674 Storelli F, Samer C, Reny JL, Desmeules J, Daali Y. Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives. Clin Pharmacokinet. 2018;57:1267-1293. [PMID: 29667038 DOI: 10.1007/s40262-018-0650-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
675 Gaultier GN, McCready W, Ulanova M. The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease. BMC Immunol 2019;20:41. [PMID: 31718534 DOI: 10.1186/s12865-019-0325-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
676 Li N, Cui Y, Yin M, Liu F. Screening potential prognostic biomarkers of long non-coding RNAs for predicting the risk of chronic kidney disease. Braz J Med Biol Res 2019;52:e8333. [PMID: 31721901 DOI: 10.1590/1414-431X20198333] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
677 El Hussein MT, Kilfoil L. Managing End-Stage Renal Disease: An Alphabetized Mnemonic Strategy. The Journal for Nurse Practitioners 2019;15:732-6. [DOI: 10.1016/j.nurpra.2019.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
678 Marchelek-Myśliwiec M, Dziedziejko V, Nowosiad-Magda M, Wiśniewska M, Safranow K, Pawlik A, Domański L, Dołęgowska K, Dołęgowska B, Stępniewska J, Ciechanowski K. Bone Metabolism Parameters in Hemodialysis Patients With Chronic Kidney Disease and in Patients After Kidney Transplantation. Physiol Res 2019;68:947-54. [PMID: 31647290 DOI: 10.33549/physiolres.934118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
679 Arjunan A, Jeelani MS, Docherty S, Taylor J. Chronic kidney disease referrals from general practitioners pre- and post National Institute for Health and Care Excellence guidance 2014. Clin Med (Lond) 2019;19:490-3. [PMID: 31641066 DOI: 10.7861/clinmed.2019-0105] [Reference Citation Analysis]
680 Massy ZA, Liabeuf S. From old uraemic toxins to new uraemic toxins: place of 'omics'. Nephrol Dial Transplant 2018;33:iii2-5. [PMID: 30281133 DOI: 10.1093/ndt/gfy212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
681 Radišić Biljak V, Grubb A, Guerra IC, Cavalier E, Raymondo S, Sierra-Amor R, Mussap M, Kamathan SN, Yucel D, Datta P, Wada T, Alcantara FF. The first step in creating national Chronic Kidney Disease (CKD) guidelines - a questionnaire. Biochem Med (Zagreb) 2019;29:030301. [PMID: 31379457 DOI: 10.11613/BM.2019.030301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
682 Rao ZZ, Gu HQ, Wang XW, Xie XW, Yang X, Wang CJ, Zhao X, Xian Y, Wang YL, Li ZX, Xiao RP, Wang YJ; Chinese Stroke Center Alliance investigators. Renal Dysfunction and In-Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy. J Am Heart Assoc 2019;8:e012052. [PMID: 31595836 DOI: 10.1161/JAHA.119.012052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
683 Wang J, Fu D, Senouthai S, You Y. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury. Mol Med Rep 2019;20:5134-44. [PMID: 31638199 DOI: 10.3892/mmr.2019.10733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
684 Pizarro MH, Santos DC, Melo LGN, Barros BSV, Muniz LH, Porto LC, Silva DA, Gomes MB. Influence of genomic ancestry and self-reported color-race in CKD in a nationwide admixed sample of Brazilian patients with type 1 diabetes. Diabetes Metab Syndr Obes 2019;12:1831-40. [PMID: 31571958 DOI: 10.2147/DMSO.S210585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
685 Jacob SR, Raveendran R, Kannan S. Causes, comorbidities and current status of chronic kidney disease: A community perspective from North Kerala. J Family Med Prim Care 2019;8:2859-63. [PMID: 31681656 DOI: 10.4103/jfmpc.jfmpc_478_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
686 Park M, Lee SM, Yoon HJ. Association between alcohol intake and measures of incident CKD: An analysis of nationwide health screening data. PLoS One 2019;14:e0222123. [PMID: 31539384 DOI: 10.1371/journal.pone.0222123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
687 Cobbaert CM, Arslan F, Caballé Martín I, Serra AA, Picó-Plana E, Sánchez-Margalet V, Carmona-Fernández A, Burden J, Ziegler A, Bechel W. Automated urinalysis combining physicochemical analysis, on-board centrifugation, and digital imaging in one system: A multicenter performance evaluation of the cobas 6500 urine work area. Pract Lab Med 2019;17:e00139. [PMID: 31649991 DOI: 10.1016/j.plabm.2019.e00139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
688 Liu X, Zhang B, Huang S, Wang F, Zheng L, Lu J, Zeng Y, Chen J, Li S. Metabolomics Analysis Reveals the Protection Mechanism of Huangqi-Danshen Decoction on Adenine-Induced Chronic Kidney Disease in Rats. Front Pharmacol 2019;10:992. [PMID: 31551789 DOI: 10.3389/fphar.2019.00992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
689 Chertow GM, Pergola PE, Chen F, Kirby BJ, Sundy JS, Patel UD; GS-US-223-1015 Investigators. Effects of Selonsertib in Patients with Diabetic Kidney Disease. J Am Soc Nephrol 2019;30:1980-90. [PMID: 31506292 DOI: 10.1681/ASN.2018121231] [Cited by in Crossref: 28] [Cited by in F6Publishing: 42] [Article Influence: 9.3] [Reference Citation Analysis]
690 Hu L, Tian K, Zhang T, Fan CH, Zhou P, Zeng D, Zhao S, Li LS, Smith HS, Li J, Ran JH. Cyanate Induces Oxidative Stress Injury and Abnormal Lipid Metabolism in Liver through Nrf2/HO-1. Molecules 2019;24:E3231. [PMID: 31491954 DOI: 10.3390/molecules24183231] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
691 Shin SH, Wendland MF, Zhang B, Tran A, Tang A, Vandsburger MH. Noninvasive imaging of renal urea handling by CEST-MRI. Magn Reson Med 2020;83:1034-44. [PMID: 31483529 DOI: 10.1002/mrm.27968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
692 Qin L, Gabazza EC. Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges. Int J Mol Sci 2019;20:E4313. [PMID: 31484418 DOI: 10.3390/ijms20174313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
693 Tan J, Luo L, Zhang M, Chen H, Zhang D, Dong C, Xia B, Fu L, Tang F, Liu X, Tan Q, Wu Y. A Chinese and Western medication adherence scale in patients with Chronic Kidney Disease. Patient Prefer Adherence 2019;13:1487-95. [PMID: 31507316 DOI: 10.2147/PPA.S207693] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
694 Kanlaya R, Thongboonkerd V. Molecular Mechanisms of Epigallocatechin-3-Gallate for Prevention of Chronic Kidney Disease and Renal Fibrosis: Preclinical Evidence. Curr Dev Nutr 2019;3:nzz101. [PMID: 31555758 DOI: 10.1093/cdn/nzz101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
695 Czaya B, Faul C. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia. Int J Mol Sci 2019;20:E4195. [PMID: 31461904 DOI: 10.3390/ijms20174195] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
696 Palomino J, Echavarria R, Franco-Acevedo A, Moreno-Carranza B, Melo Z. Opioids Preconditioning Upon Renal Function and Ischemia-Reperfusion Injury: A Narrative Review. Medicina (Kaunas) 2019;55:E522. [PMID: 31443610 DOI: 10.3390/medicina55090522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
697 Mwenda V, Githuku J, Gathecha G, Wambugu BM, Roka ZG, Ong'or WO. Prevalence and factors associated with chronic kidney disease among medical inpatients at the Kenyatta National Hospital, Kenya, 2018: a cross-sectional study. Pan Afr Med J 2019;33:321. [PMID: 31692795 DOI: 10.11604/pamj.2019.33.321.18114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
698 Zhang Y, Liu Y, Bi X, Hu C, Ding F, Ding W. Therapeutic Approaches in Mitochondrial Dysfunction, Inflammation, and Autophagy in Uremic Cachexia: Role of Aerobic Exercise. Mediators Inflamm 2019;2019:2789014. [PMID: 31530994 DOI: 10.1155/2019/2789014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
699 Fukuma S, Ikenoue T, Sasaki S, Saigusa Y, Misumi T, Saito Y, Yamada Y, Goto R, Taguri M. Nudging patients with chronic kidney disease at screening to visit physicians: A protocol of a pragmatic randomized controlled trial. Contemp Clin Trials Commun 2019;16:100429. [PMID: 31497673 DOI: 10.1016/j.conctc.2019.100429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
700 Santin F, Canella D, Borges C, Lindholm B, Avesani CM. Dietary Patterns of Patients with Chronic Kidney Disease: The Influence of Treatment Modality. Nutrients 2019;11:E1920. [PMID: 31443269 DOI: 10.3390/nu11081920] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
701 Wang G, Ouyang J, Li S, Wang H, Lian B, Liu Z, Xie L. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases. J Transl Med 2019;17:264. [PMID: 31409386 DOI: 10.1186/s12967-019-2016-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 7.7] [Reference Citation Analysis]
702 Forné C, Cambray S, Bermudez-Lopez M, Fernandez E, Bozic M, Valdivielso JM; NEFRONA investigators . Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease. Clin Kidney J 2020;13:631-9. [PMID: 32905292 DOI: 10.1093/ckj/sfz094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
703 Nikkinen O, Nieminen T, Alahuhta S, Ohtonen P, Vakkala M. Chronic kidney disease and acute kidney injury in arthroplasty patients over 65 years of age. Acta Anaesthesiol Scand 2019;63:859-70. [PMID: 30888058 DOI: 10.1111/aas.13352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
704 Kang H, Hong SH. Risk of Kidney Dysfunction from Polypharmacy among Older Patients: A Nested Case-Control Study of the South Korean Senior Cohort. Sci Rep 2019;9:10440. [PMID: 31320704 DOI: 10.1038/s41598-019-46849-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
705 Borges Bonan N, Schepers E, Pecoits-Filho R, Dhondt A, Pletinck A, De Somer F, Vanholder R, Van Biesen W, Moreno-Amaral A, Glorieux G. Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease. Sci Rep 2019;9:10236. [PMID: 31308443 DOI: 10.1038/s41598-019-46724-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
706 Trudzinski FC, Alqudrah M, Omlor A, Zewinger S, Fliser D, Speer T, Seiler F, Biertz F, Koch A, Vogelmeier C, Welte T, Watz H, Waschki B, Fähndrich S, Jörres R, Bals R; German COSYCONET consortium. Consequences of chronic kidney disease in chronic obstructive pulmonary disease. Respir Res 2019;20:151. [PMID: 31299972 DOI: 10.1186/s12931-019-1107-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
707 Kitamura M, Mochizuki Y, Miyata Y, Obata Y, Mitsunari K, Matsuo T, Ohba K, Mukae H, Yoshimura A, Nishino T, Sakai H. Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation. Int J Mol Sci 2019;20:E3413. [PMID: 31336777 DOI: 10.3390/ijms20143413] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
708 Cheng CW, Wang CH, Chen WS, Wang CC, Cherng WJ. Predictors of long-term survival prior to permanent pacemaker implantation in octogenarians or older. Aging Clin Exp Res 2019;31:1001-9. [PMID: 30259339 DOI: 10.1007/s40520-018-1044-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
709 Guo Y, Ma J, Xiao L, Fang J, Li G, Zhang L, Xu L, Lai X, Pan G, Chen Z. Identification of key pathways and genes in different types of chronic kidney disease based on WGCNA. Mol Med Rep 2019;20:2245-57. [PMID: 31257514 DOI: 10.3892/mmr.2019.10443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
710 Hagiyama M, Nakatani Y, Takashima Y, Kato T, Inoue T, Kimura R, Otani T, Sato Y, Mori H, Arima S, Ito A. Urinary Cell Adhesion Molecule 1 Is a Novel Biomarker That Links Tubulointerstitial Damage to Glomerular Filtration Rates in Chronic Kidney Disease. Front Cell Dev Biol 2019;7:111. [PMID: 31316980 DOI: 10.3389/fcell.2019.00111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
711 Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Kobayashi M, Minoura A, Ikeda K, Ozaki E, Hoshino H, Kokaze A. Association of the combination of weight gain after 20 years of age and current obesity with chronic kidney disease in Japan: a cross-sectional study. BMJ Open 2019;9:e027752. [PMID: 31230014 DOI: 10.1136/bmjopen-2018-027752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
712 Balla J, Balla G, Zarjou A. Ferritin in Kidney and Vascular Related Diseases: Novel Roles for an Old Player. Pharmaceuticals (Basel) 2019;12:E96. [PMID: 31234273 DOI: 10.3390/ph12020096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
713 Hsu YH, Chuang HC, Lee YH, Lin YF, Chiu YJ, Wang YL, Wu MS, Chiu HW. Induction of Fibrosis and Autophagy in Kidney Cells by Vinyl Chloride. Cells 2019;8:E601. [PMID: 31212930 DOI: 10.3390/cells8060601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
714 Morii K, Yamasaki S, Doi S, Irifuku T, Sasaki K, Doi T, Nakashima A, Arihiro K, Masaki T. microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress. PLoS One 2019;14:e0218468. [PMID: 31199854 DOI: 10.1371/journal.pone.0218468] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
715 Li F, Wang M, Wang J, Li R, Zhang Y. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease. Front Cell Infect Microbiol 2019;9:206. [PMID: 31245306 DOI: 10.3389/fcimb.2019.00206] [Cited by in Crossref: 36] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
716 Gomes MB, Santos DC, Pizarro MH, Melo LGN, Barros BSV, Montenegro R Jr, Fernandes V, Negrato CA. Relationship between health care insurance status, social determinants and prevalence of diabetes-related microvascular complications in patients with type 1 diabetes: a nationwide survey in Brazil. Acta Diabetol 2019;56:697-705. [PMID: 30868316 DOI: 10.1007/s00592-019-01308-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
717 Feng YL, Cao G, Chen DQ, Vaziri ND, Chen L, Zhang J, Wang M, Guo Y, Zhao YY. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mol Life Sci 2019;76:4961-78. [PMID: 31147751 DOI: 10.1007/s00018-019-03155-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 81] [Article Influence: 16.0] [Reference Citation Analysis]
718 Yamakado S, Cho H, Inada M, Morikawa M, Jiang YH, Saito K, Nakaishi K, Watabe S, Takagi H, Kaneda M, Nakatsuma A, Ninomiya M, Imachi H, Arai T, Yoshimoto T, Murao K, Chang JH, Chen SM, Shih YC, Zeng MJ, Ke LY, Chen CH, Yoshimura T, Miura T, Ito E. Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy. BMJ Open Diabetes Res Care 2019;7:e000661. [PMID: 31245009 DOI: 10.1136/bmjdrc-2019-000661] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
719 Fujiyoshi A, Miura K, Ohkubo T, Miyagawa N, Saito Y, Miyazawa I, Shiino A, Kadota A, Kadowaki S, Hisamatsu T, Torii S, Takashima N, Tooyama I, Ueshima H. Proteinuria and Reduced Estimated Glomerular Filtration Rate are Independently Associated With Lower Cognitive Abilities in Apparently Healthy Community-Dwelling Elderly Men in Japan: A Cross-sectional Study. J Epidemiol 2020;30:244-52. [PMID: 31130560 DOI: 10.2188/jea.JE20180258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
720 Zhang C, He X, Murphy SR, Zhang H, Wang S, Ge Y, Gao W, Williams JM, Geurts AM, Roman RJ, Fan F. Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury. J Pharmacol Exp Ther 2019;370:206-17. [PMID: 31118214 DOI: 10.1124/jpet.119.258954] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
721 Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ. Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health Study. Am J Kidney Dis 2019;74:501-9. [PMID: 31128770 DOI: 10.1053/j.ajkd.2019.02.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
722 Cameron-Christie S, Wolock CJ, Groopman E, Petrovski S, Kamalakaran S, Povysil G, Vitsios D, Zhang M, Fleckner J, March RE, Gelfman S, Marasa M, Li Y, Sanna-Cherchi S, Kiryluk K, Allen AS, Fellström BC, Haefliger C, Platt A, Goldstein DB, Gharavi AG. Exome-Based Rare-Variant Analyses in CKD. J Am Soc Nephrol 2019;30:1109-22. [PMID: 31085678 DOI: 10.1681/ASN.2018090909] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
723 Wang Z, Wang S, Zhao J, Yu C, Hu Y, Tu Y, Yang Z, Zheng J, Wang Y, Gao Y. Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats. Int J Med Sci 2019;16:644-53. [PMID: 31217731 DOI: 10.7150/ijms.31075] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
724 Ren Q, Shi Q, Ma T, Wang J, Li Q, Li X. Quality of life, symptoms, and sleep quality of elderly with end-stage renal disease receiving conservative management: a systematic review. Health Qual Life Outcomes 2019;17:78. [PMID: 31053092 DOI: 10.1186/s12955-019-1146-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
725 Heaney LM, Davies OG, Selby NM. Gut microbial metabolites as mediators of renal disease: do short-chain fatty acids offer some hope? Future Sci OA 2019;5:FSO384. [PMID: 31114707 DOI: 10.4155/fsoa-2019-0013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
726 Peng S, He J, Huang J, Lun L, Zeng J, Zeng S, Zhang, Liu X, Wu Y. Self-management interventions for chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol 2019;20:142. [PMID: 31027481 DOI: 10.1186/s12882-019-1309-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
727 Nogueira PCK, Konstantyner T, Carvalho MFC, Pinto CCX, Paz IP, Belangero VMS, Tavares MS, Garcia CD, Neto OAF, Zuntini KLDCR, Lordelo MDR, Oi SSP, Damasceno RT, Sesso R. Development of a risk score for earlier diagnosis of chronic kidney disease in children. PLoS One 2019;14:e0215100. [PMID: 31002677 DOI: 10.1371/journal.pone.0215100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
728 Fiedler GM, Vogt B. [Laboratory tests for kidney disease]. Internist (Berl) 2019;60:485-501. [PMID: 30997523 DOI: 10.1007/s00108-019-0598-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
729 Montes-Rivera J, Arellano-Mendoza M, Nájera N, Del Valle-Mondragón L, Villarreal F, Rubio-Gayosso I, Perez-Duran J, Meaney E, Ceballos G. Effect of (-)-epicatechin on the modulation of progression markers of chronic renal damage in a 5/6 nephrectomy experimental model. Heliyon 2019;5:e01512. [PMID: 31025018 DOI: 10.1016/j.heliyon.2019.e01512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
730 Kim GS, Oh HH, Kim SH, Kim BO, Byun YS. Association between prediabetes (defined by HbA1C, fasting plasma glucose, and impaired glucose tolerance) and the development of chronic kidney disease: a 9-year prospective cohort study. BMC Nephrol 2019;20:130. [PMID: 30992067 DOI: 10.1186/s12882-019-1307-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
731 Olcucuoglu E, Tonyali S, Tastemur S, Kasap Y, Sirin ME, Gazel E, Olcucuoglu E, Odabas O, Ates C, Olcucu MT. Comparison of long-term kidney functions after radical nephrectomy and simple nephrectomy. PeerJ 2019;7:e6701. [PMID: 30997287 DOI: 10.7717/peerj.6701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
732 Chan TC, Zhang Z, Lin BC, Lin C, Deng HB, Chuang YC, Chan JWM, Jiang WK, Tam T, Chang LY, Hoek G, Lau AKH, Lao XQ. Long-Term Exposure to Ambient Fine Particulate Matter and Chronic Kidney Disease: A Cohort Study. Environ Health Perspect 2018;126:107002. [PMID: 30392394 DOI: 10.1289/EHP3304] [Cited by in Crossref: 52] [Cited by in F6Publishing: 69] [Article Influence: 17.3] [Reference Citation Analysis]
733 Kosa SD, Monize J, Leenus A, Leenus S, Samra S, Szwiega S, Shi D, Valvasori S, Gafni A, Lok CE, Thabane L. Reporting quality of pilot clinical trials in chronic kidney disease patients on hemodialysis: a methodological survey. Pilot Feasibility Stud 2019;5:53. [PMID: 30997141 DOI: 10.1186/s40814-019-0436-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
734 Chen DQ, Cao G, Chen H, Argyopoulos CP, Yu H, Su W, Chen L, Samuels DC, Zhuang S, Bayliss GP, Zhao S, Yu XY, Vaziri ND, Wang M, Liu D, Mao JR, Ma SX, Zhao J, Zhang Y, Shang YQ, Kang H, Ye F, Cheng XH, Li XR, Zhang L, Meng MX, Guo Y, Zhao YY. Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan. Nat Commun 2019;10:1476. [PMID: 30931940 DOI: 10.1038/s41467-019-09329-0] [Cited by in Crossref: 66] [Cited by in F6Publishing: 105] [Article Influence: 22.0] [Reference Citation Analysis]
735 Zhao J, Zhang QL, Shen JH, Wang K, Liu J. Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy. Acta Pharmacol Sin 2019;40:507-13. [PMID: 29941869 DOI: 10.1038/s41401-018-0029-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
736 Chen Y, Lin L, Tao X, Song Y, Cui J, Wan J. The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis. BMC Nephrol 2019;20:106. [PMID: 30922260 DOI: 10.1186/s12882-019-1298-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
737 Chen L, Chen DQ, Liu JR, Zhang J, Vaziri ND, Zhuang S, Chen H, Feng YL, Guo Y, Zhao YY. Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Exp Mol Med 2019;51:1-18. [PMID: 30918245 DOI: 10.1038/s12276-019-0234-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
738 Vivante A, Skorecki K. Introducing routine genetic testing for patients with CKD. Nat Rev Nephrol 2019;15:321-2. [PMID: 30903026 DOI: 10.1038/s41581-019-0140-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
739 Gupta AK, Coburn JM, Davis-Knowlton J, Kimmerling E, Kaplan DL, Oxburgh L. Scaffolding kidney organoids on silk. J Tissue Eng Regen Med 2019;13:812-22. [PMID: 30793851 DOI: 10.1002/term.2830] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
740 Sueyoshi M, Fukunaga M, Mei M, Nakajima A, Tanaka G, Murase T, Narita Y, Hirata S, Kadowaki D. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats. Clin Exp Nephrol 2019;23:908-19. [PMID: 30895529 DOI: 10.1007/s10157-019-01727-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
741 Sugiyama S, Jinnouchi H, Yoshida A, Hieshima K, Kurinami N, Jinnouchi K, Tanaka M, Suzuki T, Miyamoto F, Kajiwara K, Jinnouchi T. Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center. J Clin Med Res 2019;11:267-74. [PMID: 30937117 DOI: 10.14740/jocmr3761] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
742 Yang M, Lao L. Emerging Applications of Metabolomics in Traditional Chinese Medicine Treating Hypertension: Biomarkers, Pathways and More. Front Pharmacol 2019;10:158. [PMID: 30906260 DOI: 10.3389/fphar.2019.00158] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
743 Choi HR, Oh TK, Kim J, Jeon YT. Analgesia after major laparoscopic surgery in patients with chronic kidney disease: A retrospective cohort study. Sci Rep 2019;9:3939. [PMID: 30850670 DOI: 10.1038/s41598-019-40627-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
744 Sattar S, Ahmed N, Akhter Z, Aijaz S, Lakhani S, Malik R, Pathan A. In-Hospital outcomes in acute coronary syndrome patients with concomitant severe chronic kidney disease undergoing percutaneous coronary intervention. Pak J Med Sci 2019;35:291-7. [PMID: 31086503 DOI: 10.12669/pjms.35.2.276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
745 Guo C, Li S, Rao XR. New Goals and Strategies of Chinese Medicine in Prevention and Treatment of Chronic Kidney Disease. Chin J Integr Med 2019;25:163-7. [PMID: 30815804 DOI: 10.1007/s11655-019-3065-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
746 Liu H, Lü Z, Tian C, Ouyang W, Xiong Y, You Y, Chen L, Deng Y, Zhao X, Sun X. [Mechanism of Shenbing decoction Ⅲ in the treatment of proteinuria in chronic kidney disease: a network pharmacology-based study]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:227-34. [PMID: 30890513 DOI: 10.12122/j.issn.1673-4254.2019.02.16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
747 Umapathy S, Nasimsha N, Kumar M, Kalidoss R, Thomas AC, Lakshmi M, Gafoor ER. Design and development of portable prototype for human breath analysis: a comparative study between haemodialysis patients and healthy subjects. Biomed Phys Eng Express 2019;5:025045. [DOI: 10.1088/2057-1976/ab005c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
748 Lin P, Wu M, Qin J, Yang J, Ye C, Wang C. Magnesium lithospermate B improves renal hemodynamics and reduces renal oxygen consumption in 5/6th renal ablation/infarction rats. BMC Nephrol 2019;20:49. [PMID: 30755161 DOI: 10.1186/s12882-019-1221-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
749 Zhao J, Gu S, McDermaid A. Predicting outcomes of chronic kidney disease from EMR data based on Random Forest Regression. Math Biosci 2019;310:24-30. [PMID: 30768948 DOI: 10.1016/j.mbs.2019.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
750 Mun KH, Yu GI, Choi BY, Kim MK, Shin MH, Shin DH. Association of Dietary Potassium Intake with the Development of Chronic Kidney Disease and Renal Function in Patients with Mildly Decreased Kidney Function: The Korean Multi-Rural Communities Cohort Study. Med Sci Monit 2019;25:1061-70. [PMID: 30733429 DOI: 10.12659/MSM.913504] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
751 Aucella F, Corsonello A, Leosco D, Brunori G, Gesualdo L, Antonelli-Incalzi R. Beyond chronic kidney disease: the diagnosis of Renal Disease in the Elderly as an unmet need. A position paper endorsed by Italian Society of Nephrology (SIN) and Italian Society of Geriatrics and Gerontology (SIGG). J Nephrol 2019;32:165-76. [PMID: 30659521 DOI: 10.1007/s40620-019-00584-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
752 Acharya UR, Meiburger KM, Koh JEW, Hagiwara Y, Oh SL, Leong SS, Ciaccio EJ, Wong JHD, Shah MNM, Molinari F, Ng KH. Automated detection of chronic kidney disease using higher-order features and elongated quinary patterns from B-mode ultrasound images. Neural Comput & Applic 2020;32:11163-72. [DOI: 10.1007/s00521-019-04025-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
753 Mannocci A, Ciarlo I, D'Egidio V, Del Cimmuto A, de Giusti M, Villari P, La Torre G. Socioeconomic Deprivation Status and Air Pollution by PM10 and NO2: An Assessment at Municipal Level of 11 Years in Italy. J Environ Public Health 2019;2019:2058467. [PMID: 30719049 DOI: 10.1155/2019/2058467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
754 Kanlaya R, Thongboonkerd V. Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases. Adv Nutr 2019;10:112-21. [PMID: 30615092 DOI: 10.1093/advances/nmy077] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
755 Liu X, Huang S, Wang F, Zheng L, Lu J, Chen J, Li S. Huangqi-Danshen Decoction Ameliorates Adenine-Induced Chronic Kidney Disease by Modulating Mitochondrial Dynamics. Evid Based Complement Alternat Med 2019;2019:9574045. [PMID: 30713579 DOI: 10.1155/2019/9574045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
756 Chironda G, Bhengu B. Barriers to management of Chronic Kidney Disease (CKD) CKD in a renal clinic in KwaZulu-Natal Province, South Africa – A qualitative study. International Journal of Africa Nursing Sciences 2019;10:116-23. [DOI: 10.1016/j.ijans.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
757 Min R, Wang H, Zhang X, Li X, Fang P, Bai X. Facing the urban-rural gap in patients with chronic kidney disease: Evidence from inpatients with urban or rural medical insurance in central China. PLoS One 2018;13:e0209259. [PMID: 30596680 DOI: 10.1371/journal.pone.0209259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
758 Angell B, Jha V. Universal Care for Kidney Diseases: Sustainable Development or Path to Financial Ruin? Kidney Int Rep 2019;4:361-4. [PMID: 30899860 DOI: 10.1016/j.ekir.2018.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
759 Corremans R, Vervaet BA, D'Haese PC, Neven E, Verhulst A. Metformin: A Candidate Drug for Renal Diseases. Int J Mol Sci 2018;20:E42. [PMID: 30583483 DOI: 10.3390/ijms20010042] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
760 Wei Z, Kwan BC, Chow KM, Cheng PM, Luk CC, Lai KB, Li PK, Szeto CC. Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases. BMC Nephrol 2018;19:367. [PMID: 30567508 DOI: 10.1186/s12882-018-1178-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
761 Ding J, Xing Z, Jiang Z, Zhou H, Di J, Chen J, Qiu J, Yu S, Zou L, Xing W. Evaluation of renal dysfunction using texture analysis based on DWI, BOLD, and susceptibility-weighted imaging. Eur Radiol 2019;29:2293-301. [PMID: 30560361 DOI: 10.1007/s00330-018-5911-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
762 Uhm JY, Kim HR, Kang GH, Choi YG, Park TH, Kim SY, Chang SS, Choo WO. The association between shift work and chronic kidney disease in manual labor workers using data from the Korea National Health and Nutrition Examination Survey (KNHANES 2011-2014). Ann Occup Environ Med 2018;30:69. [PMID: 30564370 DOI: 10.1186/s40557-018-0279-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
763 Wang M, Yang J, Zhou Y, Wang C. ShenShuai II Recipe Attenuates Apoptosis and Renal Fibrosis in Chronic Kidney Disease by Increasing Renal Blood Flow and Improving Oxygen Consumption. Evid Based Complement Alternat Med 2018;2018:7602962. [PMID: 30643536 DOI: 10.1155/2018/7602962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
764 Sharma SH, Pablo JL, Montesinos MS, Greka A, Hopkins CR. Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903. Bioorg Med Chem Lett 2019;29:155-9. [PMID: 30538066 DOI: 10.1016/j.bmcl.2018.12.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
765 Wan J, Li W, Zhong Y. Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism. J Clin Lab Anal 2019;33:e22696. [PMID: 30485538 DOI: 10.1002/jcla.22696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
766 Zheng Y, Wang NS, Liu YN, He LQ, Jian GH, Liu XS, Ni ZH, Cheng XH, Lin HL, Zhou WH, Wang YP, Fang JA, He YN, Yang HT, Zhao LJ, Ding HL, Wang LH, Yu RH, Li WG, Ye ZM, Guo W, Zhan YL, Mao HJ, Hu Z, Yao C, Cai GY, Chen XM. Effects of Niaoduqing Particles () on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study. Chin J Integr Med 2019;25:168-74. [PMID: 30467695 DOI: 10.1007/s11655-018-2998-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
767 Zheng Z, Hu H, Tong Y, Hu Z, Cao S, Shan C, Lin W, Yin Y, Li Z. MiR-27b regulates podocyte survival through targeting adenosine receptor 2B in podocytes from non-human primate. Cell Death Dis 2018;9:1133. [PMID: 30429458 DOI: 10.1038/s41419-018-1178-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
768 Qi R, Yang C. Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury. Cell Death Dis 2018;9:1126. [PMID: 30425237 DOI: 10.1038/s41419-018-1157-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 83] [Article Influence: 13.3] [Reference Citation Analysis]
769 George C, Matsha TE, Erasmus RT, Kengne AP. Haematological profile of chronic kidney disease in a mixed-ancestry South African population: a cross-sectional study. BMJ Open 2018;8:e025694. [PMID: 30391922 DOI: 10.1136/bmjopen-2018-025694] [Cited by in Crossref: 6] [